A 3-Phase, Data-Driven Protocol For An Overlooked Mechanism
In Aging, Chronic Disease, And Mental Health
Disclaimer: Step 6 is for educational purposes only. It does not diagnose, treat, or cure any disease, and it creates no physician-patient relationship. Within the SR™ program, Step 6 serves as a referral gate. The Burris Gut Health Checklist identifies when a client should be referred to an MD for testing and supervision. The checklist is completed at intake; when indicated, referral occurs at Step 6, or first for anyone too sick to work through SR™. Do not implement anything in it, including supplements or changes to medications such as antidepressants or PTSD medications, without your MD’s supervision. These statements have not been evaluated by the Food and Drug Administration. SR™ Practitioners provide a support role only and do not give medical advice.
Gut dysfunction and repair involve many interacting mechanisms, and even with more than 470 peer-reviewed references, this guide cannot cover all of them. It moves from why, to what to measure, to what to do. Statements marked (Author’s Observation) come from my own experience and have not yet been studied in published research.
SR™ is sequenced psychological first, physiological second, and for most people that order should hold. But SR™ can override a poor gut, and that is the danger. Through the 2000s, SR™ carried me through symptoms that, looking back, were signs of a failing gut. The gains were real, so I had no reason to look further. The first distinct symptoms appeared in 2009, and by 2013 I had crashed (see Why This Guide Exists: My Story). It took the next decade to trace the cascade to the mechanisms described in this guide. A poor gut can significantly slow progress in SR™ and wear away gains already made (Author’s Observation).
For this reason, we complete the Burris Gut Health Checklist at intake. If any score is 5 or above over the past 30 days, you will begin the SR™ Gut Barrier and Microbiome Restoration under your MD’s supervision.
When Step 6 Comes First: Some people are too sick to work through SR™. This includes people with anorexia and people sickened by medication. For them, Step 6 comes first under their MD’s supervision, and SR™ begins once they are well enough to engage.
For anyone with anorexia or another eating disorder, the fasting components of this protocol, including the Warrior/OMAD eating window in Phase 1 and the extended fasts in Phase 3, are not used. Step 6 must be adapted by an MD experienced in treating eating disorders.
For anyone sickened by medication, do not stop or change any medication on your own. Your MD decides whether and how medications are adjusted.
Quick Start: Complete the Burris Gut Health Checklist at intake, rating how you have felt over the past 30 days. If any score is 5 or above, begin the SR™ Gut Barrier and Microbiome Restoration, under your MD’s supervision. Read Test Do Not Guess to work with your MD on testing, then Assume And Implement before starting Phase 1.
I tell you this story in the hope that you will comprehend how insidious oxalate poisoning is, and why any noticeable physiological change, no matter how small, must be addressed.
In the late 1990s, I was a single father of a brilliant child who, at 19, after his software engineering training, asked me to help him take over a contract to build NetSyncLive, a program that synchronized television and the internet for live gameplay. I had introduced SR™ into psychiatric care in 1990, and by 1999 I was ready to launch the Burris Institute. I was still working in the film industry as a producer and actor to keep everything funded. 1999 was a hard year. I broke my ankle, and six months later I had major back surgery. During anesthesia I woke up and pulled out the intravenous line delivering the sedative. To say I was hit a lot harder with the sedatives afterward is an understatement. That, in combination with the antibiotics that followed, is what I believe made me vulnerable to oxalate poisoning. Holding multiple leadership positions at once was surely a contributing factor, but I do not believe it would have made me vulnerable on its own (Author’s Observation).
I felt off shortly after the surgery but could not pin it down. A decade later, at graduation ceremonies in 2009, the first distinct symptoms appeared. In November 2011, I passed large oxalate kidney stones. In mid-2012, I had a gallbladder attack. Instead of surgery, I did an olive oil flush and passed a wide variety of debris, including rock-hard emerald stones I could have made jewelry from. In January 2013, after cranking out about 500 sit-ups, I had a catastrophic event: I could not stand upright and had to crawl to the bathroom.
Over the next six years I burned through 30 MDs trying to get to the root of it. In 2016, a urologist who insisted on a cystoscopy gave me an infection so severe that I was sent to the ER six times and hospitalized five, on antibiotics the entire time. The last round came through a PICC line, and it was my last hope. The infection came back again. This time I was prepared with a regimen of therapeutic oregano oil. That was not a risk for me, because the only other option was worse. At that point I turned all of my research skills to gut health and posted a gut health checklist on Burris Connect. In the decade of data collected since, I have seen only one person who did not have gut health issues (Author’s Observation).
It took me another three years, until 2019, to get to the root of the problem, and another six to get ahead of the ongoing damage the oxalate crystals had done. Twenty years passed between the surgery that started it and the day I understood what was happening. Every symptom along the way had an explanation that was wrong. That is what insidious means.
Aging, chronic disease, and emotional suffering share a common thread that is only now coming into full scientific focus: the failure of the intestinal barrier. While researchers have long recognized that conditions such as cardiovascular disease, type 2 diabetes, neurodegeneration, autoimmune disorders, and depression involve persistent low-grade inflammation, the question of what drives that inflammation has remained open. A growing body of evidence now points to the intestinal epithelium as the convergence point where multiple upstream insults translate into systemic inflammatory disease.
The intestinal barrier is the body's largest interface with the external environment. Its integrity depends on a complex interplay of epithelial tight junction proteins, the mucus layer, commensal microbiota, short-chain fatty acid (SCFA) production, mucosal immune function, and mitochondrial energy metabolism within epithelial cells [1]. When this system functions properly, it allows selective nutrient absorption while preventing bacteria, endotoxins, and other harmful substances from entering the bloodstream. When it fails, the consequences are far-reaching.
Intestinal barrier dysfunction, commonly referred to as "leaky gut," allows the translocation of microbial components, particularly lipopolysaccharide (LPS), into the bloodstream. This triggers a cascade of immune activation and chronic, low-grade systemic inflammation that has been directly linked to the development and progression of metabolic, autoimmune, and aging-related disorders [2]. A 2024 review published in Internal and Emergency Medicine confirmed that barrier disruption, caused by bacterial infections, oxidative stress, alcohol exposure, and dysbiosis, is highly connected to conditions including obesity, non-alcoholic fatty liver disease, neurodegeneration, cardiovascular disease, and type 1 diabetes [2].
This process does not operate in isolation. The research consistently identifies a self-reinforcing cycle: age-related changes in the microbiome reduce populations of SCFA-producing bacteria (such as Faecalibacterium prausnitzii and Akkermansia muciniphila), which degrade the intestinal barrier, increase LPS translocation, drive systemic inflammation, and in turn worsen dysbiosis in a feed-forward loop [3, 4]. Intestinal permeability increases with age due specifically to microbial dysbiosis.
A 2023 review published in Disease Models & Mechanisms characterized intestinal barrier dysfunction as an evolutionarily conserved hallmark of aging [5]. The phenomenon termed "inflammaging," chronic, low-grade inflammation that arises in the absence of overt infection, is now understood to be tightly coupled to this age-related decline in the barrier.
What makes gut barrier dysfunction so central is that nearly every recognized driver of chronic disease and aging either damages the barrier directly or is amplified by its failure. The variables that converge on this single point include the following.
Microbiome Dysbiosis: Age-associated shifts in microbial composition, marked by losses in Clostridiales and Bifidobacterium and enrichment of Proteobacteria and pathobionts, reduce SCFA synthesis, degrade the mucus layer, and increase intestinal permeability [4, 6]. Depleted SCFA-producing bacteria also impair butyrate availability, the primary energy source for colonocytes and a critical regulator of tight junction integrity.
Mitochondrial Dysfunction: Maintenance of the epithelial barrier is energy-dependent. Mitochondrial dysfunction within intestinal epithelial cells, including impaired oxidative phosphorylation and excessive reactive oxygen species (ROS) production, disrupts tight junction proteins and compromises epithelial self-renewal capacity [1, 7]. ROS-induced barrier disruption has been shown to facilitate bacterial translocation even independent of cell death. Emerging research identifies mitochondrial dysfunction as both a consequence and a perpetuator of intestinal inflammation, establishing it as a key amplifier of the cycle [8].
Immune Senescence and Inflammaging: Immunosenescence, the age-related decline of immune function characterized by thymic involution, reduced hematopoietic stem cell output, and impaired adaptive immunity, both contributes to and is worsened by gut barrier failure [3].
Diet, Stress, and Circadian Disruption: The Western diet, psychological stress, alcohol exposure, circadian rhythm disruption, and antibiotic use are all recognized extrinsic disruptors of barrier integrity [2]. Oxidative stress from these exposures compounds the vicious cycle of intestinal permeability, chronic low-grade inflammation, increased pro-inflammatory cytokine production, enhanced ROS generation, and further barrier degradation.
The Gut-Brain Axis: Barrier dysfunction does not merely affect peripheral tissues. When microbial endotoxins enter systemic circulation, they increase blood-brain barrier permeability, activate microglia, and drive neuroinflammation [6, 9]. This mechanism has been linked to anxiety, depression, PTSD, and neurodegenerative diseases, including Alzheimer's disease [10, 11]. The dysregulation of the gut-brain axis through intestinal barrier failure represents a plausible biological substrate for the well-documented comorbidity of chronic physical disease and mental health disorders.
Candida, Oxalates, and Fungal Overgrowth: A weakened intestinal barrier creates conditions favorable for Candida translocation into the bloodstream and systemic infection. Simultaneously, when oxalate-reducing microbes are depleted through dysbiosis, oxalate crystals accumulate in tissue, irritate the intestinal lining, damage mitochondria, and further weaken the barrier, creating yet another self-reinforcing loop of damage and inflammation.
Inflammaging is usually explained by dysbiosis, a leaking barrier, senescent cells, and immune aging [3, 5]. Those are real, but two drivers that run through this entire document, oxalates and Candida, are missing from that list, and they are missing from the clinical workup as well. The connection is not speculative. Both of them trip the same alarm that defines inflammaging in older adults.
In 2025, the Make America Healthy Again (MAHA) initiative identified eight chronic diseases as the top focus areas for reducing the nation’s disease burden. We have added a ninth, mental health disorders, many of which are chronic and all of which are part of the gut barrier dysfunction equation. Together these form The SR™ Chronic 9. These conditions rarely occur in isolation. About 1 in 3 adults with diabetes has chronic kidney disease [460], and adults with diabetes are nearly twice as likely to have heart disease or stroke as adults without diabetes [461]. Each of these conditions has documented links to intestinal barrier dysfunction and the systemic inflammation it triggers. This is not coincidental. It reflects the central role that gut barrier failure plays in translating environmental and metabolic insults into organ-specific disease.
Mental Health: The intestinal barrier does not merely regulate what enters the bloodstream from the digestive tract. It also serves as a critical gatekeeper for the brain. When this barrier fails, the consequences extend well beyond gastrointestinal symptoms, reaching directly into the neural circuits that govern mood, cognition, stress resilience, and emotional regulation. A growing body of peer-reviewed evidence now identifies gut barrier dysfunction as a mechanistic driver of multiple psychiatric conditions, including major depressive disorder (MDD), generalized anxiety disorder (GAD), bipolar disorder (BD), and post-traumatic stress disorder (PTSD) [6, 10, 26].
Obesity: Disrupted gut permeability represents both a predisposing and an aggravating condition in obesity. The translocation of LPS across a compromised barrier initiates metabolic endotoxemia, driving the chronic low-grade inflammation that underlies insulin resistance, adipose tissue dysfunction, and weight gain [27]. Germ-free mice colonized with microbiota from obese donors develop weight gain and altered glucose tolerance, directly implicating the microbiome-barrier axis in obesity pathogenesis [27].
Cancer: The dynamic interaction between the gut microbiota, the intestinal barrier, the immune system, and SCFA production directly influences cancer development, progression, and treatment response [28]. Barrier disruption promotes dysbiosis that reduces mitochondrial beta-oxidation in epithelial cells, expands non-anaerobic bacteria, and creates a pro-inflammatory, pro-tumorigenic microenvironment [28]. Chemotherapy itself further damages the barrier by killing gut stem cells, increasing endotoxin translocation, and compounding immune suppression [29].
Heart Disease and Stroke: Increased intestinal permeability is observed in patients and mouse models of cardiovascular disease, including hypertension, atherosclerosis, heart failure, and myocardial infarction. This increased permeability enhances systemic inflammation, alters gut immune function, and has been demonstrated as predictive of adverse cardiovascular outcomes [30]. Stroke has been linked to gut dysbiosis and intestinal barrier dysfunction, with bacterial LPS translocation driving vascular inflammation and endothelial damage [30]. Heart failure itself induces gut ischemia and congestion, which further degrades barrier function, creating a bidirectional cycle of gut and cardiac deterioration [31, 32].
Diabetes: Type 2 diabetes has been associated with increased intestinal permeability, enabling bacterial penetration across the gut barrier and resulting in metabolic endotoxemia that drives low-grade systemic inflammation [27]. Hyperglycemia itself increases intestinal permeability via glucotoxicity, altering tight junction integrity and creating a vicious cycle of barrier impairment, inflammation, and insulin resistance [33]. In germ-free mice, resistance to diet-induced obesity and glucose intolerance is observed, confirming the microbiota's role in metabolic disease [27].
Chronic Lung Diseases (COPD): The gut-lung axis connects intestinal barrier dysfunction to pulmonary inflammation. Systemic endotoxemia originating from a permeable gut activates innate immune pathways that amplify airway inflammation and contribute to the progression of chronic obstructive pulmonary disease. Gut dysbiosis and reduced SCFA production impair systemic immune regulation, with downstream effects on pulmonary immune homeostasis [34].
Alzheimer's Disease and Dementia: Intestinal dysbiosis and increased gut barrier permeability enable bacterial LPS translocation systemically, leading to activation of pro-inflammatory immune cells, increased blood-brain barrier permeability, and microglial activation [9]. These inflammation-driven processes contribute to neurodegeneration, amyloid-beta accumulation, and cognitive decline [10, 11]. The gut-brain axis has emerged as a plausible mechanistic pathway connecting intestinal barrier failure to the neuroinflammatory cascade underlying Alzheimer's disease and related dementias.
Arthritis: Elevated serum zonulin levels, bacterial dysbiosis, and a permeable gut barrier have been observed in patients with rheumatoid arthritis, while subclinical intestinal inflammation has been documented in ankylosing spondylitis [34]. Activated immune cells in mucosal tissues with compromised barriers can migrate to joints and other organs, driving the systemic autoimmune inflammation characteristic of these conditions. Treatment with a zonulin antagonist has inhibited the development of arthritis in mouse models, confirming the intestinal-articular axis [34].
Chronic Kidney Disease (CKD): Reduced SCFA-producing taxa in CKD patients increase intestinal permeability, enabling the translocation of endotoxins and bacterial DNA into the systemic circulation. These factors activate TLR4/TLR9 signaling, triggering inflammatory cascades that exacerbate systemic microinflammation and accelerate organ damage. Gut-derived uremic toxins, including TMAO, indoxyl sulfate, and p-cresyl sulfate, further compromise cardiovascular and cerebrovascular health in CKD, establishing the gut-kidney axis as a critical driver of disease progression.
Mental health disorders are not only one of The SR™ Chronic 9; they run through the other eight. People with mental disorders face more than twice the risk of death and lose a median of 10 years of life [462]. When a mental health disorder accompanies a chronic disease, healthcare costs rise by 72% [463]. The relationship runs in both directions:
Obesity: Depression raises the odds of developing obesity by 58%, and obesity raises the odds of developing depression by 55% [464].
Cancer: Depression and anxiety raise cancer incidence by 13% and cancer-specific mortality by 21% [465].
Heart Disease And Stroke: Depression raises the risk of coronary heart disease by 30% [466].
Diabetes: Depression raises the risk of type 2 diabetes by 37%, and the two occur together about twice as often as chance would predict [467].
Chronic Lung Disease (COPD): Depression or anxiety raises the risk of COPD onset or flare-ups by 43%, and COPD raises the risk of depression by 69% [468].
Alzheimer’s Disease And Dementia: Late-life depression raises the risk of all-cause dementia by 85% and Alzheimer’s disease by 65% [469].
Arthritis: Major depression affects 16.8% of people with rheumatoid arthritis [470].
Chronic Kidney Disease (CKD): More than one in four people with CKD are depressed, and depression raises their risk of death by 59% [471].
Treating the body while leaving the mind untreated leaves the multiplier in place.
The vagus nerve is the main physical connection between the gut and the brain. About 80% of its fibers are afferent, meaning they carry information up from the gut and other organs to the brain, while only about 20% are efferent and carry commands down from the brain to the organs [35]. In other words, the gut does most of the talking. These ascending fibers report on stretch, nutrients, inflammation, and signals from gut bacteria, and they connect to brain regions that regulate fear, mood, reward, and appetite [35]. This is why a damaged gut barrier is not only a digestive problem. When the barrier fails, the signals traveling up the vagus nerve change, and the brain responds to those changes.
PTSD: In veterans and others with PTSD, the fear response stays active long after the danger has passed. In a sham-controlled study of people who had experienced trauma (but did not have a PTSD diagnosis), noninvasive stimulation of the vagus nerve reduced activity in fear-related brain regions while participants listened to recordings of their own trauma stories [36]. In rats, stimulating the vagus nerve during fear extinction training helped the animals unlearn conditioned fear and reduced PTSD-like symptoms [37]. These studies stimulated the nerve directly and did not test gut restoration. However, they show that the vagal pathway is a real lever on the fear circuitry, and the gut is the largest source of the signals that travel along it.
Depression And Suicidality: The vagus nerve also links the gut microbiome to depression [38]. In mice, a Lactobacillus strain reduced anxiety-like and depression-like behavior and changed GABA receptors in the brain, but these effects disappeared when the vagus nerve was cut [39]. Vagus nerve stimulation is FDA-approved for treatment-resistant depression, and a systematic review of neuromodulation treatments concluded that it may reduce suicidality, although the evidence is still limited [40]. If you are a veteran in crisis or having thoughts of suicide, dial 988 and press 1, or text 838255, to reach the Veterans Crisis Line. Anyone else can call or text 988. Gut restoration is meant to support mental health care, not replace it.
Anxiety: In rats, cutting the vagal afferent fibers from the gut reduced innate anxiety and altered how fear was learned [41]. In mice with colitis, gut inflammation signaled through vagal afferents to the amygdala, the brain’s fear center, and produced anxiety-like behavior. Interrupting that pathway reduced the anxiety [42]. An inflamed gut can send signals that drive anxiety.
Addiction: Vagal fibers from the gut feed directly into the brain’s reward system. In mice, stimulating vagal fibers from the upper gut triggered dopamine release and was rewarding enough that the animals worked to receive it [43]. This means the gut helps decide what the brain craves. In a small trial in alcohol-dependent men, ear-based vagus nerve stimulation improved depression and sleep during protracted withdrawal, but it did not reduce alcohol craving [44]. The vagus nerve is part of the craving circuitry, but stimulating it alone is not a treatment for addiction.
Weight Control: The vagus nerve carries fullness signals from the gut to the brain. In diet-induced obesity, vagal afferent neurons become less responsive to these satiety signals, which promotes overeating and weight gain [45]. In mice, removing leptin signaling from vagal afferent neurons caused overeating and obesity [46].
Other Conditions: Ascending vagal signals also contribute to interoception, the brain’s sense of the body’s internal state, and to the perception of gut pain [35]. Disturbed interoception is common in anxiety, depression, and PTSD.
The Anti-Inflammatory Return Path: The 20% of fibers that travel downward also matter. They form the cholinergic anti-inflammatory pathway, through which the brain signals the immune system to reduce inflammation in the gut and the rest of the body [47]. The loop is complete: the gut reports inflammation to the brain, and the brain sends signals back to calm it.
Caution: Most of this evidence comes from animal studies and from studies that stimulate the vagus nerve with devices. No human study has yet shown that repairing the gut barrier improves PTSD, depression, or suicidality through the vagus nerve. My expectation that it can is based on these pathways and my own experience.
How food composition shapes these signals, and why it led to the SR™ Flexible Carnivore design, is covered in Phase 1.
None of these variables operate in isolation. Mitochondrial decline, cellular senescence, immune aging, psychological stress, dietary insult, and microbial imbalance each contribute independently to the burden of chronic disease. However, the intestinal barrier is where these pathways converge and where their effects are translated into systemic consequences. A 2023 review further confirmed that understanding the interplay among the microbiome, the gut barrier, and the immune system is critical to piecing together mechanisms of age-related chronic disease [7].
This is why the SR™ Gut Barrier and Microbiome Restoration places gut barrier restoration at its center. Rather than treating downstream inflammation in individual organ systems, the protocol targets the barrier itself by rebuilding beneficial microbial populations, restoring SCFA production, supporting mitochondrial function in epithelial cells, managing oxalate burden, and addressing Candida overgrowth. By restoring intestinal epithelial integrity, the protocol aims to interrupt the feed-forward cycle of dysbiosis, translocation, and inflammaging at its source.
The SR™ Gut Barrier and Microbiome Restoration is organized around this principle: while chronic disease and aging involve many interacting variables, gut barrier dysfunction is the central convergence point where those variables become systemic disease; therefore, it is the barrier that must be addressed first.
New research is revealing that gut health may be the missing link between the body’s physical decline and emotional suffering. A 2024 study showed that a common gut yeast, Candida albicans, can cross the intestinal lining by damaging gut cells, a step the host immune response normally limits [20]. In mice, Candida that reached the bloodstream caused brain inflammation and memory deficits [22]. Candida translocation through the intestinal barrier into the bloodstream (leaky gut) is essential for systemic infection and inflammation [21]. Other findings highlight that an unbalanced microbiome, especially one lacking beneficial bacteria, can disrupt communication along the gut–brain axis, influencing mood, focus, and resilience [26]. Chronic diseases like cardiovascular disease, diabetes, arthritis, and cancer often involve persistent inflammation as a key mechanism [48].
An important part of this equation involves oxalates. Oxalates are naturally occurring compounds found in plants that, when the body can’t break them down efficiently, are stored in tissue and bone and become toxic when released. When oxalate-reducing microbes are depleted, these crystals can irritate intestinal tissue, damage energy-producing mitochondria, and further weaken the gut barrier. This allows more toxins and inflammatory signals to enter the bloodstream, intensifying symptoms of both chronic disease and mental distress [49].
The SR™ Gut Barrier and Microbiome Restoration targets these interconnected processes at their root. It helps restore beneficial microbes that metabolize oxalates, strengthen the intestinal lining, and calm the inflammation that drives physical illness and emotional imbalance. Rebuilding the gut ecosystem provides a realistic, science-based path to reversing the cycle of chronic disease and mental health disorders.
The synergistic trifecta of gut homeostasis comprises gastrointestinal stem cells, the intestinal mucosa, and the gut microbiome. If any of these components is disrupted, it affects the other; therefore, all must be addressed simultaneously.
The gastrointestinal stem cell produces all the adult cell lineages of the gastrointestinal mucosa and is thereby perceived as the most important regulatory element in gastrointestinal function [50]. Stem cell regeneration is the very foundation of recovering normal gut function. The endocannabinoid system (ECS) is a significant part of the stem cell equation because cannabinoid receptors are attached to the stem cells, and cannabinoid signaling regulates cell proliferation, differentiation, and survival [51].
Tight junctions are integral molecular components of the intestinal mucosa, specifically within the epithelial cells that form the mucosal barrier [52]. Inflammatory bowel disease is characterized by cycles of mucosal injury and ulceration [53]. My question is, can any bowel disorder that may lead to over one hundred forty autoimmune diseases happen without a mucosal injury? I believe that, in most cases, the answer is no. The medical literature regarding DBS/IBS is unclear. Still, it should be absolutely clear, as one of the basic functions of the mucosal layer is to provide adequate containment of luminal microorganisms and molecules while preserving the ability to absorb nutrients [54]. This is what makes Akkermansia muciniphila a fundamental focal point of the SR™ Microbiome Protocol.
Microbiota refers to the collection of all the microorganisms, including bacteria, fungi, protozoa, and viruses, that inhabit a specific environment, such as the human gut, skin, mouth, or other body sites. Our primary focus will be on the microbiota, which affects the makeup of the microbiome.
Microbiome refers to the populations of microorganisms in the body’s various ecosystems (for example, the gut and skin microbiome). A comprehensive understanding of the microbes that dominate each system is still being discovered [55].
A breach in the mucosa can exacerbate immune reactions toward the microbiome [54]. This means that the immune system will attack the microbiome once the mucosa is breached. My Genova Comprehensive Stool Analysis indicated a very low bacterial diversity on the first test.
With the importance of this trifecta made clear, I established a protocol to heal the gut and clear the remaining symptoms. Some individuals can heal by modifying their diet, others can heal with probiotics, and still others can heal without intervention, allowing the autonomic regenerative processes of the mucosa to restore them. However, an intervention is mandatory for those who have become ill or chronically ill and cannot escape the disruption of the self-perpetuating cycle of the mucosa and microbiome. This cannot be stated emphatically enough, especially with anorexics who may have gotten to the point of not being able to eat because of severely damaged intestinal mucosa.
Oxalic acid is a plant toxin found in virtually every fruit, vegetable, grain, and legume. If the gut microbiota cannot process these toxins, they accumulate in the body. Oxalates physically damage tissues via crystal formation and oxidative stress, disrupt the gut microbiome by suppressing oxalate-degrading bacteria, and contribute to kidney stones and biliary issues. The resulting disruption of the gut microbiome also creates an environment in which opportunistic Candida can overgrow. Through these interconnected mechanisms, oxalates lead to a myriad of disorders and diseases [14, 56]. People often overlook the liver and gallbladder when rebalancing the gut, but they are part of the equation and must be addressed effectively.
Oxalates are the most insidious of all plant toxins, as they are the only plant toxin that accumulates in virtually every tissue of the body, including bone [15, 57]. There are two primary ways to become poisoned by oxalates: endogenously (internally) through metabolism or exogenously (externally) through the diet. Endogenous poisoning is usually from a rare genetic disorder or A. Niger, which is a mold and also referred to as black mold.
Oxalic acid is a plant compound that is ubiquitous in the plant kingdom. It can damage tissue and ultimately slowly kill you if you consume large amounts of superfoods such as spinach, chocolate, Swiss chard, or almonds, among many others. However, several factors other than consuming large amounts of this can make one vulnerable to this toxin, which is embedded in one's bones and tissues. Humans should limit their oxalate intake to less than 150 mg per day. This recommendation is reduced to less than 50 mg per day if you have a history of kidney stones. If you eat more than 150 mg of oxalates per day, the question is not whether you are poisoned but how poisoned you are (Author’s Observation).
Escherichia coli are commonly found within the nidus of calcium oxalate kidney stones and may play a pivotal role in stone genesis [58]. Candida albicans and Escherichia coli are also believed to be synergistic pathogens [59]. This is why some, such as Great Plains Labs, believe that Candida causes excess oxalate accumulation. In other studies, a higher-than-usual concentration of oxalate was found to inhibit many gut microbes, including the oxalate-degrading Oxalobacter formigenes, and was associated with dysbiosis and an enrichment of acid-tolerant pathobionts [18]. Candida is an opportunistic pathogen, and oxalate does not create it. However, a disrupted microbiome is one of the conditions that allows Candida to shift from a harmless resident to an opportunistic pathogen [23], so once oxalate disrupts the microbiome, it creates an environment conducive to Candida overgrowth (Author’s Observation). Once initiated, either mechanism becomes self-perpetuating and may eventually kill you unless you have a means of disrupting it. Death may not be directly from oxalate poisoning, but from the resulting disorders and diseases caused by being poisoned. I suspect oxalates when a death is determined to be a natural cause, especially if the person is under the age of 70 (Author’s Observation).
The question is: once either mechanism is initiated, how do you interrupt it and rebalance the microbiome? To be clear, oxalates are not the devil. The liver produces oxalates as part of our metabolic processes [60]. They bind with heavy metals and minerals and carry them out of the body. The issue arises when they accumulate in excess.
Additionally, elevated plasma urinary oxalate has been associated with several other pathological conditions, including diabetes mellitus, obesity, autism, atherosclerosis, cardiovascular events, and neurological disorders. Patients with primary hyperoxaluria are particularly prone to oxalosis, a condition characterized by the presence of calcium oxalate deposits in various extrarenal tissues, primarily in the heart, smooth muscle cells of vessels, bones, skin, and other organs.
However, oxalate deposition has also been reported in non-primary hyperoxaluria patients, affecting extrarenal tissues such as the breast, lungs, thyroid gland, prostate, synovial fluid, and vascular tissues [14].
Systemic Manifestations of Oxalate Disorders [15]
Breast Cancer and Oxalates: Breast cancer is the most commonly diagnosed cancer worldwide [61]. In 2015, the effect of oxalates was first demonstrated in a human breast cell line. At that time, the mechanism by which oxalate exerts its action on breast cells was still largely unknown [62]. A 2023 study gained a much better understanding of the role of oxalates and microcalcifications in breast tissue [63]. Although a direct connection between breast cancer and oxalates has not been established, it is known that oxalates cause mitochondrial dysfunction [16], and mitochondrial DNA mutations are commonly found in cancer cells, which can promote the rewiring of bioenergetics and regulate tumor metabolism and progression [64].
BPH, Prostate Cancer, and Oxalates: Prostate cancer is the second most commonly diagnosed cancer and the fifth leading cause of cancer death among men worldwide [65]. Oxalates may cause benign prostatic hyperplasia (BPH) and prostate cancer; however, a direct link has not been established [14]. As stated above, however, there is clear evidence of oxalate-induced mitochondrial dysfunction [16, 64].
Lycopene consumption can reduce the blood concentration of insulin-like growth factor 1 (IGF-1), a key factor in the development of breast and prostate cancer. Therefore, lycopene’s reduction in this growth factor may reduce the risk of these cancers [66]. Many of these studies use tomato products such as tomato paste, tomato sauce, or tomato juice, but only report lycopene, even though there are many other constituents in the tomato lycopene equation. Grabbing a lycopene supplement in hopes of reducing cancer risk is ill-advised, as lycopene supplements can come with a host of contraindications. This is why, when it comes to lycopene, I only use organic tomato paste. For those concerned about lectins, the skin and seeds of the tomato contain the highest levels, which are removed during processing into tomato paste [66]. Lycopene is also an antifungal that induces apoptosis (cell death) in Candida [67].
Tomato Paste Dosing: Dietary ingestion of 50 g of tomato paste daily for 10 weeks significantly reduced mean plasma PSA levels in patients with benign prostate hyperplasia [68]. Organic tomato paste comes in 6-ounce cans. I took 3 ounces per day (84 grams) for 3 months to bring my PSA back to normal.
The Role of Sulforaphane and Cancer: Glucose (sugar) and glutamine are known to feed cancer cell growth [69, 70]. Sulforaphane triggers apoptosis through caspase activation. In prostate and colon cancer models, it disrupts mitochondrial membranes and elevates ROS selectively in tumor cells [71]. Sulforaphane derepresses tumor suppressors, alters DNA methylation, and targets cancer stem cells in gastric and lung cancers. Sulforaphane also enhances chemotherapy efficacy and immune function [72]. Broccoli sprouts are high in Sulforaphane, and you can also get it in supplement form.
The reason the SR™ Gut Barrier and Microbiome Restoration is essential in mental health and chronic diseases is that consistent physiological processes occur in all chronic diseases and some, but not all, mental health disorders. Unless these processes are effectively addressed, mental health disorders and chronic diseases will remain chronic.
Once the microbiome is disrupted, you become vulnerable to oxalate accumulation and poisoning, regardless of what caused the disruption.
Collagen, bone broth, and gelatin are among the most widely recommended foods for healing a leaky gut. They were also the first things I started with. At the time, I did not know that oxalates were at the root of my dysbiosis, and I did not know that I was causing more damage.
Hydroxyproline is an amino acid found almost exclusively in collagen, the main protein in bone broth, gelatin, and collagen supplements. When the body breaks down hydroxyproline, the liver and kidneys convert part of it to glyoxylate, which is then converted to oxalate [73]. In other words, these foods contain little oxalate themselves, yet they supply the raw material the body uses to make its own.
This has been measured in people. In a controlled study of healthy adults, urinary oxalate excretion was 43% higher on a gelatin diet than on a whey protein diet, and urinary glycolate, another product of hydroxyproline breakdown, was 5.3 times higher [74]. The effect depends on the amount consumed. Single gelatin loads of 5 and 10 grams raised urinary oxalate, while loads of 1 and 2 grams did not [74]. Daily servings of collagen powder, gelatin, or bone broth fall in the range where the increase appears.
Oxalate made inside the body is not a minor source. A substantial share of the oxalate excreted in urine is produced endogenously rather than absorbed from food [75], and hydroxyproline from collagen-rich foods is one of the recognized dietary contributors to that endogenous load [56].
Glycine is the most abundant amino acid in collagen. Roughly one in every three amino acids in collagen is glycine. Because of this, some people assume that glycine is what drives the oxalate increase from collagen, and that glycine taken on its own should be avoided for the same reason. That is not correct.
The 43% increase comes from hydroxyproline, not glycine. The two amino acids are handled very differently by the body. Hydroxyproline is broken down through a dedicated pathway that leads directly to glyoxylate and then to oxalate [73]. Glycine is used mainly to build proteins, glutathione, creatine, and other essential compounds, and only a small fraction of it is ever converted to glyoxylate.
This has also been measured directly. In a human tracer study, glycine infused at a normal physiological rate produced no detectable labeled oxalate in the urine, meaning glycine accounted for less than 5% of urinary oxalate [76]. Only when glycine was infused at a rate ten times higher, enough to raise blood glycine by 29%, did it contribute meaningfully to urinary oxalate. The authors concluded that glycine metabolism makes only a minor contribution to oxalate production under normal conditions [76].
The oxalate problem with collagen is not its glycine. It is the hydroxyproline that comes packaged with it. That is why glycine can be supplied on its own without bringing the oxalate load along with it.
For anyone whose dysbiosis includes oxalate overload, collagen, bone broth, and gelatin move recovery in the wrong direction. A low oxalate diet reduces what comes in from plants, but daily collagen, bone broth, or gelatin quietly adds oxalate back from the inside. A gut and kidneys already struggling to clear oxalate are handed more, and every oxalate dump further disrupts the microbiome (Author’s Observation). This is why collagen, bone broth, and gelatin are excluded from the SR™ Gut Barrier and Microbiome Restoration protocol whenever oxalates are part of the dysbiosis equation.
This does not mean the goal behind these foods is wrong. The gut lining still needs support. In this protocol, that support comes from zinc-carnosine and colostrum, along with the glutamine supplied naturally by meat. Glycine is supplied on its own in the Support Stack, without the hydroxyproline load that comes with collagen. As with every part of this protocol, discuss your choices with your MD and use the Oxalic Acid 24-Hour Urine Test to see where you stand.
The SR™ Chronic 9 combines the eight adult diseases named by the Make America Healthy Again (MAHA) Commission with mental health disorders. The question is, what do all these conditions have in common? They are all linked to a disrupted microbiome, Candida, and leaky gut. In some cases, it is a chicken-and-egg conundrum; nonetheless, there is still a solid link, and addressing the disrupted microbiome makes perfect sense.
Thoroughly revised estimates indicate that the typical adult human body comprises approximately 30 trillion human cells and about 38 trillion bacterial cells [88]. I am certain this will continue to be updated. The bottom line is that the human body has many more bacterial cells than human cells, which makes for a complex balancing act when attempting to correct a bacterial (gut microbiome) imbalance.
The symptoms of microbiome disruption are wide and varied, affecting each person differently. If oxalate poisoning is present, it is challenging to determine what is directly caused by oxalate dumping and what results from dysbiosis. Regardless, the damaged microbiome must be repaired, and this requires a systematic, focused effort. This is where the SR™ Gut Barrier and Microbiome Restoration comes in.
Restoring the microbiome involves multiple steps, and a literature review reveals that, although most probiotics are generally considered safe and beneficial for healthy individuals, caution is necessary when selecting and monitoring probiotics for patients with compromised immune systems, leaky gut, or critical illnesses [89]. For this and other variables, especially with extended fasting, you must engage a Functional Medicine MD.
Even if you are not poisoned by oxalates, you will still benefit from the SR™ Gut Barrier and Microbiome Restoration if you have any microbiome disruption, are experiencing any malaise, or are over the age of 40.
Candida overgrowth is an overlooked piece of the chronic disease and mental health equation. When someone becomes inflamed or realizes they are oxalate-poisoned, managing symptoms from inflammation or oxalate dumping becomes the singular focus. However, it is absolutely critical that one understands the foundational mechanism of this inflammation.
Candida is one of the earliest and most common opportunistic organisms to overgrow when gut bacterial balance and host defenses are compromised [23]. The implications of this overgrowth are far-reaching and include all of The SR™ Chronic 9. If Candida is not immediately and effectively addressed, it can translocate to other parts of the body, including the brain, where it has been implicated in dementia. The reason it has been implicated is that Candida can form amyloid in human and animal tissues, significantly influencing biofilm formation, immune evasion, and possibly contributing to plaque-like pathology, including in the CNS [22].
Like oxalates, candida overgrowth is a slow, insidious process that manifests as multiple symptoms.
Because microbiome disruption arises from multiple overlapping mechanisms, SR™ Gut Barrier and Microbiome Restoration is organized around three integrated core objectives, each with specific, actionable subobjectives to guide individualized recovery.
Objective 1: Testing – Build an Individualized Baseline
Objective 2: Map Primary Mechanisms – Identify What’s Driving Disruption
Objective 3: 3-Phase Recovery Implementation
Diagnostic testing has measurable false-negative rates, and a negative or absent result does not prove that a condition is absent. Diagnostic error affects an estimated one in twenty US adults in outpatient care each year, roughly 12 million people, and about half of those errors have the potential to cause harm [91]. The National Academies of Sciences, Engineering, and Medicine concluded that most people will experience at least one diagnostic error in their lifetime [92]. The same logic applies to research: the failure of a study to detect an effect is not proof that no effect exists [93].
For anyone living with persistent gut and mood symptoms, this distinction matters. Standard workups are designed to rule out acute and structural disease. They are not designed to measure intestinal permeability, microbial imbalance, nutrient insufficiency, or oxalate burden. Behavioral health assessment that relies solely on the absence of positive findings may therefore underestimate need, and interventions targeting such presentations warrant evaluation on their outcomes rather than exclusion on the basis of negative workups. This is the foundation of the SR™ principle that follows: when symptoms persist, test, do not guess, and track the results over time.
Another major issue with Candida overgrowth is the inaccuracy of testing. I was tested multiple times over a decade via blood, urine, and stool, and only tested positive once. This can give one a false sense that the memory, gait, neurological, and cognitive issues may be caused by something else, and enable exponential proliferation of Candida, which is what happened to me. This is why the SR™ Gut Barrier and Microbiome Restoration begins with addressing Candida overgrowth. This assures a foundational approach that is not dependent on false negatives.
Public awareness of fungal disease is low; a 2019 national survey found that most adults in the United States had little familiarity with invasive fungal infections [94]. The lack of patient awareness around Candida and leaky gut test inaccuracies is likely influenced by a combination of technical challenges, limited provider education and awareness, clinical decision-making priorities, and communication barriers within healthcare settings (Author's Observation). A recommendation for all MDs who treat Candida and leaky gut is to tell their patients that the tests are unreliable.
Blood cultures miss ~50% of invasive candidiasis cases due to low fungal loads in blood, uneven distribution, and small sample volumes, delaying or preventing detection. Non-culture tests like PCR show pooled sensitivity of 73% but vary by sample type (whole blood performs better than serum), target genes, and detection limits (≤10 CFU/ml needed), with lower performance for certain species, such as C. parapsilosis or C. glabrata. Antigen assays (mannan, CAGTA, BDG) have sensitivities from 42-96% but often fail in uncomplicated candidemia or colonized patients without deep infection [95].
Zonulin assays, a common marker, suffer from poor correlation with functional permeability tests like lactulose-mannitol due to commercial ELISA kits detecting unrelated proteins rather than true zonulin/prehaptoglobin-2, leading to unreliable negatives. Antibody tests for zonulin or occludin can yield false negatives in pediatrics (lacking norms) or under steroid suppression, while direct zonulin fluctuates naturally. Functional sugar tests remain the gold standard but still miss subtle permeability changes [96].
If any score on your intake Burris Gut Health Checklist is 5 or above over the past 30 days, find a Functional Medicine MD who can order the following tests. After getting these tests, you will have enough data to order more tests if necessary, remodel the microbiome, and correct your dysbiosis
*Links to the following tests, tools, etc., are available at BurrisConnect.com.
Kelly Burris: Comprehensive Stool Test: 9-20
Kelly Burris: Comprehensive Stool Test: 9-22
A SIBO test was one of the first things I did when I initiated my research on the gut over a decade ago, but there have been considerable advancements since then. Dr. William Davis, author of Super Gut, claims that a device called the FoodMarble Aire and FoodMarble Aire 2 is better than the clunky and hard-to-get SIBO test. I cannot attest to this because I have not tried it, so you will need to do your own research. The Aire device is also much less expensive than conventional testing.
Your functional medicine practitioner can determine what other tests you may need based on these tests.
If you rated yourself a 5 or above on any question on your intake Burris Gut Health Checklist, you will need to inspect your stool regularly for bile sludge, which will show up as emerald green chunks or stone-shaped, and Candida, which is solid white, not to be confused with mucus, which is translucent (Author’s Observation). There is no literature on oxalates in stool, but I have found a correlation between tiny black specks in stool and other oxalate symptoms; however, many other explanations exist for this phenomenon. You will need an LED flashlight and 2.25 power reading glasses or stronger to do a thorough examination.
Increased Beneficial Microbes: Intermittent fasting (IF) regimens, such as Warrior/OMAD or ADF fasting, consistently enrich key probiotic taxa; This is why we call them The Top 10 Probiotics. However, they require consistency. You will also see how these 10 probiotics affect disease processes.
In summary, Warrior/OMAD every day and 24 to 36-hour fasts every 2–3 days (or comparable IF schedules) enrich probiotics, such as Lactobacillus and Bifidobacterium, as well as other SCFA-producing genera, while increasing microbiome diversity [107]. These shifts coincide with higher SCFA output, a more substantial gut barrier, lower pathogen levels, and reduced gastrointestinal inflammation, which are hallmarks of improved gut health [105, 108].
The literature acknowledges the death of pathogens but overlooks the possibility that it may induce the release of toxins that can cause severe malaise. This is indicative of how much more research needs to be done on gut health. In my opinion, the feeling of being poisoned during a 16 to 36-hour fast, or any other form of fasting, will be the primary reason for ending a fasting protocol, not hunger.
While it is critical to address environmental toxins, food additives, oxalates, and a myriad of other factors that disrupt the microbiome, it is equally crucial to understand how to reverse that disruption for individuals currently suffering. The probiotics listed below may not be commercially available, but they are free and effective for anyone who follows the SR™ Gut Barrier and Microbiome Restoration.
Lactobacillus spp. and Bifidobacterium spp.
A large study reports that primary resistance to PD-1/PD-L1 (PD-1/PD-L1 inhibitors are anticancer drugs that allow the immune system to better attack cancer) is linked to gut microbiome composition, and that [118]:
Roseburia spp.
Ruminococcus spp.
Bifidobacterium spp. and Lactobacillus spp.
Lactobacillus spp. and Bifidobacterium spp.
Bifidobacterium spp. and Lactobacillus spp.
Coprococcus spp.
Bifidobacterium spp. and Lactobacillus spp.
Roseburia spp.
Ruminococcus spp.
In a 5/6 nephrectomy rat model of CKD, supplementation with A. muciniphila (2×10^8 CFU/0.2 mL for 8 weeks) was reported to [143]:
Bifidobacterium spp. and Lactobacillus spp.
The links between the Top 10 Probiotics and anxiety, depression, and sleep are covered in the next section, Effects Of The Top 10 Probiotics On Anxiety, Depression, And Sleep.
The evidence demonstrates that these specific probiotic bacteria play significant roles in the prevention and management of various chronic diseases. Their mechanisms of action include modulating inflammation, improving gut barrier function, producing beneficial metabolites like short-chain fatty acids, and regulating immune responses. While the evidence is strongest for certain bacteria in specific conditions (like Akkermansia muciniphila in metabolic disorders and Faecalibacterium prausnitzii in inflammatory conditions), research continues to expand our understanding of these complex microbe-host interactions in chronic disease.
The bidirectional communication network between the central nervous system and gut microbiome, known as the gut-brain axis, provides the foundation for understanding how probiotics may influence mental health. This complex system involves neural, immune, endocrine, and metabolic pathways that allow gut bacteria to impact brain function and behavior, including mood regulation and sleep patterns.
1. Lactobacillus spp.
Lactobacillus species have been extensively studied for their psychobiotic properties:
2. Bifidobacterium spp.
Bifidobacterium species demonstrate significant effects on mood regulation and sleep:
3. Coprococcus spp.
4. Ruminococcus spp.
5. Roseburia spp.
Candida overgrowth and gut dysbiosis feed each other. Laboratory and animal research shows that several groups of beneficial bacteria antagonize Candida, and that losing them, for example after antibiotics, makes it easier for Candida to colonize the gut [156, 157]. Whether each of these groups is consistently depleted during Candida infections in people has not been established, so the list below is based on what each group does against Candida.
1. Lactobacillus spp.
Lactobacillus species directly antagonize Candida [158]. Under normal conditions, these beneficial bacteria:
Their loss creates a more favorable environment for Candida, and their interactions with Candida have been documented in both the gut and the vagina [156]. Multiple studies demonstrate that Lactobacillus species can inhibit Candida growth and biofilm formation [159], suggesting a reciprocal antagonistic relationship.
2. Bifidobacterium spp.
Bifidobacterium species also antagonize Candida [160]. These beneficial bacteria normally:
Loss of Bifidobacteria contributes to dysbiosis and weakens gut defenses. In laboratory studies, bifidobacteria produced compounds that act against Candida and its biofilms [160].
In mice, F. prausnitzii inhibited Candida colonization and reduced Candida-aggravated colitis [161]. This keystone species:
Its loss may contribute to increased inflammation and compromised gut barrier function, creating conditions that further promote Candida colonization and invasion [161]. The anti-inflammatory properties of F. prausnitzii appear particularly important, as inflammation can further disrupt microbial balance and enhance conditions favorable to Candida.
4. Roseburia spp.
Roseburia species are butyrate producers whose loss is associated with several diseases [162], and Candida colonization alters how the gut bacterial community recovers after antibiotics [157]. These bacteria:
Their depletion may facilitate Candida adhesion and invasion of the intestinal epithelium by reducing butyrate production and increasing intestinal permeability [162]. Like F. prausnitzii, Roseburia species contribute to maintaining a healthy gut environment that naturally restricts Candida overgrowth.
5. Ruminococcus spp.
Ruminococcus species are among the commensal bacteria that interact with Candida in the gut [156]. These bacteria:
Their loss impairs gut metabolism and may contribute to a dysbiotic environment that favors Candida proliferation [156]. The metabolic activities of Ruminococcus help maintain a diverse and stable gut ecosystem that is more resistant to pathogen overgrowth.
An important question in understanding the relationship between Candida and gut bacteria is whether bacterial depletion precedes Candida overgrowth or results from it. Evidence suggests both mechanisms may occur [156, 163]:
The pattern of bacterial depletion may vary depending on [163]:
Research focusing specifically on gut microbiome changes provides the most direct evidence for the patterns described above, while systemic infections may have more complex and widespread effects.
Conclusion:
Based on NIH-published research, the beneficial bacteria with the clearest activity against Candida are:
Loss of these beneficial bacteria creates a favorable environment for Candida by reducing competition, altering the gut environment, and compromising barrier function. In mice, commensal anaerobes, including clostridial Firmicutes and Bacteroides, are also critical for resisting Candida colonization [164], and antibiotics combined with mucosal damage and low immunity allow Candida to spread [163]. The roles of Coprococcus spp. [156] and Akkermansia muciniphila are less clear.
Understanding these microbial dynamics offers potential therapeutic approaches, including targeted probiotic supplementation to restore these bacteria and create conditions less favorable for Candida overgrowth. Future research should further clarify the temporal relationships and mechanistic interactions between Candida and specific bacterial species.
I could go on with many more disorders and diseases caused by a microbiome disruption, but that would require another book. For now, I hope this drives home how important a balanced microbiome is.
I am a big believer in the Test-Do-Not-Guess approach, which works well regarding vitamins, minerals, amino acids, and heavy metals, among others. However, testing for conditions like Candida and intestinal permeability (leaky gut) is highly inaccurate, which can exacerbate damage. I am not saying do not get tested for Candida and leaky gut (Zonulin and LPS tests), what I am saying is that if you have been suffering with the myriad of symptoms or even just one symptom, it is better to assume and implement foods and supplements, Not Medications, that will begin addressing these processes, regardless of attempted diagnosis. No one discusses the issue of false negatives in Candida and leaky gut testing, and I am unable to explain it.
Candida can cause or exacerbate leaky gut syndrome by damaging intestinal barrier integrity and promoting increased permeability [165]. One of the many reasons we initiate the SR™ Gut Barrier and Microbiome Restoration with the eradication of Candida, along with dietary adjustments and supplements, is to heal the intestinal mucosa and tight junctions so that only what is meant to get through actually does, and nothing else.
There are several components to consider when eradicating Candida overgrowth.
*We Use Foods, Not Meds, That Can Accomplish This
Multiple meta-analyses demonstrate that probiotic supplementation improves cognitive function in patients with AD and Mild Cognitive Impairment (MCI). Treatment with probiotics improved Mini-Mental State Examination (MMSE) scores in AD patients and reduced inflammatory markers. These effects likely occur through restoration of gut microbiota balance, reduction of systemic inflammation, and modulation of the gut-brain axis [166].
Candida albicans is the most common Candida species and cannot be controlled until the body's oxalate levels are within a safe range (Author’s Observation). There is, however, some question as to whether Candida contributes to oxalate crystal formation. Nonetheless, Candida and oxalates are self-perpetuating mechanisms. This is one of the primary reasons so many people report that it keeps coming back. One can have a Candida flare-up without oxalates, but it is highly unlikely that it is not part of the equation. Candida is classified as a yeast and fungus, and its fungal form is the most aggressive and tenacious when restoring the microbiome [167].
If C. albicans were cultured from the vagina, it was always found in the stool. Conversely, if it was not isolated from the stool, it was never found in the vagina. These data are presented as an explanation for the recurrent nature of Candida vaginitis. Thus, a cure for vaginitis would not be possible without prior eradication of C. albicans from the gut [168]. This mechanism is one of the many reasons that Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 rank first on our extended fermentation list.
It is estimated that 75% of females will have a yeast infection at some point in their lives. This completely discredits the notion that yeast overgrowth is primarily found in immunocompromised people.
Among the foods I have used to target Candida overgrowth, Nori seaweed stands out as particularly effective. However, its impact may vary from person to person, and it is important to proceed cautiously and monitor your response.
Bulgarian yogurt is generally well tolerated because its longer fermentation reduces lactose, and A2 varieties should be chosen whenever possible (see Why A2 Half And Half Only). If yogurt is not suitable for you, you can use the seaweed sheets to roll up your regular meals.
Candida is very good at adapting. However, there are 3 things Candida cannot adapt to: starvation via fasting, extended-fermentation yogurt, and seaweed (Author’s Observation). After trying every form of fasting, I came to realize that the two most effective fasting protocols are ones you can do consistently: the Warrior (4-hour eating window) and OMAD (one meal a day).
Of everything in this protocol, CoreBiome tributyrin in Phase 2 produced the most significant change I experienced. I believe that is because Phase 1 had already prepared the ground; it is the last piece, not a shortcut (Author's Observation).
I started slowly with all of it. Every component of this protocol produced Candida die-off for me, and the combination produced a lot of it. I added one component at a time, began at the lowest amount, held it for several days, and increased only as my symptoms allowed. I kept a daily note of stool, sleep, energy, and any flu-like symptoms. When a component caused symptoms I could not tolerate, I dropped back to the previous amount rather than stopping.
Glycine, Extended Fermentation Yogurt, Nori Seaweed, And Walnuts
Oregano Oil, Black Seed Oil, Or Nystatin As Backups
24 To 44 Hour Fast And Olive Oil Flush
The Support Stack used during all three phases is described in its own section, immediately after Phase 3.
Every meal sends a message to the brain. Specialized cells in the gut lining, called neuropod cells, form direct connections with vagal neurons and relay information about nutrients, such as sugar, to the brain within milliseconds [169]. What you eat shapes what the vagus nerve reports, and that in turn shapes appetite, mood, and cravings. The SR™ Flexible Carnivore design is built around this.
Protein: Digested protein releases peptides and triggers gut hormones, such as CCK, GLP-1, and PYY, that signal fullness through the vagus nerve [170]. This is one reason a protein-centered meal satisfies longer than a carbohydrate-centered one.
Fat And Sugar: In mice, fat and sugar activate separate gut-to-brain vagal circuits. When they are eaten together, the two circuits combine to drive overeating beyond what either causes alone [171]. Removing added sugar breaks this pairing. This is a central reason the SR™ Flexible Carnivore approach eliminates sugar while keeping natural animal fats.
Removing Irritants: Processed food additives, such as emulsifiers, promote low-grade intestinal inflammation [172], which alters the signals traveling up the vagus nerve. Eliminating processed foods removes these irritants.
Fiber, Protein, And Short-Chain Fatty Acids: The approach is flexible, not strictly carnivore, because fiber matters too. When gut bacteria ferment fiber, they produce short-chain fatty acids, which activate vagal afferent neurons and suppress food intake [173]. Without fiber, bacteria can still make some short-chain fatty acids from protein and from the gut’s own mucus [472, 473], but neither is a substitute when the gut is damaged. Protein fermentation also produces ammonia, p-cresol, and hydrogen sulfide, which promote inflammation and gut permeability [474], and an all-animal diet shifts the microbiome away from butyrate producers toward inflammation-linked species such as Bilophila wadsworthia [475]. In mice, even intermittent fiber deprivation led gut bacteria to feed on the protective mucus layer and erode it [476]. Fiber lowers the toxic byproducts of protein fermentation [477] and keeps bacteria fed without consuming the mucus barrier. If there is gut damage, fiber is not optional.
Walnuts And Seaweed: Walnuts are the protocol’s most proven fiber source for the microbiome. In a controlled feeding trial, 42 grams of walnuts daily for three weeks increased the butyrate-producing bacteria Faecalibacterium and Roseburia and lowered proinflammatory secondary bile acids [478]. Nori contributes differently. Its fiber, porphyran, is digested by gut bacteria carrying genes that are common in Japanese populations, who eat seaweed daily, but absent in North American gut data [479]. For most Western guts, nori’s value in this protocol is its anti-Candida effect alongside extended fermentation yogurt (Author’s Observation), not short-chain fatty acid production. Along with inulin and pumpkin, these foods keep the gut fed through Phase 1, and tributyrin is added in Phase 2 to deliver butyrate directly.
Serotonin: Approximately 90% of the body’s serotonin is made in the gut, mainly by enterochromaffin cells [174]. Gut serotonin does not cross into the brain. Instead, it activates vagal nerve endings that relay signals to the brain [174]. A healthier gut lining supports healthier serotonin signaling.
When fat reaches the small intestine, it triggers the release of cholecystokinin (CCK), a hormone that activates vagal afferents and signals fullness to the brain [175]. In my experience, as with other carnivores, fat is highly satiating, and a meal of fatty meat keeps me full for many hours. Some mouse studies seem to contradict this. In mice fed high-fat diets, vagal satiety signaling became blunted, and the animals overate [45, 176]. However, these were refined, obesogenic laboratory diets that typically combine fat with sugar or starch, not whole animal fat eaten without sugar. No human study has yet tested whether whole-food animal fat, eaten without sugar, blunts vagal satiety signaling. The flexible design accounts for this: fat comes from whole foods, sugar is removed, and fiber is added back.
In a survey of 2,029 adults following a carnivore diet, participants reported few adverse effects, high satisfaction, and improvements in health and well-being [177]. However, the results were self-reported, the participants chose to respond, and there was no control group, so the findings cannot prove that the diet caused the improvements.
Note: Bone broth, a staple of many carnivore diets, is excluded from this protocol whenever oxalates are a factor. See Why Collagen, Bone Broth, And Gelatin Should Not Be Used in the oxalate section.
Even though this diet contains some carbs, I still found it necessary to pay attention to how much fat I ate. If constipation is an issue, then I was not eating enough fat. I did not eat just any fat. Vegetable oils (grain oils) or seed oils were not a consideration. If you are cooking with it, the smoke point is also a consideration. Ghee, for instance, has a much higher smoke point than butter, so I do not use butter or olive oil for cooking.
There are many more good ones; these just happen to be the ones I use.
Flexible carnivore, in its most simplistic terms, is meat, fat, water, and salt.
The Warrior designation means it is a 20-hour fast with a 4-hour eating window. The Flexible designation of this diet is because it is not purely carnivore. This is because when the body detects low or no oxalate intake, it begins purging the oxalates stored in the body (Author’s Observation). This is why it is important to come off them slowly; oxalates are toxic and abrasive to the gut's mucosal lining. Additionally, the introduction of Candida die-off and bile sludge, which can be caused in part by oxalate dumping, can make the process extremely unpleasant.
Working up to this must be implemented slowly because if you are severely infected with oxalates, Candida, and bile sludge, the malaise from this combination can be catastrophic.
Phase 1 is where I prepared my body for Phase 3.
I prefer the OMAD protocol, but I do Warrior because of the timing needed for the Phase 2 backups and the scheduling of colostrum. I choose my 4-hour window from 10 AM to 2 PM and fit all my food and two doses of colostrum and zinc carnosine at the beginning and end of this window. I take 10 grams of colostrum, mixed with water, and take zinc carnosine one hour before I eat and again an hour after I eat. I sometimes mix colostrum into extended-fermentation yogurt, as colostrum works synergistically with yogurt. Any 4-hour window that works for you will work. The colostrum did not seem to elicit any improvement after 30 days.
Glycine is taken throughout all three phases. Its role in gut barrier and Candida support is covered under Support 3: Glycine, and its broader benefits are covered under Glycine in Amino Acid Uses, Toxicity And Side Effects.
Restoring the gut barrier and microbiome requires multiple mechanisms working together, including diet, fasting, probiotics, colostrum, zinc-carnosine, and the rest of the Support Stack. Based on my results, glycine is the foundation the other mechanisms build on (Author’s Observation). It supplies the raw material for the gut wall, the antioxidant that protects it, and the signals that calm inflammation and favor beneficial bacteria. The six effects below explain why.
Warning: Taking glycine in therapeutic amounts (above 15 grams per day) before bed can cause hypersensitivity to morning light, so that normal morning sunlight or indoor lighting feels harsh, and your sleep and wake times can shift further than expected (Author’s Observation). This has not been tested directly in humans, but the mechanism is plausible. Glycine promotes sleep and lowers core body temperature by acting on NMDA receptors in the suprachiasmatic nucleus, the brain’s master clock [187]. Those same NMDA receptors are the main pathway through which light resets the master clock [188]. In mouse brain tissue, glycine applied directly to the master clock shifted its rhythm, and the direction of the shift depended on the time of day it was applied [189]. In humans, 3 grams of L-serine, the amino acid the body uses to make most of its glycine, taken before bed enhanced the shift in the body clock produced by bright light the next morning [190]. If you notice this sensitivity, move more of your daily glycine earlier in the day, reduce the bedtime portion, and ease into morning light rather than going straight into bright sunlight. Discuss any dosing changes with your MD.
Oxalate And Vitamin B6: Glycine is not hydroxyproline, and its contribution to oxalate is far smaller, but it is not zero. In a human tracer study, glycine accounted for less than 5% of urinary oxalate at normal blood levels, but it contributed meaningfully when infused at ten times that rate [76]. At therapeutic doses, a small percentage of a large intake can still add to your oxalate load. Vitamin B6 helps counteract this. The liver enzyme that converts glyoxylate, the immediate precursor of oxalate, back into glycine is alanine:glyoxylate aminotransferase (AGT), and it requires P-5-P, the active form of vitamin B6, as its cofactor [191, 192]. When AGT works efficiently, glyoxylate is recycled into glycine instead of being oxidized to oxalate. In cell studies, adding vitamin B6 made AGT more effective and lowered oxalate and glyoxylate output [191]. In a clinical trial in primary hyperoxaluria type 1, a genetic disorder of AGT, vitamin B6 lowered urinary oxalate by an average of 25.5% [192]. Because that trial used high doses in a genetic disorder, the size of the benefit in people without it has not been established. Test your B6 status (Test, Do Not Guess), use the P-5-P form rather than pyridoxine HCl, and see the warning under B6 (Pyridoxine).
In a single-patient case report on refractory obsessive-compulsive disorder and body dysmorphic disorder, glycine at 0.6 to 0.8 grams per kilogram per day was used over 5 years, with marked improvement in both disorders and no reported adverse effects [193]. In my experience, 15 grams per day is a good maintenance dose, and above 15 grams is a therapeutic dose (Author’s Observation). I saw a noticeable improvement in gait and balance at 10.5 grams (1 tablespoon) of Microingredients glycine twice daily and never past 3 PM. I mix the glycine into my extended fermentation yogurt. When starting any new therapeutic, begin slowly with one teaspoon once per day, then increase from there. Everyone's optimal therapeutic dose will be different, so working closely with your functional medicine practitioner is imperative.
Glutamine is one of the most commonly recommended supplements for repairing the gut lining, and it was part of my original protocol. I removed it. The glutamine powder was inflammatory for me, and I do not need it because I get my glutamine from meat.
This is also one of the reasons I believe so many people recover when they switch to a carnivore diet. Glutamine is the primary fuel for the cells that line the small intestine, and it helps maintain the tight junctions that seal the gut barrier [194]. Meat is a rich natural source of glutamine, so a carnivore diet provides more of it daily through food, without a powder. If you are considering glutamine supplementation for a specific reason, discuss it with your MD.
My meals consist primarily of grass-fed, grass-finished beef with wild-caught salmon, shrimp, or scallops twice a week and two to six organic pastured egg yolks at every meal. For dessert, I have one cup of extended fermented yogurt with four to six full sheets of Nori seaweed and two teaspoons of glycine. Other seaweeds can be used, but Nori is low in iodine, and it would be difficult to overdose on it. Iodine is a mineral that very few people get enough of, but no worries when you are eating six sheets of Nori seaweed per day.
I use vitamins and minerals that showed up as deficient on my tests. Minerals and B vitamins took the biggest hit from the oxalate poisoning. I do not randomly take vitamins and minerals, nor do I follow recommendations from anyone. I go by the test data only.
What is the objective of this food? You must ask this question about any food you eat outside the carnivore diet. The following are the non-carnivore foods I kept, along with my reasoning.
Acclimating to this diet can take days, and you could very well heal yourself while doing so. Unfortunately, this was not the case for me, but I do not expect everyone to be as severely infected as I was.
Implementation of the SR™ Warrior/OMAD Flexible Carnivore Diet requires starting slowly with intermittent fasting. This means choosing an eating window of 6 or 8 hours, then slowly narrowing it until you reach a 4-hour window. I prefer OMAD, but this was not possible in Phase 2 because the oregano oil had to be separated from the extended-fermentation yogurt for at least a couple of hours.
The reason it is critical to be consistent with your fasting protocol is that, especially if you are chronically ill, the microbiome has been disrupted, and a new baseline has been established, so it must be brought back to a new healthy baseline. The question is, how long will it take on the SR™ Warrior/OMAD Protocol? The literature is all over the map on this due to the range of variables, including diet, genetics, the degree of microbiome disruption, and, in my opinion, the most significant variable of all: the level of oxalate infection. Every time the body dumps oxalate, it disrupts the microbiome (Author’s Observation). This does not even consider the effects of drug or alcohol consumption, poor food choices, and stress.
The estimate to establish a new microbiome baseline is weeks to months. In my case, it may be years, as I have already been on the SR™ for months with good results, but I am still dumping oxalates, which I have little control over.
Fasting can be challenging if you are poisoned by oxalates and have a Candida overgrowth, as it accelerates oxalate elimination and causes Candida to die off (Author’s Observation). The malaise can be extreme, so it's essential to listen to your body and continually adjust your approach. I discovered that Candida die-off and bile sludge symptoms were much more severe than oxalate toxicity, so I stayed focused on fasting and restoring the microbiome to improve the body's ability to process oxalate dumping.
Extended Fermentation Yogurt With GR-1 And RC-14. This is my daily ferment: four 5-billion CFU capsules (20 billion CFU) per batch, fermented 36 hours at 100°F, rotated with the other three Fantastic 4 cultures as described under Probiotics: The Fantastic 4. I mix my glycine into it, tear seven sheets of nori into it at serving every other day, and add 42 grams of walnuts. On days I do not use the yogurt, the nori goes into a seaweed burrito wrapped around my regular meal. Start with a quarter cup of yogurt and one sheet of nori; the yogurt and nori together are the strongest anti-Candida combination in Phase 1, and the die-off reflects that (Author's Observation).
Akkermansia is at the top of the probiotics list, but is not part of the Fantastic Four because we do not buy it or ferment it. It was just discovered in 2004, and as of late, everyone who manufactures probiotics has jumped on the Akkermansia bandwagon, but only one manufacturer, as of this writing, has proven that its probiotic reaches the mucosal layer. I do not recommend this probiotic unless you are unable to fast for at least 17 hours for whatever reason.
Akkermansia increases during fasting even without an extended fast. Nine subjects studied during Ramadan, who fasted 17 h/day for 29 days, showed a significant increase in Akkermansia [199].
Akkermansia muciniphila is a next-generation probiotic bacterium that plays crucial roles in maintaining gut health and influencing systemic metabolic and immune functions. Its key functions and mechanisms include:
Overall, Akkermansia muciniphila functions as a microbial guardian by maintaining the intestinal barrier, regulating metabolism, shaping the immune system, producing beneficial metabolites, and potentially impacting neurological health through multiple interconnected pathways.
Nori seaweed on its own can be effective in eradicating Candida overgrowth, but in combination with extended fermentation L. rhamnosus GR-1 and L. reuteri RC-14, it is absolutely lethal, so much so that during the heaviest die-off I had to regulate the seaweed down to 2 sheets per day and limit the probiotics to one-half cup of extended fermentation yogurt or less. I am now at seven sheets every other day (Author’s Observation). Thus far, C. albicans has not been able to adapt to this seaweed probiotic combination. Seaweed is so effective that one would want to start slowly and work up to a dose that works.
Nori’s value in this protocol is its anti-Candida effect, not fiber. Its fiber, porphyran, is digested by gut bacteria carrying genes that are common in Japanese populations, who eat seaweed daily, but absent in North American gut data [479]. For most Western guts, the protocol’s fiber comes from walnuts, inulin, and pumpkin.
Nori is the lowest-iodine of the common seaweeds, far below kelp or kombu, but iodine content varies by brand. Choose a brand that prints iodine on the label, and if you have a thyroid condition, keep your total under the 1,100 microgram adult upper limit [205] and recheck TSH (see Thyroid Test). Body size does not change this limit.
One virulence factor of C. albicans is its ability to form biofilms. The ability to create biofilm makes C. albicans more tolerant to commercial antifungal agents. The published evidence comes from a laboratory study of a related red seaweed, Gracilaria verrucosa, rather than nori itself. In that study, the highest inhibitory effect was observed in a fungal culture treated with a 25% seaweed extract concentration for 24 hours. The G. verrucosa extract contained steroids, terpenoids, and tannins that effectively inhibited biofilm formation by C. albicans at a concentration of 25% after exposure for 24 hours [206]. L. rhamnosus GR-1 and L. reuteri RC-14 also break down biofilm.
Warning: Brown Seaweed inhibits the formation of oxalate crystals [207]. This is significant because what I found is that it also significantly increases oxalate dumping. There is no literature on this, but I tested this multiple times, and it increases oxalate dumping every time I use it.
I was on Phase 1 for 12 weeks before the Candida die-off calmed down enough to go to Phase 2. This will be different for everyone.
We are now in the age of choosing a probiotic based on what you want to fix or change in your body and mind, and L. reuteri is a good example of this. However, this choice goes far beyond bacterial species. One must also select the strain of the species, which most manufacturers do not disclose on their labels. BioGaia, for instance, is one of the few that lists the strains it uses. This, along with being the most researched among human sources, is one of the many reasons L. reuteri remains at the top of my list after using it for over a decade.
L. reuteri strains lacked the robust inhibitory antimicrobial effects of bacterial pathogens when combined with other probiotic Lactobacillus species, such as L. acidophilus, L. gasseri, and L. johnsonii. By contrast, L. reuteri potently inhibited L. casei, which highlights the importance of species compatibility considerations when creating mixed-species probiotic formulations [208]. What this means is that you must know your objectives. If you want to maximize the effectiveness of L. reuteri, you must confirm that it does not conflict with any other probiotic in your probiotic formula. The same goes for Dr. Davis’s SIBO formula. L. reuteri should be made and taken separately from L. gasseri.
In other cases, probiotics can work synergistically. L. acidophilus (strains NK1, K3III24, 100 ash), Bifidobacterium adolescentis MC 42, B. bifidum, and B. gallinarum GB synergistically produce lectins with antimicrobial activity against clinical strains of nystatin-resistant Candida albicans, S. aureus, and their biofilms [160]. After significant research, I confirmed that Lactobacillus reuteri 6475 and 17938 and Bifidobacterium longum 1714 could be mixed in the same batch. This is also true with Lactobacillus gasseri BNR17 and Lactobacillus acidophilus La-14. This enables me to prepare The Fantastic Four simultaneously in two separate bowls.
Bacteriocins are ribosomally synthesized antimicrobial peptides produced by bacteria or, for our purposes, probiotics. They can kill or inhibit bacterial strains closely related or non-related to the bacteria themselves, but will not harm the bacteria themselves through specific immunity proteins. Bacteriocins may become a potential drug Candidate for replacing antibiotics to treat multiple drug-resistant pathogens in the future [209]. 99% of all bacteria probably produce at least one bacteriocin, most of which have not yet been identified because few researchers have looked for them [210]. We will, therefore, not attempt to give you the number of Bacteriocins per probiotic listed in The Fantastic 4 Probiotics.
In vitro, oxalate degradation does not reflect the ability of bacteria to metabolize oxalate in vivo after intestinal colonization [211]. This statement was made during an extensive study on probiotics and various disease states, including oxalate degradation. However, oxalate degradation by Lactobacillus indicates that out of 60 strains tested from 12 different species, strains L. acidophilus, and L. gasseri were most efficient in their ability to degrade oxalate in vitro [212]. In other words, science is not yet definitive, and one must experiment to find what works for each species and strain, as I do. The in vitro, however, does at least point one in the right direction.
On my first comprehensive stool test, I scored a 10 out of 10 on Dysbiosis and Metabolic imbalance and a 7 on inflammation. If you have ever wondered what suicidality looks like in the gut, this first test is it. On my second comprehensive stool test, I brought those scores down to 0, 2, and 2, respectively. On the first test, all primary gut bacteria were deficient with Euryarchaeota phylum, so low that it did not register. More on this below. Oxalobacter formigenes, which is a well-established gut bacterium that uses oxalates as fuel, was intact when tested. Because of the severity of my infection, this was not enough, and even taking up to 1.7 trillion CFU of the best probiotic I could find was not sufficient either. This was because the purging of oxalates consistently disrupted bacteria, far beyond what was tested. A study published as I was finishing this paper confirmed the need for a broader spectrum of gut bacteria or effective bacteriotherapy to address oxalate breakdown [213].
Warning: Inulin is a high FODMAP food (explained below), which means it can cause gastrointestinal distress if used in excess. Inulin is a fructan-type oligosaccharide that's found in many plants, which represents the O in FODMAP. This is a dichotomy because this high FODMAP fiber is instrumental in restoring the gut. Yet, if you have gastrointestinal issues, you will immediately be told to avoid high FODMAP foods. Slowly introducing inulin is critical. This is one of many cases where you absolutely do NOT want the whole food, as you will see below.
This is the probiotic information you need after someone tells you to eat more fiber. I will drill down on Faecalibacterium and what I consider to be the Fantastic 4 probiotics, with a comprehensive overview of L. reuteri, L. gasseri, L. acidophilus, and B. longum at the bottom. These are all oxalate degraders and will drive home the importance of Inulin. The following are inulin-responsive probiotics and are listed in order of responsiveness to inulin [218]. I personally have not found a probiotic that is not responsive to inulin. This is why it is also used in our yogurt-making process.
Faecalibacterium
Faecalibacterium is just one of 37 species listed here. The bottom line is the use of inulin is a critical factor in restoring the gut microbiome and overall emotional and physical health.
Inulin Safety: Under 40 grams daily is safe for healthy adults [216]. I currently only use inulin to make extended-fermentation yogurt, and even then I am careful about how much I use.
Until a study in 2024, it was thought that guar gum was beneficial for the gut. In a mouse model, a Guar gum-containing diet (GuD) increased the susceptibility to colonic inflammation. Unfavorable changes in gut microbiome activity leading to compromised gut barrier function following guar gum feeding contributed to increased colitis susceptibility [220].
Oxalate-Degrading Bacteria in Bifidobacterium and Lactobacillus [217]
It is more than just selecting the right probiotic species and strains; it is also about the dose or colony-forming units (CFUs) being accurate. We do this by extending the fermentation of yogurt or whatever you are fermenting, usually for up to 36 hours. Dr. William Davis has done the most experimentation with this and found that extending it to 48 hours killed many of the bacteria. This may not be the case with all probiotics, but it was with L. reuteri 6475 and 17938. Dr. Davis was able to take 2 billion CFUs of 6475 and 17938 and turn them into 200 to 260 billion CFUs per half cup of yogurt. He measured this with flow cytometry. Flow cytometry is a lab test that uses lasers to analyze the physical and chemical characteristics of cells and particles. Without extended fermentation, the effects of these probiotics may not even be noticeable.
The Fantastic 4 probiotics cover a broad range of issues, and I have tested them all. However, this science is still in its infancy, so expect even better results as it becomes more refined.
Displacement of possible pathogens is one of the many reasons why I believe I felt better with all the Fantastic 4. Attachment to the intestinal mucosa displaces Candida and makes it difficult to return. This is an essential factor for probiotics in the context of intestinal inflammation. Some probiotic microbes also share binding sites with enteropathogens and can hinder their attachment to host cells by binding to the same sites [160].
The gastrointestinal tract (GIT) is home to an organized microbial community (microbiota), which participates in metabolic, nutritional, biochemical, and immunological processes within the body. Hence, cell-to-cell interactions regulate microbial multiplication and maintain intestinal homeostasis, leading to a range of host responses against commensal and pathogenic organisms. The microbiome is an active ecosystem influenced by factors such as genetics, metabolism, nutrition, geographical location, stress, and antimicrobial treatment [160].
Some probiotics aid in the breakdown of complex macronutrients and provide the host with digestive enzymes and vitamins, thereby enhancing nutrient absorption. The ability of probiotics to promote lactose fermentation has made them useful in treating lactose intolerance in humans. Probiotic Bifidobacterium strains, such as B. longum, participate in the metabolism of oligosaccharides [160].
During aging, the gut microbiome undergoes alterations, and its mediated increase in intestinal permeability leads to chronic inflammation, decreased DNA repair efficiency, stem cell depletion, and cellular senescence in the organism. Altogether, these processes contribute to aging [5].
The decline of brain function in the elderly is linked to conditions such as delirium and dementia, and age-related changes in the gut microbiome may contribute to them [221]. Only by fully understanding the gut microbiome can we uncover more profound mysteries, with the aim of gaining a deeper understanding of its complex relationship with host aging. Unfortunately, we are not there yet, but I believe the Fantastic 4, along with the SR™ Gut Barrier and Microbiome Restoration, represents a foundational approach to living a disease-free life at any age.
Primary Objective: Eradicate Candida, Modulate Bladder Function
Attention, Men: Although the vast majority of studies on these synergistic probiotics have been conducted with women for the treatment of vaginitis, vulvovaginal candidiasis, and modulation and prevention of bladder infections, this powerful combination is also effective for the male bladder and gut. How do I know this? After reading the studies, I tried it on myself, and it worked exceptionally well for both bladder function and Candida eradication when combined with Nori Seaweed. The fascinating thing about these probiotics for women is that when taken orally, they will translocate to the vagina and kill Candida overgrowth, along with modulating the microbial environment of the vagina [158]. The same translocation, however, does not occur with the bladder. It manages to modulate this environment from the gut.
Where to purchase: Amazon.com
Tested: Yes
Administration: Extended Fermentation Yogurt
Probiotic Amount: This comes in one billion CFU capsules. There is another brand that comes in 2 billion CFU capsules. I started out with a 2 billion CFU starter. I am now using a 10 billion CFU starter.
A2 Half and Half: 24 ounces per 32-ounce bowl or 48 ounces per 8 yogurt jars
Inulin: 1 rounded tablespoon per 24 ounces or 2 rounded tablespoons per 48 ounces for 8 yogurt jars.
Fermentation Time: 36 Hours
Optimal Temperature: 100°F
Actual Temperature: 100°F
Recommended Amount: Half a Cup Daily
Therapeutic Amount: Self-determined.
Results: I did not see any noticeable results from using the capsules only. However, with extended fermentation, I saw significant results for bladder function and Candida die-off when I used it with nori seaweed within 48 hours.
Primary Objective: Microbiome Balance
L. reuteri ATCC PTA 6475, which is an isolate from Finnish mother’s milk, and L. reuteri DSM 17938, which is the daughter strain of Lactobacillus reuteri ATCC 55730, are bacteria originally isolated from the breast milk of a Peruvian mother. These are the two most researched L. reuteri strains on the market. This does not imply they are the best, just the most researched. These two strains are sold as BioGaia Gastrus on Amazon. I ultimately switched to using BioGaia Osfortis, which is just the 6475, because I like making my yogurt with the starter every time as opposed to using yogurt from a previous batch.
L. reuteri stimulates the cells lining the intestine to release oxytocin [227]. Oxytocin is normally produced in the hypothalamus, the area of the brain that controls body temperature, hunger, and thirst. However, L. reuteri is believed to inhabit the small intestine predominantly in humans and appears to have co-evolved with its other hosts. Oxytocin is a multifunctional hormone that affects not only social behavior, bone, and skin but also gut motility, inflammation, and the intestinal epithelial barrier. Therefore, L. reuteri signaling through oxytocin could potentially explain many of the systemic effects of this microbe [227].
In humans, intranasal administration of oxytocin was found to increase bonding-related behavior, including gaze-to-eye region, interpersonal trust, empathy, and social cognition. Oxytocin has also been shown to play a role in human parenting, and peripheral levels of oxytocin have been associated with reciprocal parent-infant interactions in both mothers and fathers [228].
The full effects of oxytocin are yet to be fully realized, and the fact that gut microbes can trigger oxytocin release raises more questions about the physiological and emotional systems it affects. In mice, the effects of L. reuteri on oxytocin and wound healing disappeared when the vagus nerve was cut, which suggests the gut signals the brain through this nerve [229].
Where to purchase: Amazon.com
Tested: Yes
Administration: Extended Fermentation Yogurt
Probiotic Amount: Ground up 10 tablets into a powder to equal 2 billion CFUs for 24 ounces of A2 half and half.
A2 Half and Half: 24 ounces per 32-ounce bowl or 48 ounces per 8 yogurt jars
Inulin: 1 rounded tablespoon per 24 ounces or 2 rounded tablespoons per 48 ounces for 8 yogurt jars
Fermentation Time: 36 Hours
Optimal Temperature: 100°F
Actual Temperature: 100°F
Recommended Amount: Half Cup Daily
Therapeutic Amount: Self-determined.
Results: Even though there is no literature on the ability of L. reuteri Strain 6475 and 17938 to degrade oxalates, I did notice a considerable reduction in my oxalate dumping and a lessening of symptoms. There is evidence of oxalate degradation in other L. reuteri strains.
Primary Objective: Oxalate Degradation
Where to Purchase LA-14: Amazon.com
Tested: Yes
Administration: Extended Fermentation Yogurt
Probiotic Mix Amount: One Capsule to equal 2 billion CFUs per 24 ounces of A2 half and half.
A2 Half and Half: 24 ounces per 32-ounce bowl or 48 ounces per 8 yogurt jars
Inulin: 1 rounded tablespoon per 24 ounces or 2 rounded tablespoons per 48 ounces for 8 yogurt jars
Fermentation Time: 36 Hours
Recommended Temperature Range: 98.6°F to 107.6°F
Actual Temperature: 100°F
Recommended Amount: Half Cup Daily
Therapeutic Amount: Self-determined.
Results: Mixed outcomes.
Primary Objective: Sleep
The term psychobiotic is used more often with B. longum 1714 because of its effectiveness with depression and anxiety than any other probiotic listed here.
Where to Purchase 1714: Amazon
When using it to make yogurt, one capsule is used to make the first batch, and a couple of tablespoons of the current batch are used to make future batches.
Tested: Yes
Administration: Extended Fermentation Yogurt
Probiotic Amount: One Capsule to equal 3 billion cells per 24 ounces of A2 half and half.
A2 Half and Half: 24 ounces per 32-ounce bowl or 48 ounces per 8 yogurt jars
Inulin: 1 rounded tablespoon per 24 ounces or 2 rounded tablespoons per 48 ounces for 8 yogurt jars
Fermentation Time: 36 Hours
Recommended Temperature Range: 96.8°F – 100.4
Actual Temperature: 100°F
Recommended Amount: Half a Cup Daily
Therapeutic Amount: Self-determined.
Results: I initially combined 1714 with LA-14, and it pushed the lids off the yogurt jars. I then fermented just 1714, and it did not push the lids off, but it did push the center of the lid up on the one-quart jars. 1714 is the only probiotic that did this. I also tried coconut milk, and it did not work; it remained liquid, and the cream separated, but there were chunks of coconut floating around, which is not recommended. Even with two ruined batches, I did notice a difference in sleep quality within 7 days.
1714 Sleep: Into the second batch, I took a nap and had the deepest sleep I have had in a long while. There is a question as to how long I will need to use this or any of these probiotics to achieve a permanent effect, or if that is even possible. I split a batch, so I will make 1714 and La-14 to address sleep and oxalate degradation simultaneously. Both oxalate dumping and Candida die-off disrupt sleep, and I was hoping this probiotic would override this, but it ultimately did not.
Objective: Body Composition
If you are suffering from SIBO, Dr. Davis recommends ATCC PTA 6475 and DSM 17938, L. gasseri BNR17, and Bacillus coagulans gbi-30 6086. Bacillus coagulans is not included on this list because it is not considered a natural part of the human gut flora, and I am simply not impressed with it. I highly recommend you purchase Super Gut if you want to go beyond The Fantastic 4 or if you need to ferment other foods because of dairy sensitivity.
Ultimate Yogurt Maker: This is the only one with a lifetime guarantee, which is a good thing since I run it around the clock. I do, however, recommend doing your research. You can buy this yogurt maker with eight 6-ounce jars or two one-quart bowls. It will be 48 ounces for either one, because you cannot fill the one-quart bowls to the brim without making a major mess.
2 Quart Measuring Cup: I use a large measuring cup as a mixing bowl so I can pour it directly into the 6-ounce jars when I am using those.
Extra Yogurt Bowls: I have one set of 6-ounce jars and two sets of one-quart Pyrex bowls. I got different colored silicone lids to decipher which bowl had what strain. I also bought two-cup Pyrex bowls to freeze the excess, as the 6-ounce jars are not freezer-compatible.
Every extended-fermentation yogurt recipe in this protocol calls for A2 half and half only. This is not a brand preference. It is a requirement for anyone engaged in restoring the gut barrier and microbiome.
Conventional cow’s milk contains two main forms of beta-casein, A1 and A2. They differ by a single amino acid, but that difference changes how the protein is digested. When A1 beta-casein is broken down in the gut, it releases an opioid peptide called beta-casomorphin-7 (BCM-7). A2 beta-casein releases little to none. A systematic review of the animal and human evidence found that A1 beta-casein, acting through opioid receptors in the gut, can slow intestinal transit and promote gastrointestinal inflammation, whereas A2 beta-casein does not [272].
Human trials point in the same direction. In a double-blind, randomized crossover trial, adults who drank conventional milk containing A1 beta-casein had more digestive discomfort, slower transit, higher inflammation-related markers, and lower fecal short-chain fatty acids than when they drank milk containing only A2 beta-casein [273]. Short-chain fatty acids are the primary fuel for the cells that line the colon and are central to barrier repair. An earlier blinded crossover study likewise linked A1 beta-casein to looser stools and to abdominal pain [274].
Animal studies show the mechanism at the tissue level. In mice, A1 beta-casein increased intestinal inflammatory markers, including myeloperoxidase, interleukin-4, and immunoglobulins, and provoked a Th2-type immune response in the gut that A2 beta-casein did not [275]. In rats, A1 beta-casein slowed gastrointestinal transit through an opioid-dependent pathway and increased colonic myeloperoxidase, a marker of neutrophil-driven inflammation [276].
The point is simple. Extended-fermentation yogurt is eaten daily throughout this protocol, and its purpose is to calm inflammation, feed the intestinal lining, and rebuild the microbiome. A dairy base that can promote inflammation and slow transit works against all three goals, especially in a gut that is already permeable. Extended fermentation reduces lactose, but it does not convert A1 beta-casein into A2. A2 half and half removes this variable entirely. Most human trials to date have been small, and larger studies are still needed, but the direction of the evidence and the low cost of switching make A2 the only sensible choice during gut restoration. If you cannot find A2 half and half or do not tolerate dairy at all, discuss alternatives with your MD and see SIBO Yogurt above regarding fermenting other foods.
Tributyrin is a butyrate delivery compound. I take Doctor's Best Tributyrin (CoreBiome), 300 mg softgels, and I began it in Phase 2, once the Phase 1 routine was tolerated. The manufacturer states that it supports gut barrier function within 48 hours; that is a product claim, and I did not find a peer-reviewed human trial behind it. My own experience was faster than the claim. Within 24 hours I noticed a clear improvement in my gait and balance, and I passed a massive amount of Candida, the largest die-off I have had in this protocol. I took my first dose at the same time as my daily nori seaweed, so I cannot say which of the two drove the die-off. What I can say is that the combination did more than nori and extended fermentation yogurt had done on their own over a long period of use (Author's Observation).
Dose and duration. This liquid softgel form was released in May 2025, and no published human study has tested it at any dose. The only published research on CoreBiome is the digestion and gut-model work cited below [277]. The 300 mg amount is the manufacturer's recommendation, not a dose established in a published study.
When I started tributyrin, I had been eating four tablespoons of ghee a day, used for cooking, for a long time. Ghee has more butyrate than the supplement. Four tablespoons carry about 1.5 grams of butyrate [284]. One 300 mg tributyrin softgel carries about 0.26 grams. I was eating roughly six times as much butyrate from ghee and getting none of the effect (Author's Observation). The reason is where the butyrate ends up, not how much you swallow.
Tributyrin was added to a routine I had been following for a long time: glycine, extended fermentation yogurt, nori seaweed, and walnuts. I took it with the nori, and the die-off that followed was larger than anything that routine had produced without it. I cannot separate the contribution of the two, and nori on its own is already the most potent food against Candida in this protocol (Author's Observation). No study has tested this combination, so I will not call it synergy as a scientific claim. What I can show is that each component attacks a different part of the Candida problem, and that tributyrin covers the one part the others do not.
Put together: the yogurt and nori combination kills Candida and keeps it from re-attaching; glycine repairs the wall Candida came through; walnuts clear the mitochondrial damage left behind; and tributyrin removes Candida's last two defenses, the invasive hyphal form and the biofilm that shields it. That is the most plausible explanation for why adding tributyrin to an already effective routine produced a response within 24 hours rather than weeks. Even though I noticed the most significant improvement with tributyrin, I believe that was because I was already on an aggressive gut healing protocol when I added it. Tributyrin was the last piece, and it may have been the most significant, but it worked on ground the rest of the protocol had prepared. The message is: do not skip anything (Author's Observation).
Two cautions. First, do not start all five on the same day. The die-off from this stack is substantial, and starting them together makes it impossible to tell which one is doing what. Build the routine in the order given in Phase 1 Implementation and add tributyrin once the yogurt and nori are tolerated. Second, I did not follow that advice perfectly myself: I took the first tributyrin with nori, which is why I cannot tell you which of the two did more. If you want that information for yourself, add tributyrin on a day you are not eating nori, and hold the rest of the routine constant.
Caution: The lab concentrations above are higher than what 300 mg of tributyrin produces in the gut [24], so the clinical effect likely comes from the combination of direct antifungal action, immune activation, and barrier repair rather than any one of them. Expect die-off. As with nori and the Fantastic 4, start with one capsule per day and increase only as the die-off symptoms allow.
Oregano oil with black seed oil, and nystatin through your MD, were the original Phase 2 antifungals in this protocol, and they remain available as backups: use them if tributyrin is not tolerated, or if die-off plateaus and your retest is still not clean. Everything below describes how I used them.
As a behavioral microbiome scientist, I have always been uncomfortable with oregano oil because there is no established clinical dose. The only human dosing study I am aware of gave adults with intestinal parasites 600 mg of emulsified oregano oil daily for 6 weeks [286]. It was small and had no control group, so it does not establish a validated dose. Beyond that study, timing guidance comes from clinics that use herbal antimicrobials rather than from research.
In 2016, I developed a severe bladder infection while under a urologist’s care. After five rounds of antibiotics, the last one through a PICC line, I was at the end of my rope. By the time it recurred again, I had thoroughly researched oregano oil and began a regimen of 300 mg of oregano oil containing 225 mg of carvacrol, the primary active compound in oregano oil. This finally resolved what five rounds of powerful antibiotics could not, and without the severe damage (Author’s Observation). This does not mean that oregano oil spares good bacteria; in my experience, the damage is simply not remotely as severe as with antibiotics.
For this microbiome restoration protocol, I doubled the oregano oil dose to 600 mg per day, using a product with a lower carvacrol concentration that supplied 325 mg of carvacrol, 100 mg more than my original regimen. Clinics that use herbal antimicrobials generally consider this a moderate amount and limit use to no more than 4 to 6 weeks (Author’s Observation). The one human dosing study also ran for 6 weeks [286].
Phase 2 Implementation: I purchased Micro Ingredients Oil of Oregano Softgels in a 150-pack. This worked out to 37.5 days at 600 mg/day. I would take four softgels with my main protein meal and keep them at least 2 hours away from when I ate my extended-fermentation yogurt. I took Kyolic Aged Garlic along with this.
Before I completed Phase 2, I had to engage Phase 3 because of a painful gallbladder with a fluttering, spasm-like sensation. I was so toxic that it took six olive oil flushes before the gallbladder pain and spasms calmed down. This will be different for everyone.
Phase 2 is the most aggressive step in this protocol, which is exactly why it must also be the most flexible. The goal is to reduce Candida and pathogenic overgrowth without undoing the beneficial microbial rebuilding achieved in Phase 1. How hard you need to push depends on how severe your overgrowth is, how your body responds, and what your testing shows.
Oregano oil is a powerful, broad-spectrum antimicrobial: it kills bacteria as well as fungi. Origanum oil has demonstrated antifungal activity against Candida albicans [287]. Its breadth raises concern about collateral effects on beneficial bacteria; however, in laboratory testing, carvacrol- and thymol-containing essential oils inhibited pathogens such as Salmonella and E. coli with little inhibition of lactobacilli and bifidobacteria [288]. Whether the same selectivity holds in the human gut has not been established. In a small retrospective study, herbal antimicrobial regimens that include oregano performed comparably to the antibiotic rifaximin for small intestinal bacterial overgrowth, but those regimens were clinician-directed and time-limited [289].
Some people will be able to recover without oregano oil at all. Black seed oil (Nigella sativa) is a much less harsh option and, in my experience, a more selective one. It has a long history of food use, a favorable safety record in human studies, and anti-inflammatory and antioxidant properties alongside its antimicrobial effects [290]. Its primary active compound, thymoquinone, is fungicidal against Candida glabrata in laboratory testing [291]. For those with milder overgrowth, black seed oil combined with the Phase 1 foundation of fasting, extended-fermentation yogurt, and nori seaweed may be enough. Others may use black seed oil alongside a lower dose of oregano oil, or step up to oregano oil only if symptoms and test results fail to improve.
Nystatin: A Narrower Option To Discuss With Your MD. Nystatin is a prescription antifungal, and unlike oregano oil, it is not a broad-spectrum antimicrobial. It binds to sterols in fungal cell membranes, which bacteria do not have, so it targets Candida without directly killing gut bacteria. Taken by mouth, it is not absorbed from the gut, so it acts where the overgrowth is [292]. That makes nystatin the narrower choice when testing and symptoms point to Candida rather than bacterial overgrowth. It does nothing for SIBO or other bacterial overgrowth, which is where oregano oil’s breadth can be an advantage. Clearing Candida can still shift the bacterial community indirectly, so a narrower tool is not the same as no effect on the microbiome.
If Phase 1 is already producing strong die-off symptoms, do not add nystatin, oregano oil, or black seed oil on top of them without your MD. Add one change at a time so you can tell what is causing what (Author’s Observation).
I had to go with oregano oil. My case was severe, with oxalate toxicity, Candida overgrowth, and bile sludge all at once, and it warranted the stronger approach. That does not make it the right choice for you.
All of these options must be discussed with your MD. Black seed oil can lower blood sugar and blood pressure [290], which matters if you take medication for either, and oregano oil carries its own risks with extended use. Nystatin requires a prescription, so your MD decides whether it fits your case. Whether you use oregano oil, black seed oil, nystatin, or a combination, the amount and the timeline must be determined by you and your MD based on your symptoms, your test results, and how your body responds. Use the Burris Gut Health Checklist to track your progress so that every adjustment is based on data rather than guesswork.
Phases 1 and 2 clear Candida and seal the gut barrier. Phase 3 repairs what they leave behind: damage to the mitochondria, the energy-producing structures inside every cell.
The extended fast and the olive oil flush belong here for two reasons:
Phase 3 closes with Mitochondrial Regeneration and the Mitochondria Supplement Stack, alongside three tools already in this protocol: walnuts and urolithin A, glycine and glutathione, and red-light therapy.
Phase 3 consists of a 24 to 44-hour fast one to three times a week, followed by an olive oil flush. In mice, a 24-hour fast activates fatty acid oxidation and boosts the regenerative capacity of intestinal stem cells [294], and repeated cycles of prolonged fasting promote regeneration of blood-forming stem cells [295].
The olive oil flush consisted of 3-4 ounces of olive oil with an equal amount of lemon juice, which will be reduced to 1 to 2 ounces once healed. In the early days of doing these flushes, I experimented with 4, 6, 8, 12, and 16 ounces of olive oil, and there was no increased effect past 4 ounces.
Warning: A stone that passes during a flush can become lodged in the common bile duct and cause a blockage, an infection (cholangitis), or pancreatitis, all of which can be life-threatening [296]. Do not do a flush without your MD’s approval, especially if you have known gallstones. Go to an emergency room if you develop fever or chills, yellowing of the skin or eyes, dark urine, abdominal pain that lasts more than a few hours, or persistent vomiting.
Why is this phase critical? The biliary duct network, known as the biliary tree, is a branching system that transports bile from the liver to the gallbladder and the intestine, which is essential for digestion and the elimination of metabolic waste. This sophisticated ductal network is essential for precise bile delivery and overall digestive health [297].
MDs will tell you not to do a liver-gallbladder flush and to let the bile ducts and gallbladder clear on their own. What they do not tell you is that the standard of care for gallstones is the surgical removal of the gallbladder (cholecystectomy). Let's take a look at the data.
Deaths in the US From Gallbladder Surgery: Approximately 2,000 to 3,000 deaths annually
Deaths Worldwide From Olive Oil Flushing: No documented deaths
MDs will also tell you that gallstones cannot pass through the cystic duct. As someone who has passed rock-hard gallstones that you could make jewelry out of, I can definitely say this is false. It is true, however, that stones can get stuck in the cystic duct. This happened to me twice, and I had to do another flush the following morning. This was in 2012, when I initiated this process, and it has not happened since, primarily because I do liver gallbladder flushes on the regular.
Bile sludge is thought to be a precursor to gallstones and liver stones. I have experienced both, and I can tell you that this is indeed accurate. Advanced spectroscopic techniques have greatly improved the analysis of gallstone composition [298], and in one chemical analysis of 40 gallstones, 25 contained oxalate [299]. There are many types of gallstones, and oxalate is a common component.
Any time I take olive oil, I always use an equal amount of lemon juice. If constipation is an issue, I will do 2-3 ounces in the morning and 2- 3 ounces at night before bed. After 2 months of 24-hour fasting, constipation became less of an issue, so I lowered the dose.
The most common symptomatic manifestation of gallstones is episodic upper abdominal pain. Characteristically, this pain is severe and located in the epigastrium and/or the right upper quadrant. The onset is relatively abrupt and often awakens the patient from sleep. The pain is steady in intensity, may radiate to the upper back, be associated with nausea, and lasts for hours to up to a day. Dyspeptic symptoms of indigestion, belching, bloating, abdominal discomfort, heartburn, and specific food intolerance are common in persons with gallstones but are probably unrelated to the stones and frequently persist after surgery [300]. This is only one of the many reasons surgery does not make sense for most people.
Bile acids are synthesized from cholesterol and are known to be involved with the emulsification and digestion of dietary lipids and fat-soluble vitamins. Outside of this role, bile acids can act as cell signaling effectors. Bile acids are the end products of cholesterol metabolism and can contribute to hepatic, intestinal, and metabolic disorders [301].
Neuromyelitis Optica [302] is one of the neurological autoimmune conditions in which altered bile acid levels have been found [303, 304]. This was one of the multitude of symptoms I had and recovered from. Another theory is that oxalate crystals travel down the optic nerve from the brain (Author’s Observation). This is why I am still flushing oxalate crystals from my eyes with water up to 10 times a day. The medical literature does not make the connection between oxalate and this condition, nor does it explain how to reduce bile sludge effectively.
Check with your Functional Medicine MD to determine the dosage of each supplement.
Mitochondria are engaged in the pathogenesis of human diseases and aging directly or indirectly through a broad range of signaling pathways. They are the cell's primary source of ATP (Adenosine triphosphate) and play a pivotal role in cell life and death. ATP is the energy source for use and storage at the cellular level [305]. This is why most in the medical community refer to the mitochondria as the cell's powerhouse.
Due to their central role in cell life and death, mitochondria are also involved in the pathogenesis and progression of numerous human diseases, including, among others, cancer, neurodegenerative and cardiovascular disorders, diabetes, traumatic brain injury, and inflammation [305].
The mitochondrial response to stress is communicated both locally within the cell and systemically throughout the body. Exposure to stress mediators precipitates the mitochondrial release of signaling molecules, collectively called mitokines. Mitokines serve as signals that indicate mitochondrial fitness, which is particularly important in environmental stressors. Mitokines include various mitochondrial metabolites, calcium, and reactive oxygen species (ROS). When elevated, ROS overwhelms the cell's antioxidant capacity and promotes oxidative stress, causing cell death and tissue damage. These mechanisms allow mitochondria to influence broad physiological processes throughout the body, including molecular mechanisms of aging and stress-related conditions, psychiatric disorders, cardiovascular disease, obesity, diabetes, and cancer [306].
If you view your body as an electric vehicle, the batteries would be the mitochondria. Unfortunately, over time, the batteries become dysfunctional and slowly die, while your energy slows down until the entire machine dies unless there is consistent maintenance and replacement of the dysfunctional cells. I know this is an oversimplification, but the important thing is to understand the impact and importance of mitochondria. Maintenance and replacement of the mitochondria is a multipronged approach that includes diet, exercise, and supplementation, which we will discuss below.
If you would like to go full geek on mitochondria, especially in terms of the brain and human behavior, you may want to look at a book called Brain Energy. I am not in agreement with this author's assertion that the mitochondria are at the root of mental illness, but he is at least headed in a good direction.
PQQ (Pyrroloquinoline Quinone): PQQ is associated with biological processes such as mitochondriogenesis, reproduction, growth, and aging. In addition, PQQ attenuates clinically relevant dysfunctions (e.g., those associated with ischemia, inflammation, and lipotoxicity) [307]. This is the only supplement I am aware of that regrows new mitochondria.
Niacin: Niacin (vitamin B3) comes in two main forms, nicotinamide (also called niacinamide) and nicotinic acid. Nicotinic acid causes flushing, while nicotinamide does not. Both increase NAD+ (nicotinamide adenine dinucleotide), but only nicotinic acid improves your lipid profile [308]. Niacin modulates SIRT1 (sirtuin 1) [309], which is how nicotinic acid inhibits vascular inflammation [309].
NAD+: Nicotinamide adenine dinucleotide (NAD+) is an important coenzyme for redox reactions (electron transport and transfer), making it central to energy metabolism.
The slow, inevitable aging process has been described as a "cascade of robustness breakdown triggered by a decrease in systemic NAD+ biosynthesis and the resultant functional defects in susceptible organs and tissues [310]. Niacin is an efficient NAD+ booster for treating mitochondrial myopathy [311]. In this study, 750 to 1000 mg was used for 4 and 10 months, but I have looked at individual data that showed improvements in NAD+ with much less using nicotinic acid. I take 500 mg of nicotinic acid after eating. Taking it on an empty stomach can cause significant flushing. This is another vitamin that you will want to start slowly. I am currently using niacinamide.
NMN and NR (Nicotinamide Mononucleotide and Nicotinamide Riboside): I do not recommend NMN or NR.
By middle age, our NAD+ levels have plummeted to half that of our youth. Numerous studies have demonstrated that boosting NAD+ levels increases insulin sensitivity, reverses mitochondrial dysfunction, and extends lifespan. NAD+ levels can be increased by activating enzymes that stimulate the synthesis of NAD+, by inhibiting an enzyme (CD38) that degrades NAD+, and by supplementing with NAD precursors, including niacin [310].
Luteolin: CD38 is an enzyme that increases with age via inflammation, and this decreases NAD+. This inflammation is induced by senescent cells (damaged cells that have stopped dividing but do not die). Luteolin and other supplements, such as apigenin, suppress CD38 [312]. This is why autophagy may be even more important as we age because the body consumes senescent cells when in an autophagic state, which, in theory, should also help to lower CD38. I say in theory because there are no studies on this subject at this time.
Urolithin A: Urolithin A (UA) is produced by gut microflora from foods rich in ellagitannins. UA has been shown to improve mitochondrial health preclinically and in humans. Not everyone has a microbiome capable of producing UA, making supplementation with UA an appealing strategy [313]. Urolithin A has been shown to promote mitophagy (clearance of dysfunctional mitochondria), mitochondrial function, and improved muscle function across species in different experimental models and across multiple clinical studies [196]. One cause of the loss of mitochondrial homeostasis during aging is the accumulation of dysfunctional mitochondria [196]. Fasting and exercise also induce mitophagy. Mitophagy must occur to enable mitochondrial biogenesis (generation of new mitochondria).
AKG (Alpha-Ketoglutarate): Recent studies in experimental models have shown that dietary AKG reduces reactive oxygen species (ROS) production and systemic inflammatory cytokine levels, regulates metabolism, extends lifespan, and delays the occurrence of age-related decline [314]. Mechanistically, AKG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of complex mitochondrial enzymes [315].
ALA (R-Alpha Lipoic Acid): The R in Alpha Lipoic Acid indicates it is the natural, more bioavailable form. This supplement must be taken on an empty stomach for maximum bioavailability. ALA is synthesized in the mitochondria and plays an essential role as a cofactor, assisting in the enzymatic nutrient breakdown.
ALA is considered generally safe. A meta-analysis of 71 randomized placebo-controlled trials found that ALA did not increase the risk of side effects, including in studies of children and adolescents [316]. The max I take is 600 mg a day on an empty stomach.
CoQ10 (Coenzyme Q10): In addition to shuttling electrons in the mitochondrial respiratory chain, CoQ10 serves several additional cellular functions, including the transfer of electrons in plasma membranes and lysosomes, modulation of apoptosis (cell death) proton transport of uncoupling proteins, and antioxidant activity including inhibition of lipid peroxidation [317]. My numbers were good for CoQ10, so I do not supplement, but if I did supplement, I would use the freeze-dried beef heart capsules.
L Carnitine: L-carnitine is one of the key nutrients for proper mitochondrial function and is notable for its role in fatty acid oxidation.
L-carnitine also plays a major part in protecting cellular membranes, preventing fatty acid accumulation, modulating ketogenesis and glucogenesis, and in the elimination of toxic metabolites. L-carnitine deficiency has been observed in many diseases, including organic acidurias, inborn errors of metabolism, endocrine imbalances, and liver and kidney disease [318]. I do not supplement with l-carnitine.
Creatine: Creatine monohydrate (CrM) is one of the most widely used nutritional supplements among active individuals and athletes to improve high-intensity exercise performance and training adaptations. However, research suggests that CrM supplementation may also serve as a therapeutic tool in the management of some chronic and traumatic diseases. Creatine supplementation has been reported to improve high-energy phosphate availability as well as have antioxidative, neuroprotective, anti-lactic, and calcium-homoeostatic effects. These characteristics may directly impact mitochondrion survival and health, particularly during stressful conditions such as ischemia and injury [319]. I do not supplement with creatine.
Omega-3 Fatty Acids: Mitochondrial dysfunction represents a common early pathological event in brain aging and in neurodegenerative diseases, e.g., Alzheimer's (AD), Parkinson's (PD), and Huntington's disease (HD), as well as in ischemic stroke. In vivo and ex vivo experiments using animal models of aging and AD, PD, and HD mainly showed improvement in mitochondrial function after treatment with polyunsaturated fatty acids (PUFA), such as docosahexaenoic acid (DHA) [320]. My test showed low omega-3, so I supplement with Total Omega 3 Full Spectrum by Sports Research.
B Complex: Mitochondria are compromised by a deficiency of any B vitamin [321]. More details on this are in the B vitamin section of this paper.
Vitamin D: Skeletal muscle mitochondrial function is the biggest component of whole-body energy output. Mitochondrial energy production during exercise is impaired in vitamin D-deficient subjects. Vitamin D supplementation initiated in older people improved muscle mass and strength [322].
Vitamin C: Vitamin C quenches mitochondrial ROS (reactive oxygen species) and inhibits oxidative mitochondrial DNA damage [323].
Minerals: Mitochondria are particularly rich in minerals, where they function as essential cofactors for mitochondrial physiology and overall cellular health. Eleven of the 12 minerals essential for human health have important roles within mitochondrial metabolism. However, this picture is not yet complete [324]. The bottom line is to make sure that all minerals are well-balanced.
When done right, Candida die-off represents multiple mechanisms that cause high levels of toxicity and severe malaise. A primary objective is to break down the biofilm that protects Candida, which releases its own toxins and can cause constipation, one of the most significant issues associated with Candida die-off (Author’s Observation). Then there are all the pathogens that are harbored within this protective layer on top of the Candida itself. This process can then lead to further inflammation and a persistent disruption of the microbiome. To counteract this, several support components are available for all three phases, as listed below.
It is critical to initiate the SR™ Gut Barrier and Microbiome Restoration with the support stack because the toxins from Candida die-off, biofilm, and all the pathogens they harbor can overwhelm the system and may cause you to quit the protocol before completion.
Olive oil: Although olive oil is the foundation for Phase 3, it is listed first here because it is used to clear the liver, gallbladder, and bile ducts of bile sludge. Even though I followed my own protocol, I had to interrupt it in month four to do an olive oil flush to clear bile sludge, which was characterized by right abdominal pain just below the bottom rib and consistent sleep disruption. Most people will not be able to do a 24-hour fast, then drink 4 ounces of olive oil out of the gate. This is why it is used only as support initially. However, like me, because of the high toxic load and gallbladder pain, one may need to interrupt the protocol and focus on flushing the toxins from the liver and gallbladder.
An in vitro study showed that olive leaf aqueous extracts destroyed 15% of C. albicans within 24 hours [328].
In a small study, heavy exercise increased gut permeability in healthy volunteers, with 70% improvement with both zinc-carnosine and colostrum, and even better results when using both [329]. This, of course, is not the exact mechanism within our context, but it was close enough for me to take myself and recommend.
I used PepZinGI, a patented zinc-carnosine complex with the most research behind it; however, I cannot say definitively that it is the most effective. As for the colostrum, I use Micro Ingredients Bovine Colostrum Powder. This colostrum is freeze-dried and grass-fed, two key factors to consider when purchasing colostrum.
I take colostrum with zinc-carnosine as a 30-day course at the start of Phase 1, one hour before and one hour after my eating window, then stop. The study behind this combination ran 14 days [329]; 30 days is my recommendation, not a study result. Zinc itself continues as a regular supplement after the colostrum course ends, except on days I eat a high-zinc food such as pumpkin seeds. Any time I take zinc I take copper with it, because zinc drives copper down (see Support 10: Copper). Your test results, not this paragraph, should decide your zinc, copper, and other supplement combinations (Author's Observation).
Colostrum contains 10 components effective toward candida overgrowth, but lactoferrin is the most effective. Many supplement companies market high IgG (immunoglobulin G), but this can reduce lactoferrin levels. My objective was to balance the microbiome; therefore, the colostrum needed to be balanced. I added 250 mg of lactoferrin twice daily, along with colostrum and zinc-carnosine, and initially experienced a significant die-off and backed off to 250 mg daily. I then picked it back up to 250 mg twice daily and saw improvement every day. This combination represented the most significant for healing the gut. The following is a breakdown of what lactoferrin affects.
Lactoferrin exhibits broad antifungal activity against several Candida species, including C. albicans, C. glabrata, and C. tropicalis. One of the primary mechanisms involves iron deprivation. The iron-free form of lactoferrin significantly reduces the viability of C. albicans cells depending on time, temperature, and pH, with the most pronounced effect at neutral pH and 37 degrees Celsius. When lactoferrin is saturated with iron, its fungicidal properties are abolished, confirming that iron removal from the environment is a crucial factor limiting the growth of yeast-like fungi [330].
A systematic review and meta-analysis confirmed that bovine lactoferrin and its peptide derivatives can significantly inhibit the growth of C. albicans, both in azole-susceptible and azole-resistant strains [331].
Lactoferrin significantly inhibited biofilm formation in clinical isolates of Pseudomonas aeruginosa, with the most marked effect at 2 mg/ml. Supplementation of lactoferrin to preformed biofilm demonstrated a reduction in biofilm, suggesting that lactoferrin may also have destructive effects on established biofilm [332].
Lactoferrin has also been reported to inhibit biofilm formation by, and to disrupt established biofilms of, Staphylococcus species, including methicillin-resistant strains [333].
The anti-biofilm effects extend to oral pathogens as well. Biofilm formation of P. gingivalis and P. intermedia over 24 hours was effectively inhibited by lower concentrations (at or above 8 micrograms/ml) of various iron-bound forms of bovine and human lactoferrin [334].
In terms of broader mechanisms, lactoferrin inhibits biofilm formation and disrupts existing biofilms either by preventing lectin-dependent bacterial adhesion or by stimulating bacterial motility. Lactoferrin also appears to inhibit bacterial adhesion to epithelial cells and intestinal mucosa [333].
Bovine lactoferrin demonstrates high bioavailability after oral administration, high selectivity toward cancer cells, and a broad range of molecular targets that control tumor proliferation, survival, migration, invasion, and metastasis. Notably, lactoferrin can promote or inhibit cell proliferation and migration depending on whether it is acting on normal or cancerous cells, and its administration is well tolerated without significant adverse effects [335].
The mechanisms are multifaceted. In the presence of lactoferrin, different cancer cells suffer significant damage, including cell cycle arrest, cytoskeletal damage, and induction of apoptosis, along with decreased cell migration [336].
Lactoferrin also works through iron metabolism. By chelating free iron ions, lactoferrin reduces oxidative stress and inhibits the mechanisms that promote carcinogenesis, while also exhibiting immunomodulatory and anti-inflammatory effects that may enhance the body's antitumor response [337].
One important caveat: some studies have indicated that high levels of endogenous human lactoferrin expression may be linked to increased carcinogenesis and metastasis, reflecting its context-dependent role in cancer. The distinction between exogenous supplementation and endogenous expression appears to matter considerably [338].
Lactoferrin's antimicrobial reach is broad. It displays antiviral activity against both DNA and RNA viruses, including rotavirus, respiratory syncytial virus, herpes viruses, and HIV. The antiviral effect lies in the early phase of infection, where lactoferrin prevents viral entry into host cells either by blocking cellular receptors or by directly binding to virus particles [339].
Lactoferrin's antiviral activity has been studied against SARS-CoV-2, Zika, Dengue, Hepatitis, and Influenza viruses in vitro, demonstrating not only competitive binding properties but also potential intracellular impacts on host cells, such as enhancing cellular defenses [340].
Oral supplementation shows practical protective value. Lactoferrin consumption reduced the incidence of noroviral gastroenteritis in children, leading to protection against viral infections [341].
Warning: The effects of glycine on cancer are context-dependent, so check with your physician first before implementing this supplement if you have cancer.
Glycine is a precursor of glutathione, and glutathione is needed by the immune cells that clear Candida. In a mouse model, glutathione reductase, the enzyme that recycles glutathione into its active form, promoted fungal clearance and suppressed inflammation during systemic Candida albicans infection [342]. When I took therapeutic amounts of glycine, I passed so much material that appeared to be Candida that I had to cut back several times. Clearing Candida biofilm matters for another reason: the biofilm can shelter viruses. Herpes simplex virus 1, which causes cold sores, showed decreased sensitivity to antiviral drugs and laser treatment when entrapped in Candida albicans biofilm [343].
In a single-patient case report on refractory obsessive-compulsive disorder and body dysmorphic disorder, glycine at 0.6 to 0.8 grams per kilogram per day was used over 5 years, with marked improvement in both disorders and no reported adverse effects [193]. Per my weight, 0.8 grams per kilogram would be 61 grams per day, more than twice my highest dose. My own dosing history follows.
Warning: Glycine is generally well-tolerated at typical doses, although high doses commonly cause digestive side effects such as nausea, vomiting, and diarrhea [344]. When I increased my intake to 27 grams a day, I passed large amounts of what appeared to be Candida and biofilm, the most I have ever experienced. Glycine is not an established antifungal, but several of its known actions could help explain what I observed. In laboratory studies, glycine protects the intestinal barrier by preserving tight junction proteins under cellular stress [179], and it reduces inflammatory activity in immune cells by activating glycine-gated chloride channels [182]. Glycine is also a precursor of glutathione, the body’s primary intracellular antioxidant, which declines with age and can be restored in older adults by supplementing glycine with cysteine [181]. Finally, glycine interferes with the construction of bacterial cell walls [186], which may weaken the bacterial component of mixed bacterial and fungal biofilms in the gut.
I took 6 grams of glycine per day before increasing it, and I did not notice any die-off. Eighteen grams and above caused significant to massive Candida die-offs, so I settled on 9 grams (one tablespoon). I later increased to 18 grams, then at 21 grams I noticed an improvement in my gait and balance, and then at 27 grams I got up in the morning and emptied my bladder for the first time in 15 years. I am now using between 21 and 27 grams per day over a period of 14 hours. Glycine is the most effective amino acid I have used for a multitude of issues, and it has the weakest study data.
For glycine’s additional benefits and side effects, see Glycine under Supplements. For dosing and the morning light and oxalate warning, see Glycine under Phase 1 Implementation.
NAM (niacinamide) exhibited significant antifungal activity against C. albicans, including fluconazole-resistant isolates. NAM could also effectively suppress biofilm formation. In addition, NAM exhibited antifungal activity against non-Candida albicans species and Cryptococcus neoformans. The antifungal activity of NAM was further confirmed in a mouse model of disseminated candidiasis. These findings suggested that NAM might exhibit antifungal activities by affecting cell wall organization [345].
S. boulardii CNCM I-745 releases a serine protease capable of digesting pathogenic toxins, such as Clostridium difficile toxin A and similar pro-inflammatory molecules, thereby reducing their binding to intestinal receptors and limiting mucosal damage. This enzymatic detoxification is relevant to Candida die-off because fungal metabolites and endotoxin-like compounds (e.g., acetaldehyde, mannans) can provoke similar inflammatory cascades, although this protection has not been studied in Candida die-off [346] (Author’s Observation).
NIH data show that CNCM I-745 inhibits pro-inflammatory signaling. These pathways are central in immune activation during Candida die-off. Based on this, I use CNCM I-745 to help limit the inflammatory burden of die-off [347] (Author’s Observation).
The probiotic supports the repair and maintenance of epithelial tight junctions, reducing intestinal permeability caused by microbial toxins and inflammation. By maintaining this barrier [348], CNCM I-745 may limit the passage of Candida-derived toxins into circulation and ease die-off symptoms like fatigue and headaches (Author’s Observation).
CNCM I-745 fosters restoration of beneficial gut microbiota and promotes short-chain fatty acid production (notably butyrate) that supports mucosal healing and toxin clearance. In my experience, these actions speed recovery after microbial die-off [349] (Author’s Observation).
In a mouse model, astaxanthin has been shown to be a potent antioxidant and anti-inflammatory compound that positively influences gut microbiota, reduces systemic and local inflammation, and supports gut barrier integrity [350]. I used one bottle of this, but did not experience the effects of S. boulardii, so I stopped taking it.
Tryptophan plays a crucial role in sleep regulation, primarily because it serves as a precursor to serotonin and melatonin, two neurochemicals central to sleep-wake cycles. Increased tryptophan intake, whether by supplementation or tryptophan-rich foods, has been shown in randomized controlled trials and meta-analyses linked from NIH sources to improve sleep quality and duration in individuals with mild insomnia or sleep disorders [351].
For tryptophan’s additional benefits, side effects, and dosing, see Tryptophan (TRP) under Supplements.
Support 8: L-Theanine (in the form of Suntheanine®)
L-Theanine, an amino acid primarily found in tea leaves, supports sleep by modulating neurotransmitter activity, promoting relaxation, and improving sleep quality according to NIH-referenced studies. Research demonstrates that L-Theanine increases brain levels of gamma-aminobutyric acid (GABA), serotonin, and dopamine, neurotransmitters that are closely linked with relaxation and regulation of the sleep-wake cycle [352]. I used Tryptophan to help me fall asleep and L-theanine to stay asleep. This is, at best, difficult when oxalate dumping and experiencing Candida die-off.
Magnesium Citrate if Oxalate poisoned or Magnesium Glycinate if not poisoned. Magnesium glycinate and citrate are among the most bioavailable forms of magnesium, and both assist in over 300 metabolic processes, including mitochondrial function [353]. For our purposes, magnesium glycinate serves as a sleep aid [354], and magnesium citrate helps prevent calcium oxalate crystals from forming.
Conversely, adequate or supplemental dietary copper has been shown to support intestinal barrier integrity, especially in settings such as alcohol-induced intestinal injury. Proper copper supplementation can promote cell growth, reduce oxidative stress (ROS), and restore expression of genes related to the intestinal barrier [355]. The zinc/copper ratio impacts immune, neurological, and hormonal health; maintaining balance is critical [356].
Sunlight (especially UVB) and red/near-infrared light via photobiomodulation (PBM) modulate the gut microbiome by promoting beneficial bacteria, suppressing dysbiosis, and supporting immune and anti-inflammatory pathways. Concurrently, these light therapies enhance mitochondrial energy production and cellular repair mechanisms, fostering a healthier gut environment. This interplay between mitochondrial stimulation and microbiome restoration elucidates potential therapeutic avenues for gut-related diseases and systemic health [357].
A therapeutic effect from sunlight exposure can typically be achieved with about 20 minutes of sunbathing during early morning (7-10 am) or late afternoon (3-5 pm). This timing minimizes harmful ultraviolet radiation exposure while allowing beneficial wavelengths, such as red and near-infrared light, to exert their effects safely [358].
Photobiomodulation (PBM Or Red Light Therapy)
Warning: The outcomes regarding red light therapy and cancer are mixed and context-dependent, so engaging in red light therapy if you have cancer requires MD approval.
PBM specifically utilizes controlled exposure to red (600–700 nm) and near-infrared light (700–900 nm) to stimulate biological effects that are beneficial for mitochondrial function and healing [359]. These wavelengths are a subset of the whole solar spectrum found in sunlight
While there are over 3,000 studies on PBM, no specific manufacturers were used in these studies; however, standards were set for manufacturers to follow. NovaaLab is one of the manufacturers that follow these standards, and their devices are FDA-cleared as Class II medical devices, which is a primary consideration when purchasing a PBM device. This, among many other issues, makes it a top choice.
There are, however, a couple of issues. The first issue is that you must purchase it directly from the manufacturer, and the second is the cost. I purchased the Novaa Light Pad XL, and it was four times the cost of similar-sized light pads on Amazon. It was an easy rationalization for me, however, because I wanted every assurance that I would recover and function at my absolute peak.
Aged garlic extract improved gut microbiota, as evidenced by higher microbial richness and diversity, with a marked increase in Lactobacillus and Clostridium species after 3 months of supplementation. It was also effective in reducing blood pressure in patients with uncontrolled hypertension, and has the potential to improve arterial stiffness, inflammation, and gut microbial profile. Aged garlic extract is well tolerated and has a high safety profile as a stand-alone or adjunctive antihypertensive treatment, with multiple benefits for cardiovascular health [360].
Water: Drinking filtered water is a no-brainer, but mineral and hydrogen water can also have profound effects.
Mineral Water: In a mouse model, kidney crystal formation and fibrosis were attenuated by drinking alkaline mineral water. Furthermore, alkaline mineral water also reduced kidney injury, cell apoptosis, oxidative stress, and inflammation [361]. I put this to the test by drinking mineral water only for three days. After the third day, I had the worst oxalate dump I had ever experienced, and by that time, I was halfway through the fifth year of a low oxalate diet. I now drink only mineral water at least three days a month and at every extended fast.
Warning: While molecular hydrogen can interact with and enhance virtually every cell in the body and assist in restoring the gut, it can also enhance the proliferation of cancer cells [362]. This is why a cancer screening and working closely with your MD are highly recommended before starting a hydrogen water protocol if you suspect you may have cancer.
The research supporting hydrogen-rich water has been moved to Appendix: Hydrogen-Rich Water Research, located just before the References.
Generating HRW: There are several ways to generate HRW. I use an HRW generator, and there are several things you should look for when purchasing one. Here are some attributes of the one I use, the Veemter 3 IN 1 Hydrogen Water Bottle Generator. I highly recommend doing your research before you purchase one. The specs of the one I use are below.
PPB (Parts Per Billion): The average is 1,500 PPB. The one I use has two modes: Push the button once, and you get 1,500 PPB; push the button twice, and you get 6,000 PPB. This is sometimes measured in PPM (parts per million), but this is an easy conversion: 1,000 PPB is 1 PPM. I could not find any third-party testing for this parameter.
SPE/PEM Technology: SPE and PEM refer to solid phase extraction and proton exchange membrane.
Platinum Titanium Core Electrolytic Sheet: I would not use any less than this.
Base Materials: The body of the hydrogen water bottle is made of high-quality food-grade borosilicate glass, and the lid is made of food-grade stainless steel.
3 Modes: This means you can generate HRW within the container, screw a water bottle to an accessory that is provided or breathe it. I do not use any of the accessories, and I do not drink out of the generator.
Results: I initially tried the single push of the button for 1,500 PPB of hydrogen with no issues, so I then tried the next mode and had a raging case of diarrhea for 24 hours. I returned to the single mode for two days and tried the 6,000 PPB mode again; the diarrhea only lasted a couple of hours. I now generate 2 to 6 15.5-ounce HRW daily in the 6,000 PPB mode. Once I got settled in, I started to feel better.
Thoroughly mix the first 3 ingredients before adding the heavy cream to keep the spice from clumping, then stir again. I use a 9-inch glass pie pan and rub it down with butter or Ghee, so it is easy to clean. Next, preheat the oven or toaster oven to 350 degrees and bake for 30 minutes. Let it cool for 20 minutes after taking it out of the oven.
Magnesium, potassium, sodium, and calcium work synergistically. Oxalic acid binds with heavy metals and minerals. This is why close attention must be paid to this balance. It is difficult to accurately measure calcium and magnesium because the body will pull these two minerals into the bloodstream from bone to keep them in balance. The question regarding magnesium is, do I sleep well, and are my dreams clear and vivid (Author’s Observation)? If the answer is no, sufficient magnesium may be an issue. 'Approximately 50% of Americans consume less than the Estimated Average Requirement (EAR) for magnesium, and some age groups consume substantially less' [371].
Other comments on this diet suggest no issues regarding mineral balance, supplementation, or glycine balance. Everyone seems to agree on the fat-to-protein ratio and water and salt. Nonetheless, I addressed all these issues. I had been battling Candida for over a decade and was suffering from several mineral and vitamin deficiencies. Magnesium and calcium are based on RDA sodium, and potassium is based on AI (adequate intake). You will need to look up your requirements, as the following numbers are based on my gender and age.
I do not listen to any recommendations regarding supplements because they always come down to Test: Do Not Guess. It is critical, however, to have a basic understanding of supplementation.
The magnesium deception: All magnesium must be bound to something, and most manufacturers include what it is bound to as part of the milligram rating. This can be deceiving, as only about 16% of it is elemental magnesium. The bulk magnesium I recommend clearly states the amount of elemental magnesium you get per serving. If magnesium does not clearly state the amount of elemental magnesium, I would not purchase it.
Ascorbic Acid And Ascorbate: Ascorbic acid is vitamin C, the same molecule found in fruit. Nearly all supplements, whether labeled ascorbic acid or ascorbate, are made synthetically and are chemically identical to the vitamin C in food. Buffered forms such as sodium or calcium ascorbate are gentler on the stomach.
For this reason, DHA was thought to be the most important regarding neurological function, but a recent study found that EPA (eicosapentaenoic acid) was responsible for increased CNS remyelination. The myelin sheath is what protects nerve cells and what becomes damaged in MS [378].
Amino acids (AAs) are organic compounds containing amino and acid groups. Proteinogenic AAs serve as substrates for protein synthesis in animal cells and occur naturally as L-AAs (the molecules used to produce proteins in the human body), except for glycine [379].
Enhanced intake of most amino acid supplements may not be risk-free and can cause a number of detrimental side effects. This is why I have isolated the amino acids I use and no longer use Collagen Peptides.
Collagen peptides also carry a hydroxyproline load that the body converts to oxalate. See Why Collagen, Bone Broth, And Gelatin Should Not Be Used in the oxalate section.
Non-essential amino acids, also known as dispensable amino acids, can be excluded from a diet. The human body can synthesize these amino acids using only the essential amino acids. For most physiological states in a healthy adult, the above nine amino acids are the only essential amino acids. However, amino acids like arginine and histidine may be considered conditionally essential because the body cannot synthesize them in sufficient quantities during certain physiological periods of growth, including pregnancy, adolescent growth, or recovery from trauma [380]. Some amino acids may be needed in larger amounts than the body makes, such as glycine, the most important amino acid.
Detailed assessment of all possible sources of glycine shows that synthesis from serine accounts for more than 85% of the total and that the amount of glycine available from synthesis, about 3 g/day, together with that available from the diet, in the range of 1.5-3.0 g/day, may fall significantly short of the amount needed for all metabolic uses, including collagen synthesis by about 10 g per day for a 70 kg human. This result supports earlier suggestions in the literature that glycine is a semi-essential amino acid and that it should be taken as a nutritional supplement to guarantee a healthy metabolism [178].
Glycine has also been suggested as a conditionally essential amino acid. In metabolic disorders associated with obesity, type 2 diabetes (T2DM), and non-alcoholic fatty liver disease (NAFLD), lower circulating glycine levels have been consistently observed, and clinical studies suggest the existence of beneficial effects induced by glycine supplementation.
I consider glycine the most important and versatile amino acid for the following reasons.
Experimental research has shown that L-tryptophan, as the sole precursor of serotonin, plays an important role in brain serotonin synthesis and is involved in mood, behavior, and cognition. Furthermore, clinical trials have provided some initial evidence of L-tryptophan’s efficacy for treating psychiatric disorders, particularly when combined with other therapeutic agents [388].
In the bloodstream, tryptophan competes with other large neutral amino acids such as histidine, isoleucine, leucine, methionine, phenylalanine, threonine, tyrosine, and valine for the BBB transporter [388]. This is why I do not use any other amino acids when I supplement with tryptophan.
I consider tryptophan the second most important amino acid for the following reasons.
Although TRP has been studied for 6 decades, few side effects, which include tremors, nausea, and dizziness, have been reported. A more common effect of high doses of TRP, which can be expected due to the stimulating effect of TRP on serotonin synthesis, is fatigue or drowsiness. In 1989, an outbreak of eosinophilia-myalgia syndrome, a serious and sometimes fatal condition, was linked to contaminated L-tryptophan from a single manufacturer [390]. Choose tryptophan from manufacturers that provide third-party purity testing.
A potentially life-threatening condition is “serotonin syndrome” (also referred to as serotonin toxicity), which includes neuromuscular abnormalities, autonomic hyperactivity, and mental state changes. Serotonin syndrome is usually precipitated by the simultaneous administration of two or more drugs that enhance serotonin availability, such as serotonin reuptake or MAO inhibitors.
In humans, intestinal cells and gut microbiome play an important role in TRP metabolism. Because TRP is a precursor to serotonin, caution should be exercised when supplementing it with drugs that affect serotonin metabolism [389].
Single doses of TRP from 1 g to 15 g were used acutely and chronically for up to 2 years. A commonly used dose is 3 g/day [389]. I started seeing potential contraindications at doses above 2 g.
Uses: L-Citrulline can be used instead of L-Arginine because it is synthesized into L-Arginine but without the side effects of taking ARG directly, including an increase in Nitric Oxide. Other benefits of short-term therapy include cardiovascular disorders, muscle wasting, intestinal resection, obesity, and insulin resistance. Unlike all other amino acids listed here, which are sourced primarily from meat, the richest source of CIT is watermelon.
Nitric Oxide: Diminished bioavailability of nitric oxide (NO), the gaseous signaling molecule that regulates numerous vital biological functions, contributes to the development and progression of multiple age and lifestyle-related diseases. Supplementation with l-citrulline has shown promise as a blood pressure lowering intervention (both resting and stress-induced) in adults with pre-/hypertension, with pre-clinical (animal) evidence for atherogenic-endothelial protection. Preliminary evidence is also available for l-citrulline-induced benefits to muscle and metabolic health (via vascular and non-vascular pathways) in susceptible/older populations [374].
Side Effects: Because the main mediators of the effects of CIT supplementation are ARG and NO, and long-term studies of the effect of ARG supplementation indicate cardiovascular and renal risks, studies examining the safety of CIT supplementation are necessary [389].
Dosing: I take 1.5 teaspoons daily.
I am primarily a carnivore, so I do not supplement with the following amino acids. However, this is not to say you may not benefit from some of these depending on your objectives and dietary needs.
In October 2004, the FDA required a black box warning for antidepressant drugs of any class that they may increase the risk of suicidality. That warning became effective in January 2005. In 2006, the FDA warning was extended to young adults aged up to 25 years. This is just one of a long list of contraindications, but this is the most significant as it potentially causes what it claims to help.
There is a strong antimicrobial effect of antidepressants from different chemical classes against gut commensal (good) bacteria representative of the predominant species found in the human gut microbiome [391].
As of this writing, the following four antidepressants are used for depression and PTSD in the VA and are widely used in the civilian world. In laboratory testing, antidepressants from several classes, including the SNRI venlafaxine, inhibited beneficial gut bacteria [391], and a screen of more than 1,000 drugs found that many non-antibiotic medications inhibit gut bacteria [392]. The three SSRIs listed here were not tested in [391], so whether they have the same effect in the human gut has not been established.
Suicidal thoughts and behaviors are not the only issues with these antidepressants. The following are several more significant contraindications, but they do not end there. I used Paxil here as an example, but all of the above antidepressants have similar warnings [393].
Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack of serotonin in the brain. Indeed, their supposed effectiveness is the primary evidence for the chemical imbalance theory. However, analyses of the published and unpublished data that drug companies hid reveal that most (if not all) of the benefits are due to the placebo effect. Some antidepressants increase serotonin levels, some decrease it, and some have no effect at all on serotonin. Nevertheless, they all show the same therapeutic benefit. Even the small statistical difference between antidepressants and placebos may be an enhanced placebo effect due to the fact that most patients and doctors in clinical trials successfully break blind.
The serotonin theory is as close as any theory in science's history to being proved wrong. Instead of curing depression, popular antidepressants may induce a biological vulnerability, making people more likely to become depressed in the future [396]. Supplements have side effects too, but they are often milder. Does it make sense, with your prescriber’s guidance, to try supplements that can improve your health in multiple ways? If your answer is yes, read on.
Warning: Do not take tryptophan without consulting your physician if you are taking antidepressants.
Vitamin (hormone) D3, K2-7, magnesium, and B Complex work synergistically. K2-7 and magnesium are especially critical when taking high or mega doses of D3. A high dose of D3 is anything up to 100,000 IU. A mega dose of D3 is 100,000 IU and above. I know this sounds like an extraordinary amount, but keep in mind that 40,000 IU of vitamin D is just 1 mg. I will break down all five of these separately, starting with D3.
Anyone who hears about D3 thinks of bone health, but this hormone goes far beyond bone health. Vitamin D receptors (VDR) are found in nearly every cell, and the ability of the cell to produce the active hormone is also widely distributed. Furthermore, the physiological functions with which vitamin D signaling is now associated are as diverse as the tissues in which the vitamin D receptor (VDR) is located [397]. I am going to list just a few attributes of D3 to attempt to drive the point home of how critical D3 is.
These bacteria represent the majority of friendly bacteria in the gut, with Firmicutes and Bacteroidetes representing 90% of gut microbiome [406].
The recommendations for vitamin D blood levels are all over the map. Low is considered <20 ng/ml, with 30 to 60 in the normal range. I consider 50 ng/ml to be the minimum, with a goal range of 70 to 90 ng/ml (Author’s Observation). This is partly because a systematic review and meta-analysis of observational studies projected that COVID-19 mortality could theoretically approach zero at 50 ng/ml [403], although randomized trials have not confirmed that supplementation prevents COVID-19 deaths [404, 405]. These targets are above current guidelines, so discuss yours with your MD.
The current D3 dosing recommendation from NIH is 600 IU for people between the ages of 1 and 70 [407]. This is one of the biggest lies in the medical community. This amount was established in the 1930s to prevent rickets in children and is woefully inadequate for multiple other issues and most people, including children. In 2024, the Endocrine Society recommended against supplementing above the RDA for healthy adults under 75 and against routine vitamin D testing, while suggesting supplementation for adults 75 and older [408]. I believe an acceptable range should be established instead of making up an ultra-conservative number to try and conform to 100% of the population. My position on this is based on the following data.
Vitamin D toxicity is uncommon, but it is well documented and increasing, and it is almost always caused by excessive supplement intake [407, 410]. In one published case, a relative reported the amount and timeline taken [411]. The main danger of too much D3 is hypercalcemia, too much calcium in the blood, which can cause kidney damage, heart rhythm problems, and calcium deposits in the arteries and other soft tissues [407]. K2 helps direct calcium into bone, but it does not lower blood calcium and does not prevent vitamin D toxicity. I take K2 with D3 for its own benefits. The NIH upper limit for adults is 4,000 IU per day [407]; if you take more, have your blood calcium and vitamin D levels monitored by your MD.
Clinical studies have unequivocally demonstrated the utility of vitamin K2-7 supplementation in ameliorating peripheral neuropathy, reducing bone fracture risk, and improving cardiovascular health. K2-7 accomplishes this with the protein synthesis of osteocalcin and various other proteins [412]. This means that K2-7 delivers calcium where it is supposed to go.
Vascular calcification is characterized by mineral depositions on the walls of the vascular system. This is the primary concern when taking high or mega doses of D3. K2 has the potential to inhibit as well as reverse the process of calcification [412]. The benefits of K2 do not stop at simply delivering calcium where it is supposed to go and freeing calcium present in the blood vessels.
There are no severe adverse effects due to the supplementation of vitamin K2-7. However, high doses of vitamin K2 can cause allergic reactions [412]. Warning: Vitamin K counteracts the blood thinner warfarin (Coumadin). If you take warfarin or another vitamin K antagonist, do not start K2 without your prescriber’s approval [413].
Sources of K2-7 include natto, which is the highest, moderate in chicken, sauerkraut, beef, and a variety of cheeses, and is low in pork, salmon, etc. [412].
I do not go beyond the dose that is part of the D3 K2 supplement that I take.
Magnesium assists in activating vitamin D, which helps regulate calcium and phosphate homeostasis to influence the growth and maintenance of bones.
All enzymes that metabolize vitamin D seem to require magnesium, which acts as a cofactor in the enzymatic reactions in the liver and kidneys [414]. This is why you can become deficient in magnesium if high doses of D3 are taken, even if you are taking the daily RDA. As D3 intake increases, magnesium intake must also increase.
As mentioned above, three months of B100 or B5 (pantothenic acid) and vitamin D improved sleep, reduced pain, and unexpected resolution of bowel symptoms [402].
This combination also creates an intestinal environment that favors the return of four foundational gut bacterial phyla, Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria, that make up the normal human microbiome [402] before and after comprehensive stool tests prove this to be accurate.
SSRIs do not make new serotonin, but tryptophan does, along with melatonin and NAD, and this is why it is added to this stack again; consult with your MD before taking tryptophan if you are taking antidepressants.
Kelly Burris: Comprehensive Stool Test: 9-20
If you look under Commensal Microbiome Analysis, you will see the four foundational bacteria and a couple of others. All were low, with Euryarchaeota Phylum below detectable levels. MDs, nutritionists, and even Functional Medicine Practitioners recommended probiotics, so I took their advice and researched the top probiotics, taking up to 1.7 trillion CFUs daily. As you can see, it had little to no effect on the commensal bacteria. This is not to say that probiotics do not work because taking the right ones can be very effective. Just do not depend on them to reestablish foundational commensal bacteria.
Kelly Burris: Comprehensive Stool Test: 9-22
Seven weeks before doing this test, I did high doses of vitamin D with 12 days of mega-dosing, which I do not recommend. I was already taking a B Complex that included 100 mg of B5. Another interesting piece is that plant-based diets are recommended to increase Firmicutes Phylum. I had been primarily a carnivore for 33 months when this test was done, yet there were significant increases in all commensal (good) bacteria. Another thing to look at with these two tests is "The Need for Microbiome Support" at the top of the page. Part of this equation is yeast overgrowth (Candida), and this test completely missed it as I was still a 10, as the first one indicated. All tests I had for yeast overgrowth were unreliable. This is after 3 comprehensive tests, 2 standard tests, and several urine tests.
Severe alcoholism can be associated with significant nutritional and vitamin deficiency, especially vitamin B1 (thiamine), associated with neurological deficits impacting mood and cognition. Benfotiamine appears to reduce psychiatric distress and may facilitate recovery in severely affected males with a lifetime alcohol use disorder [415]. Benfotiamine was part of my recovery from Neuromyelitis Optica (Author’s Observation). It is not an established treatment for NMO, a serious autoimmune disease that requires care from a neurologist.
Individuals with thiamin deficiency also require other nutrient supplementation, such as magnesium, vitamin B2 (riboflavin), B3 (nicotinamide), B6 (pyridoxine), B12, vitamin C, potassium, and phosphate. Taking a good B Complex, in my opinion, is the best way to go.
The human body excretes excess thiamin in the urine. There is a lack of evidence of toxicity from high thiamin intake from food or supplements. Food and Nutrition Board (FNB) concluded that excessive consumption of thiamin might cause adverse effects despite a lack of substantial evidence of toxicity. Per the Institute of Medicine, no established upper limit of thiamin intake is reported in the literature to cause any toxicity [416].
B2 (Riboflavin): B2 can be found in a wide variety of foods and natural sources, especially milk and organ meats, mostly in calf liver, egg, fish, nuts, certain fruits and legumes, wild rice, mushrooms, dark green leafy vegetables, yeast, beer, cheese, and dietary products.
Vertebrates poorly store B2 because of its limited absorption in humans. Therefore, orally supplied RF by a healthy diet is required to avoid ariboflavinosis, which causes cheilitis, sore tongue, and a scaly rash on the scrotum or vulva. B2 causes no known toxicity since it is excreted in the urine at higher intakes and not stored. B2 is found in different concentrations in various human body fluids and organs [417].
B3 (Niacin): B3 includes two vitamers (nicotinic acid and nicotinamide), giving rise to the coenzymatic forms nicotinamide adenine dinucleotide (NAD+). The two coenzymes are required for oxidative reactions crucial for energy production, but they are also substrates for enzymes involved in non-redox signaling pathways, thus regulating biological functions, including gene expression, cell cycle progression, DNA repair, and cell death. Vitamin B3 has long been recognized as a key mediator of neuronal development and survival in the central nervous system.
Humans obtain niacin from both endogenous and exogenous sources. Only 2% of dietary tryptophan is converted into niacin via a multistep pathway, occurring mainly in the liver. Diet provides vitamins such as nicotinic acid, nicotinamide, and tryptophan, as well as the active coenzymatic forms of niacin. Niacin is found in animal and vegetable foods. In meat and fish, the vitamin is present as nicotinamide, whose amounts are higher in unprepared foods compared to processed foods.
Severe niacin and/or tryptophan deficiency leads to a variety of clinical symptoms, including diarrhea, dermatitis, and dementia, collectively known as "pellagra." Pellagra is common in people who mostly eat maize, as well as in malnourished and alcoholic men. Other risk factors leading to vitamin B3 deficiency are nervous anorexia, AIDS, cancer, and malabsorptive disorders, such as Crohn's disease [418].
Niacin-associated hepatotoxicity is generally related to ingestions of around 3 grams per day. In contrast, the more common symptom of flushing can occur at doses as low as 30 mg per day [419]. The flushing was significant when I took just 250 mg of nicotinic acid on an empty stomach. No flushing occurred at 250 mg after eating.
B5 (Pantothenic Acid): Vitamin B5 is a naturally occurring substance in various plants and animals (i.e., eggs, milk, vegetables, beef, chicken).
An experimental vitamin B5 deficiency study associated the deficiency with symptoms such as fatigue, headache, malaise, personality changes, numbness, muscle cramps, paresthesia, muscle/ abdominal cramps, nausea, and impaired muscle coordination [420].
B5 is considered generally safe. There are currently no upper limits established since there have been no reports of vitamin B5 toxicity in humans with high intakes. However, there are still side effects involved with B5 administration [420].
B6 (Pyridoxine): B6 is involved in the vast majority of changes in the human body because it is a coenzyme involved in over 150 biochemical reactions. It is active in metabolizing carbohydrates, lipids, amino acids, and nucleic acids and participates in cellular signaling. In addition, it is an antioxidant and a compound that can lower the advanced glycation end products (AGE) level [421].
Pyridoxal 5' phosphate (P-5-P) is the active coenzyme form of vitamin B6. P-5-P deficiency leads to immunosuppression, local exacerbation of inflammatory processes, and increased secretion of proinflammatory cytokines. Conversely, replenishing P-5-P may boost immunity and maintain an equilibrium that allows control of viral replication without uncontrolled expression of cytokines [421]. At the time of my first NutrEval test, I was taking 50 mg of B6 in the form of P-5-P per day, and I was deficient. This is a good example of why you always want to test, not guess, because 50 mg should have been more than adequate, but the variable of oxalate poisoning and a disrupted microbiome significantly increased my requirement for B6.
Most studies indicate that an intake below 200 mg of pyridoxine daily does not cause issues [421]. I am taking 100 mg daily of P-5-P.
Warning: Avoid Pyridoxine HCL as it can cause peripheral neuropathy in therapeutic amounts instead of helping peripheral neuropathy [422, 423]. In laboratory studies, pyridoxine, but not the other forms of vitamin B6, caused nerve cell death and blocked vitamin B6 function [424]. Some MDs do not distinguish between P-5-P and pyridoxine HCL, which is a mistake.
B7 (Biotin): Marginal and severe degrees of biotin deficiency lead to various clinical abnormalities, including neurological disorders and dermal abnormalities. Such deficiency/suboptimal levels occur in a variety of conditions, including inflammatory bowel disease (IBD). At the metabolic level, biotin acts as a cofactor for five carboxylases that are critical for fatty acid, glucose, and amino acid metabolism. Essential roles for this vitamin in cellular energy metabolism (i.e., ATP production) and in the regulation of cellular oxidative stress, as well as in gene expression where expression of over 2,000 human genes appears to be affected by biotin status, have also been reported recently. An increase in the levels of proinflammatory cytokines has also been observed in biotin deficiency [425].
Although not impossible, it would be very difficult to overdose on biotin [426].
The most important known risk of high-dose biotin is that it can interfere with laboratory tests, including thyroid tests and troponin (used to diagnose heart attacks), causing falsely high or low results [427]. Tell your MD and the lab if you take biotin, and ask whether to pause it before a blood draw.
B9 (Folate): The decreased folate level of the body, mainly caused by environmental and hereditary factors as well as aging, can lead to genetic, epigenetic, and metabolic changes. It can be related to the development of megaloblastic anemia, various cardiovascular diseases (such as atherosclerosis and stroke), obstetrical complications (such as abruption of the placentae, spontaneous abortion, preterm delivery, neural tube defect), neuropsychiatric diseases (such as Alzheimer's disease, Parkinson's disease, depression) and tumors [428].
Recent folate intervention trials suggest that folate supplementation may increase the risk of the above chronic diseases for individuals at a higher risk [428]. This is why folate does not exceed 200% of the daily value.
B12 (Cobalamin): B12 is a cofactor for enzymes involved in synthesizing deoxyribonucleic acid (DNA), fatty acids, and myelin. B12 deficiency can lead to hematologic and neurological symptoms. Vitamin B12 is stored in excess in the liver, decreasing the likelihood of deficiency. However, hepatic stores are depleted in cases where vitamin B12 cannot be absorbed, such as dietary insufficiency, malabsorption, or lack of intrinsic factor, and deficiency ensues [416, 429, 430].
Sources of B12 are animal products such as red meat, dairy, and eggs.
No toxic effects of vitamin B-12 have been identified, even when it is administered intramuscularly at 300–3000 times the recommended dietary allowance. For this reason, no upper tolerable level for the vitamin has been established [429].
Methylcobalamin is the recommended B12.
Avoid cyanocobalamin.
Histamine is an organic nitrogenous compound involved in local immune responses, regulates physiological functions in the gut, and acts as a neurotransmitter for the brain, spinal cord, and uterus.
Oxalate dumping and Candida die-off trigger mast cell histamine release (Author’s Observation). This, in conjunction with eating high-histidine foods, can cause what appears to be histamine intolerance. I say "what appears to be" because virtually no MDs understand the process of oxalate dumping and the results it produces; therefore, they label it histamine intolerance. In my opinion, it is histamine overload if you are dealing with oxalate dumping and Candida die-off. Either way, histamine must be considered an essential piece of the oxalate Candida equation.
The first thing that is prescribed is antihistamines, and this is usually without an accurate diagnosis. Histamine intolerance or overload symptoms are similar to some of the symptoms of oxalate dumping and Candida die-off, so it just adds to the overall malaise.
Diamine oxidase (DAO) is the enzyme responsible for breaking down histamine, and I felt it was better to incorporate a food high in DAO and reduce the amount of histidine I was consuming [431]. Beef kidney is high in DAO, so I took it in freeze-dried capsule form. I was able to tell the difference, which sold me on the idea of freeze-dried animal organs. You do want to be careful about reducing histidine because it has been found to improve mental fatigue, cognitive performance, and sleep disruption [432].
It is important to have a fundamental understanding of senescence, autophagy, and apoptosis, especially as they relate to fasting.
Senescent cells are damaged cells that secrete proinflammatory cytokines, which stimulate the immune system and can cause inflammation, leading to damage to other cells. Senescent cells accumulate in various tissues with aging and at sites of pathogenesis in many chronic diseases and conditions, including metabolic dysregulation, stem cell dysfunction, aging phenotypes, chronic diseases, geriatric syndromes, and loss of resilience. Senescent cells can also stimulate the regeneration of new cells, which creates a double-edged sword [433]. This, in my opinion, is why pharmaceuticals used to kill senescent cells should be closely examined.
Immunosenescence is what it sounds like, which is the slow death of immune cells. Prolonged fasting kills senescent cells, which stimulates the generation of new cells.
Autophagy means self-eating, and regarding fasting, the body uses old and damaged stem cells and, in theory, senescent cells as fuel. This is why age, disease, and health biomarkers improve. It is impossible to know if autophagy extends one's life, but it can extend one's health. The loss of autophagy is enough to drive cellular, tissue, and organismal dysfunction with detrimental effects on health and lifespan; by contrast, boosting autophagy has the opposite effects [433].
I saw autophagy right before my eyes after suffering a massive oxalate dump, and ended up with a cobweb of floaters in my right eye. I immediately initiated a 72-hour fast, and most of the floaters disappeared. A 48-hour fast had little effect on the floaters in my other eye. This is why I also believe that meaningful autophagy only occurs between 36 and 72 hours (Author’s Observation).
Warning: A sudden shower or cobweb of new floaters, especially with flashes of light or a shadow or curtain across part of your vision, can signal a retinal tear or detachment [434]. This requires a same-day eye exam. Do not wait to see whether fasting helps.
Apoptosis is programmed cell death independent of cell damage [435]. Apoptosis and autophagy are interrelated processes, and nutrient availability influences which path a cell takes [436].
Natural products with antimicrobial activity do not appear to be present [445]. The assumption based on this research is that preservatives act as an antimicrobial. If one takes an antibiotic or antimicrobial, they must be accompanied by probiotics to assist in preventing dysbiosis, but I am certain very few people know that preservatives act as an antimicrobial.
CBD (cannabidiol) is the non-psychoactive component of cannabis. With over two thousand full-text articles on PMC, I came to find that CBD had more uses than just as an antipathogen [448]. It was the most industrial-grade anti-inflammatory I had ever used [449].
Studies on models of human diseases support the idea that CBD attenuates inflammation far beyond its antioxidant properties by targeting inflammation-related intracellular signaling events. The details on how it does this remain to be defined.
The use of THC and Candida in a mouse model was deemed ineffective [450]. However, Candida colonization delays the healing of inflammatory lesions, and inflammation promotes colonization. These effects may create a vicious cycle in which low-level inflammation promotes fungal colonization, and fungal colonization promotes further inflammation. High-level Candida colonization is frequently observed in ulcer and IBD patients and is linked to Crohn's disease, ulcerative colitis, and leaky gut [451]. During this vicious cycle, the profound anti-inflammatory processes of CBD became very useful in eradicating pathogenetic Candida (Author’s Observation).
Because cannabinoids are profoundly anti-inflammatory, infections caused by HIV-1 or HSV-1 can worsen. The anti-inflammatory action can impair dependent enzyme systems, which are central to inflammatory and cell-autonomous antiviral responses [452]. This was not the case with me, so the industrial-grade anti-inflammatory nature of CBD worked very well.
Warning: Even though CBD is difficult to overdose on, it seems good at killing yeast and removing pathogens, making starting with high doses relatively dangerous (Author’s Observation).
The only way to take CBD is in the purest form possible. This is in the form of CBD oil combined with coconut or MCT oil. Some CBD sprays contain Polysorbate 80. In mice, Polysorbate 80 promoted low-grade intestinal inflammation and metabolic syndrome, a group of conditions that increase the risk for type 2 diabetes, heart disease, and stroke [172]. Always ensure that you are taking only oil and CBD. For me, CBD was an important factor in getting through the extreme toxicity brought on by fasting and therapeutic amounts of olive oil.
I get mine at CBD Market because I don't particularly appreciate digging for coupons; they have the best prices.
Hydrogen is produced via gut bacteria (primarily Bacteroides and Firmicutes), and if these bacteria are damaged or lowered, there is a host of physiological issues associated with it [453]. Hundreds of human and animal studies of hydrogen-rich water (HRW) exist. This first group of studies is from a systematic review that looked at human outcomes only. The second group will include animal studies.
Hydrogen-Rich Water: In Vivo, In Vitro, And Animal Studies
Even though animal studies must be scrutinized much more than human studies, I never immediately discount them, especially if the subject is pertinent to my suffering.
1. Chernyavskij DA, Galkin II, Pavlyuchenkova AN, Fedorov AV, Chelombitko MA. [Role of Mitochondria in Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease]. Mol Biol (Mosk). 2023 Nov-Dec;57(6):1028-1042. doi: 10.31857/S0026898423060058. PMID: 38062958. back to text: a b c
2. Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024;19(2):275-293. doi: 10.1007/s11739-023-03374-w. PMID: 37505311; PMCID: PMC10954893. back to text: a b c
3. Caldarelli M, Rio P, Marrone A, Giambra V, Gasbarrini A, Gambassi G, et al. Inflammaging: The Next Challenge-Exploring the Role of Gut Microbiota, Environmental Factors, and Sex Differences. Biomedicines. 2024 Aug 1;12(8):1716. doi: 10.3390/biomedicines12081716. PMID: 39200181; PMCID: PMC11351301. back to text: a b c d e f
4. Conway J, De Jong EN, White AJ, Dugan B, Rees NP, Parnell SM, et al. Age-related loss of intestinal barrier integrity plays an integral role in thymic involution and T cell ageing. Aging Cell. 2025 Mar;24(3):e14401. doi: 10.1111/acel.14401. PMID: 39547946; PMCID: PMC11896561. back to text: a b c d
5. Salazar AM, Aparicio R, Clark RI, Rera M, Walker DW. Intestinal barrier dysfunction: an evolutionarily conserved hallmark of aging. Dis Model Mech. 2023;16(4):dmm049969. doi: 10.1242/dmm.049969. PMID: 37144684; PMCID: PMC10184675. back to text: a b c d
6. Clapp M, Aurora N, Herrera L, et al. Gut microbiota's effect on mental health: the gut-brain axis. Clin Pract. 2017;7(4):987. PMID: 29071061; PMCID: PMC5641835. back to text: a b c
7. Shemtov SJ, Emani R, Bielska O, Covarrubias AJ, Verdin E, Andersen JK, et al. The intestinal immune system and gut barrier function in obesity and ageing. FEBS J. 2023 Sep;290(17):4163-4186. doi: 10.1111/febs.16558. PMID: 35727858; PMCID: PMC9768107. back to text: a b c
8. Ho GT, Theiss AL. Mitochondria and Inflammatory Bowel Diseases: Toward a Stratified Therapeutic Intervention. Annu Rev Physiol. 2022 Feb 10;84:435-459. doi: 10.1146/annurev-physiol-060821-083306. PMID: 34614372; PMCID: PMC8992742. back to text: a b
9. Doney E, Cadoret A, Bhatt RR, et al. Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders. Eur J Neurosci. 2022;55(9-10):2851-2894. PMID: 33876886. back to text: a b
10. Evrensel A, Ünsalver BÖ, Ceylan ME. Neuroinflammation, Gut-Brain Axis and Depression. Psychiatry Investig. 2020 Jan;17(1):2-8. doi: 10.30773/pi.2019.08.09. PMID: 31587531; PMCID: PMC6992852. back to text: a b c
11. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. PMID: 26528128. back to text: a b
12. Furman D, Chang J, Lartigue L, Bolen CR, Haddad F, Gaudilliere B, et al. Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states. Nat Med. 2017 Feb;23(2):174-184. doi: 10.1038/nm.4267. PMID: 28092664; PMCID: PMC5320935. back to text
13. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest. 2013 Jan;123(1):236-246. doi: 10.1172/JCI63679. PMID: 23221343; PMCID: PMC3533286. back to text
14. Stepanova N. Oxalate Homeostasis in Non-Stone-Forming Chronic Kidney Disease: A Review of Key Findings and Perspectives. Biomedicines. 2023 Jun 7;11(6):1654. doi: 10.3390/biomedicines11061654. PMID: 37371749; PMCID: PMC10296321. back to text: a b c d
15. Lorenz EC, Michet CJ, Milliner DS, Lieske JC. Update on oxalate crystal disease. Curr Rheumatol Rep. 2013 Jul;15(7):340. doi: 10.1007/s11926-013-0340-4. PMID: 23666469; PMCID: PMC3710657. back to text: a b c
16. Patel M, Yarlagadda V, Adedoyin O, Saini V, Assimos DG, Holmes RP, Mitchell T. Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox Biol. 2018 May;15:207-215. doi: 10.1016/j.redox.2017.12.003. Epub 2017 Dec 15. PMID: 29272854; PMCID: PMC5975227. back to text: a b c d e
17. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011 Jan 13;469(7329):221-225. doi: 10.1038/nature09663. PMID: 21124315. back to text: a b c
18. Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures. Sci Rep. 2016 Oct 6;6:34712. doi: 10.1038/srep34712. PMID: 27708409; PMCID: PMC5052600. back to text: a b c
19. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA. An essential role for the NLRP3 inflammasome in host defense against the microbial pathogen Candida albicans. Cell Host Microbe. 2009 May 8;5(5):487-497. doi: 10.1016/j.chom.2009.05.002. PMID: 19454348; PMCID: PMC2824856. back to text
20. Sprague JL, Schille TB, Allert S, Trümper V, Lier A, Großmann P, Priest EL, Tsavou A, Panagiotou G, Naglik JR, Wilson D, Schäuble S, Kasper L, Hube B. Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection. PLoS Pathog. 2024 Mar 1;20(3):e1012031. doi: 10.1371/journal.ppat.1012031. PMID: 38427950; PMCID: PMC10907035. back to text: a b c d
21. Sprague JL, Kasper L, Hube B. From intestinal colonization to systemic infections: Candida albicans translocation and dissemination. Gut Microbes. 2022 Jan-Dec;14(1):2154548. doi: 10.1080/19490976.2022.2154548. PMID: 36503341; PMCID: PMC9746630. back to text: a b c
22. Wu Y, Du S, Johnson JL, Tung HY, Landers CT, Liu Y, Seman BG, Wheeler RT, Costa-Mattioli M, Kheradmand F, Zheng H, Corry DB. Microglia and amyloid precursor protein coordinate control of transient Candida cerebritis with memory deficits. Nat Commun. 2019 Jan 4;10(1):58. doi: 10.1038/s41467-018-07991-4. PMID: 30610193; PMCID: PMC6320369. back to text: a b c
23. Kumamoto CA, Gresnigt MS, Hube B. The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Curr Opin Microbiol. 2020 Aug;56:7-15. doi: 10.1016/j.mib.2020.05.006. Epub 2020 Jun 27. PMID: 32604030; PMCID: PMC7744392. back to text: a b c
24. Guinan J, Wang S, Hazbun TR, Yadav H, Thangamani S. Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans. Sci Rep. 2019 Jun 19;9(1):8872. doi: 10.1038/s41598-019-45467-7. PMID: 31222159; PMCID: PMC6586901. back to text: a b c d e f g h i j
25. Jiang B, Dong Y, Xiong Y, Jiang C, Ping J, Wu Q, et al. Global research trends in inflammaging from 2005 to 2024: a bibliometric analysis. Front Aging. 2025;6:1554186. doi: 10.3389/fragi.2025.1554186. PMCID: PMC12018403. back to text
26. Rathore K, Shukla N, Naik S, Sambhav K, Dange K, Bhuyan D, Imranul Haq QM. The Bidirectional Relationship Between the Gut Microbiome and Mental Health: A Comprehensive Review. Cureus. 2025 Mar 19;17(3):e80810. doi: 10.7759/cureus.80810. PMID: 40255763; PMCID: PMC12007925. back to text: a b
27. Portincasa P, Bonfrate L, Khalil M, et al. Intestinal barrier and permeability in health, obesity and NAFLD. Biomedicines. 2022;10(1):83. doi: 10.3390/biomedicines10010083. PMID: 35052763. back to text: a b c d e
28. Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol Hepatol. 2025. doi: 10.1016/S2468-1253(24)00390-X. PMID: 40086468. back to text: a b
29. Dahlgren D, Lennernas H. Review on the effect of chemotherapy on the intestinal barrier: epithelial permeability, mucus and bacterial translocation. Biomed Pharmacother. 2023;162:114644. PMID: 37018992. back to text
30. Lewis CV, Taylor WR. Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol Heart Circ Physiol. 2020;319(6):H1227-H1233. PMID: 32986965; PMCID: PMC7792706. back to text: a b
31. Paraskevaidis I, Xanthopoulos A, Tsougos E, Triposkiadis F. Human Gut Microbiota in Heart Failure: Trying to Unmask an Emerging Organ. Biomedicines. 2023 Sep 19;11(9):2574. doi: 10.3390/biomedicines11092574. PMID: 37761015; PMCID: PMC10526035. back to text
32. Nesci A, Carnuccio C, Ruggieri V, D'Alessandro A, Di Giorgio A, Santoro L, et al. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship. Int J Mol Sci. 2023 May 22;24(10):9087. doi: 10.3390/ijms24109087. PMID: 37240434; PMCID: PMC10219307. back to text
33. Thaiss CA, Levy M, Grosheva I, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science. 2018;359(6382):1376-1383. PMID: 29519916. back to text
34. Macura B, Kiecka A, Szczepanik M. Intestinal permeability disturbances: causes, diseases and therapy. Clin Exp Med. 2024 Sep 28;24(1):232. doi: 10.1007/s10238-024-01496-9. PMID: 39340718; PMCID: PMC11438725. back to text: a b c
35. Bonaz B, Sinniger V, Pellissier S. The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol. 2017;8:1452. doi:10.3389/fimmu.2017.01452. PMID: 29163522; PMCID: PMC5673632. back to text: a b c
36. Wittbrodt MT, Gurel NZ, Nye JA, Ladd S, Shandhi MMH, Huang M, et al. Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts. Brain Stimul. 2020 Sep-Oct;13(5):1333-1348. doi: 10.1016/j.brs.2020.07.002. PMID: 32659483; PMCID: PMC8214872. back to text
37. Noble LJ, et al. Effects of vagus nerve stimulation on extinction of conditioned fear and post-traumatic stress disorder symptoms in rats. Transl Psychiatry. 2017;7(8):e1217. PMID: 28892066; PMCID: PMC5611754. back to text
38. Tan C, Yan Q, Ma Y, Fang J, Yang Y. Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis. Front Neurol. 2022;13:1015175. doi:10.3389/fneur.2022.1015175. PMID: 36438957; PMCID: PMC9685564. back to text
39. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050-16055. PMID: 21876150. back to text: a b
40. Kucuker MU, Almorsy AG, Sonmez AI, Ligezka AN, Camsari DD, Lewis CP, Croarkin PE. A Systematic Review of Neuromodulation Treatment Effects on Suicidality. Front Hum Neurosci. 2021;15:660926. doi:10.3389/fnhum.2021.660926. PMID: 34248523; PMCID: PMC8267816. back to text
41. Klarer M, Arnold M, Günther L, Winter C, Langhans W, Meyer U. Gut vagal afferents differentially modulate innate anxiety and learned fear. J Neurosci. 2014;34(21):7067-7076. PMID: 24849343. back to text
42. Chen CH, Tsai TC, Wu YJ, Hsu KS. Gastric vagal afferent signaling to the basolateral amygdala mediates anxiety-like behaviors in experimental colitis mice. JCI Insight. 2023;8(12):e161874. doi:10.1172/jci.insight.161874. PMID: 37200091; PMCID: PMC10371239. back to text
43. Han W, Tellez LA, Perkins MH, et al. A Neural Circuit for Gut-Induced Reward. Cell. 2018;175(3):665-678. PMID: 30245012; PMCID: PMC6195474. back to text
44. Wang YM, Xu YY, Zhai Y, Wu QQ, Huang W, Liang Y, Sun YH, Xu LY. Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Protracted Alcohol Withdrawal Symptoms in Male Alcohol-Dependent Patients. Front Psychiatry. 2021;12:678594. doi:10.3389/fpsyt.2021.678594. PMID: 34526917; PMCID: PMC8437143. back to text
45. de Lartigue G. Role of the vagus nerve in the development and treatment of diet-induced obesity. J Physiol. 2016;594(20):5791-5815. PMID: 26959077; PMCID: PMC5063945. back to text: a b
46. de Lartigue G, Ronveaux CC, Raybould HE. Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity. Mol Metab. 2014;3(6):595-607. PMID: 25161883; PMCID: PMC4142400. back to text
47. Bonaz B, Sinniger V, Pellissier S. Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. J Physiol. 2016;594(20):5781-5790. PMID: 27059884; PMCID: PMC5063949. back to text
48. Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017 Dec 14;9(6):7204-7218. doi: 10.18632/oncotarget.23208. PMID: 29467962; PMCID: PMC5805548. back to text
49. Stepanova N. Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article. Front Pharmacol. 2021 May 28;12:692429. doi: 10.3389/fphar.2021.692429. PMID: 34122117; PMCID: PMC8193726. back to text
50. Brittan M, Wright NA. Stem cells in gastrointestinal structure and neoplastic development. Gut. 2004 Jun;53(6):899-910. doi: 10.1136/gut.2003.025478. PMID: 15138220; PMCID: PMC1774081. back to text
51. Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res. 2013 Oct;52(4):633-50. doi: 10.1016/j.plipres.2013.05.004. Epub 2013 Sep 25. PMID: 24076098. back to text
52. Luo H, Li M, Wang F, Yang Y, Wang Q, Zhao Y, Du F, Chen Y, Shen J, Zhao Q, Zeng J, Wang S, Chen M, Li X, Li W, Sun Y, Gu L, Wen Q, Xiao Z, Wu X. The role of intestinal stem cell within gut homeostasis: Focusing on its interplay with gut microbiota and the regulating pathways. Int J Biol Sci. 2022 Aug 8;18(13):5185-5206. doi: 10.7150/ijbs.72600. PMID: 35982910; PMCID: PMC9379405. back to text
53. Umar S. Intestinal stem cells. Curr Gastroenterol Rep. 2010 Oct;12(5):340-8. doi: 10.1007/s11894-010-0130-3. PMID: 20683682; PMCID: PMC2965634. back to text
54. Sánchez de Medina F, Romero-Calvo I, Mascaraque C, Martínez-Augustin O. Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis. 2014 Dec;20(12):2394-404. doi: 10.1097/MIB.0000000000000204. PMID: 25222662. back to text: a b
55. Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiome in health and diseases. Signal Transduct Target Ther. 2022 Apr 23;7(1):135. doi: 10.1038/s41392-022-00974-4. PMID: 35461318; PMCID: PMC9034083. back to text
56. Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, Holmes RP. Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F409-F413. doi: 10.1152/ajprenal.00373.2018. Epub 2018 Dec 19. PMID: 30566003; PMCID: PMC6459305. back to text: a b
57. Wollersen H, Erdmann F, Risse M, Dettmeyer R. Oxalate-crystals in different tissues following intoxication with ethylene glycol: three case reports. Leg Med (Tokyo). 2009 Apr;11 Suppl 1:S488-90. doi: 10.1016/j.legalmed.2009.01.098. Epub 2009 Feb 28. PMID: 19251453. back to text
58. Chutipongtanate S, Sutthimethakorn S, Chiangjong W, Thongboonkerd V. Bacteria can promote calcium oxalate crystal growth and aggregation. J Biol Inorg Chem. 2013 Mar;18(3):299-308. doi: 10.1007/s00775-012-0974-0. Epub 2013 Jan 20. Erratum in: J Biol Inorg Chem. 2013 Apr;18(4):485-6. PMID: 23334195. back to text
59. Klaerner HG, Uknis ME, Acton RD, Dahlberg PS, Carlone-Jambor C, Dunn DL. Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. J Surg Res. 1997 Jul 1;70(2):161-5. doi: 10.1006/jsre.1997.5110. PMID: 9245566. back to text
60. Baltazar P, de Melo Junior AF, Fonseca NM, Lança MB, Faria A, Sequeira CO, Teixeira-Santos L, Monteiro EC, Campos Pinheiro L, Calado J, Sousa C, Morello J, Pereira SA. Oxalate (dys) Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity. Genes (Basel). 2023 Aug 29;14(9):1719. doi: 10.3390/genes14091719. PMID: 37761859; PMCID: PMC10530622. back to text
61. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2. PMID: 36084384; PMCID: PMC9465273. back to text
62. Castellaro AM, Tonda A, Cejas HH, Ferreyra H, Caputto BL, Pucci OA, Gil GA. Oxalate induces breast cancer. BMC Cancer. 2015 Oct 22;15:761. doi: 10.1186/s12885-015-1747-2. PMID: 26493452; PMCID: PMC4618885. back to text
63. Piddubnyi A, Kolomiiets O, Danilchenko S, Stepanenko A, Moskalenko Y, Moskalenko R. The Prospects of Using Structural Phase Analysis of Microcalcifications in Breast Cancer Diagnostics. Diagnostics (Basel). 2023 Feb 15;13(4):737. doi: 10.3390/diagnostics13040737. PMID: 36832224; PMCID: PMC9955541. back to text
64. Liu Y, Sun Y, Guo Y, Shi X, Chen X, Feng W, Wu LL, Zhang J, Yu S, Wang Y, Shi Y. An Overview: The Diversified Role of Mitochondria in Cancer Metabolism. Int J Biol Sci. 2023 Jan 16;19(3):897-915. doi: 10.7150/ijbs.81609. PMID: 36778129; PMCID: PMC9910000. back to text: a b
65. Wang L, Lu B, He M, Wang Y, Wang Z, Du L. Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front Public Health. 2022 Feb 16;10:811044. doi: 10.3389/fpubh.2022.811044. PMID: 35252092; PMCID: PMC8888523. back to text
66. Collins EJ, Bowyer C, Tsouza A, Chopra M. Tomatoes: An Extensive Review of the Associated Health Impacts of Tomatoes and Factors That Can Affect Their Cultivation. Biology (Basel). 2022 Feb 4;11(2):239. doi: 10.3390/biology11020239. PMID: 35205105; PMCID: PMC8869745. back to text: a b
67. Choi H, Lee DG. Lycopene induces apoptosis in Candida albicans through reactive oxygen species production and mitochondrial dysfunction. Biochimie. 2015 Aug;115:108-15. doi: 10.1016/j.biochi.2015.05.009. Epub 2015 May 21. PMID: 26005097. back to text
68. Edinger MS, Koff WJ. Effect of the consumption of tomato paste on plasma prostate-specific antigen levels in patients with benign prostate hyperplasia. Braz J Med Biol Res. 2006 Aug;39(8):1115-9. doi: 10.1590/s0100-879x2006000800014. PMID: 16906286. back to text
69. Han J, Zhang L, Guo H, Wysham WZ, Roque DR, Willson AK, Sheng X, Zhou C, Bae-Jump VL. Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling. Gynecol Oncol. 2015 Sep;138(3):668-75. doi: 10.1016/j.ygyno.2015.06.036. Epub 2015 Jun 30. PMID: 26135947; PMCID: PMC4672629. back to text
70. Wang L, Li JJ, Guo LY, Li P, Zhao Z, Zhou H, Di LJ. Molecular link between glucose and glutamine consumption in cancer cells mediated by CtBP and SIRT4. Oncogenesis. 2018 Mar 13;7(3):26. doi: 10.1038/s41389-018-0036-8. PMID: 29540733; PMCID: PMC5852974. back to text
71. Su X, Jiang X, Meng L, Dong X, Shen Y, Xin Y. Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway. Oxid Med Cell Longev. 2018 Jun 6;2018:5438179. doi: 10.1155/2018/5438179. PMID: 29977456; PMCID: PMC6011061. back to text
72. Coutinho LL, Junior TCT, Rangel MC. Sulforaphane: An emergent anti-cancer stem cell agent. Front Oncol. 2023 Jan 23;13:1089115. doi: 10.3389/fonc.2023.1089115. PMID: 36776295; PMCID: PMC9909961. back to text
73. Jiang J, Johnson LC, Knight J, Callahan MF, Riedel TJ, Holmes RP, et al. Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. Am J Physiol Gastrointest Liver Physiol. 2012 Mar 15;302(6):G637-43. doi: 10.1152/ajpgi.00331.2011. PMID: 22207577; PMCID: PMC3311310. back to text: a b
74. Knight J, Jiang J, Assimos DG, Holmes RP. Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int. 2006 Dec;70(11):1929-34. doi: 10.1038/sj.ki.5001906. PMID: 17021603; PMCID: PMC2268952. back to text: a b
75. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001 Jan;59(1):270-6. doi: 10.1046/j.1523-1755.2001.00488.x. PMID: 11135080. back to text
76. Knight J, Assimos DG, Callahan MF, Holmes RP. Metabolism of primed, constant infusions of [1,2-13C2] glycine and [1-13C1] phenylalanine to urinary oxalate. Metabolism. 2011 Jul;60(7):950-956. doi: 10.1016/j.metabol.2010.09.002. PMID: 21036374. back to text: a b c
77. Witkowski M, Weeks TL, Hazen SL. Gut Microbiome and Cardiovascular Disease. Circ Res. 2020 Jul 31;127(4):553-570. doi: 10.1161/CIRCRESAHA.120.316242. Epub 2020 Jul 30. PMID: 32762536; PMCID: PMC7416843. back to text
78. Fulbright LE, Ellermann M, Arthur JC. The microbiome and the hallmarks of cancer. PLoS Pathog. 2017 Sep 21;13(9):e1006480. doi: 10.1371/journal.ppat.1006480. PMID: 28934351; PMCID: PMC5608396. back to text
79. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiome in the development of Type 1 diabetes. Nature. 2008 Oct 23;455(7216):1109-13. doi: 10.1038/nature07336. Epub 2008 Sep 21. PMID: 18806780; PMCID: PMC2574766. back to text
80. Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, Yang IA, Wark PA, Hugenholtz P, Hansbro PM. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020 Nov 18;11(1):5886. doi: 10.1038/s41467-020-19701-0. PMID: 33208745; PMCID: PMC7676259. back to text
81. Chen Z, Guo L, Zhang Y, Walzem RL, Pendergast JS, Printz RL, Morris LC, Matafonova E, Stien X, Kang L, Coulon D, McGuinness OP, Niswender KD, Davies SS. Incorporation of therapeutically modified bacteria into gut microbiome inhibits obesity. J Clin Invest. 2014 Aug;124(8):3391-406. doi: 10.1172/JCI72517. Epub 2014 Jun 24. PMID: 24960158; PMCID: PMC4109548. back to text
82. Tehrani AB, Nezami BG, Gewirtz A, Srinivasan S. Obesity and its associated disease: a role for microbiome? Neurogastroenterol Motil. 2012 Apr;24(4):305-11. doi: 10.1111/j.1365-2982.2012.01895.x. Epub 2012 Feb 20. PMID: 22339979; PMCID: PMC3303978. back to text
83. Liu BN, Liu XT, Liang ZH, Wang JH. Gut microbiota in obesity. World J Gastroenterol. 2021 Jul 7;27(25):3837-3850. doi: 10.3748/wjg.v27.i25.3837. PMID: 34321848; PMCID: PMC8291023. back to text
84. Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, Carlsson CM, Asthana S, Zetterberg H, Blennow K, Bendlin BB, Rey FE. Gut microbiome alterations in Alzheimer's disease. Sci Rep. 2017 Oct 19;7(1):13537. doi: 10.1038/s41598-017-13601-y. PMID: 29051531; PMCID: PMC5648830. back to text
85. Cammann D, Lu Y, Cummings MJ, Zhang ML, Cue JM, Do J, Ebersole J, Chen X, Oh EC, Cummings JL, Chen J. Genetic correlations between Alzheimer's disease and gut microbiome genera. Sci Rep. 2023 Mar 31;13(1):5258. doi: 10.1038/s41598-023-31730-5. PMID: 37002253; PMCID: PMC10066300. back to text
86. Scher JU, Littman DR, Abramson SB. Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases. Arthritis Rheumatol. 2016 Jan;68(1):35-45. doi: 10.1002/art.39259. PMID: 26331579; PMCID: PMC4789258. back to text
87. Wu IW, Lin CY, Chang LC, Lee CC, Chiu CY, Hsu HJ, Sun CY, Chen YC, Kuo YL, Yang CW, Gao SS, Hsieh WP, Chung WH, Lai HC, Su SC. Gut Microbiome as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. Int J Biol Sci. 2020 Jan 1;16(3):420-434. doi: 10.7150/ijbs.37421. PMID: 32015679; PMCID: PMC6990903. back to text
88. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. PMID: 27541692; PMCID: PMC4991899. back to text
89. Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health. 2014 May 5;11(5):4745-67. doi: 10.3390/ijerph110504745. PMID: 24859749; PMCID: PMC4053917. back to text
90. Zhai B, Ola M, Rolling T, Tosini NL, Joshowitz S, Littmann ER, Amoretti LA, Fontana E, Wright RJ, Miranda E, Veelken CA, Morjaria SM, Peled JU, van den Brink MRM, Babady NE, Butler G, Taur Y, Hohl TM. High-resolution mycobiota analysis reveals dynamic intestinal translocation preceding invasive candidiasis. Nat Med. 2020 Jan;26(1):59-64. doi: 10.1038/s41591-019-0709-7. Epub 2020 Jan 6. PMID: 31907459; PMCID: PMC7005909. back to text
91. Singh H, Meyer AN, Thomas EJ. The frequency of diagnostic errors in outpatient care: estimations from three large observational studies involving US adult populations. BMJ Qual Saf. 2014 Sep;23(9):727-31. doi: 10.1136/bmjqs-2013-002627. PMID: 24742777; PMCID: PMC4145460. back to text
92. Committee on Diagnostic Error in Health Care; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine; Balogh EP, Miller BT, Ball JR, editors. Improving Diagnosis in Health Care. Washington (DC): National Academies Press (US); 2015 Dec 29. doi: 10.17226/21794. PMID: 26803862. back to text
93. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995 Aug 19;311(7003):485. doi: 10.1136/bmj.311.7003.485. PMID: 7647644; PMCID: PMC2550545. back to text
94. Benedict K, Molinari NAM, Jackson BR. Public Awareness of Invasive Fungal Diseases - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020 Sep 25;69(38):1343-1346. doi: 10.15585/mmwr.mm6938a2. PMID: 32970658; PMCID: PMC7727495. back to text
95. Clancy CJ, Nguyen MH. Diagnosing Invasive Candidiasis. J Clin Microbiol. 2018 Apr 25;56(5):e01909-17. doi: 10.1128/JCM.01909-17. PMID: 29444828; PMCID: PMC5925725. back to text
96. Massier L, Chakaroun R, Kovacs P, Heiker JT. Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability. Gut. 2021 Sep;70(9):1801-1802. doi: 10.1136/gutjnl-2020-323026. Epub 2020 Oct 9. PMID: 33037053; PMCID: PMC8355880. back to text
97. Zhang X, Li J, Zheng S, Luo Q, Zhou C, Wang C. Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis. Biosci Rep. 2017 Sep 7;37(5):BSR20170947. doi: 10.1042/BSR20170947. PMID: 28811358; PMCID: PMC6448479. back to text
98. Thomas DD, Corkey BE, Istfan NW, Apovian CM. Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. J Endocr Soc. 2019 Sep;3(9):1727-1747. doi: 10.1210/js.2019-00065. PMID: 31528832; PMCID: PMC6735759. back to text
99. Suzuki A, Hirokawa M, Otsuka I, Miyauchi A, Akamizu T. Calcium oxalate crystals as a cause of multiple punctate echogenic foci in benign thyroid lesions. J Med Ultrason (2001). 2024 Jul;51(3):517-523. doi: 10.1007/s10396-024-01448-6. PMID: 38664308; PMCID: PMC11272687. back to text
100. Wong KS, Lewis JS, Gottipati S, Chernock RD. Utility of birefringent crystal identification by polarized light microscopy in distinguishing thyroid from parathyroid tissue on intraoperative frozen sections. Am J Surg Pathol. 2014 Sep;38(9):1212-1219. doi: 10.1097/PAS.0000000000000204. PMID: 24618617. back to text
101. Junuzovi?-Žuni? L, Ibrahimagi? A, Altumbabi? S. Voice Characteristics in Patients with Thyroid Disorders. Eurasian J Med. 2019 Jun;51(2):101-105. doi: 10.5152/eurasianjmed.2018.18331. PMID: 31258346; PMCID: PMC6592446. back to text
102. Ríos-Prego M, Anibarro L, Sánchez-Sobrino P. Relationship between thyroid dysfunction and body weight: a not so evident paradigm. Int J Gen Med. 2019 Aug 23;12:299-304. doi: 10.2147/IJGM.S206983. PMID: 31692525; PMCID: PMC6711558. back to text
103. Brosnan ME, Brosnan JT. Histidine Metabolism and Function. J Nutr. 2020 Oct 1;150(Suppl 1):2570S-2575S. doi: 10.1093/jn/nxaa079. PMID: 33000155; PMCID: PMC7527268. back to text
104. Zeb F, Osaili T, Obaid RS, Naja F, Radwan H, Cheikh Ismail L, Hasan H, Hashim M, Alam I, Sehar B, Faris ME. Gut Microbiome and Time-Restricted Feeding/Eating: A Targeted Biomarker and Approach in Precision Nutrition. Nutrients. 2023 Jan 4;15(2):259. doi: 10.3390/nu15020259. PMID: 36678130; PMCID: PMC9863108. back to text: a b c d e f g
105. Haasis E, Bettenburg A, Lorentz A. Effect of Intermittent Fasting on Immune Parameters and Intestinal Inflammation. Nutrients. 2024 Nov 19;16(22):3956. doi: 10.3390/nu16223956. PMID: 39599741; PMCID: PMC11597193. back to text: a b c d e f
106. Hu X, Xia K, Dai M, Han X, Yuan P, Liu J, Liu S, Jia F, Chen J, Jiang F, Yu J, Yang H, Wang J, Xu X, Jin X, Kristiansen K, Xiao L, Chen W, Han M, Duan S. Intermittent fasting modulates the intestinal microbiome and improves obesity and host energy metabolism. NPJ Biofilms Microbiomes. 2023 Apr 7;9(1):19. doi: 10.1038/s41522-023-00386-4. PMID: 37029135; PMCID: PMC10081985. back to text: a b c d
107. Paukkonen I, Törrönen EN, Lok J, Schwab U, El-Nezami H. The impact of intermittent fasting on gut microbiome: a systematic review of human studies. Front Nutr. 2024 Feb 12;11:1342787. doi: 10.3389/fnut.2024.1342787. PMID: 38410639; PMCID: PMC10894978. back to text: a b
108. Zhang X, Zou Q, Zhao B, Zhang J, Zhao W, Li Y, Liu R, Liu X, Liu Z. Effects of alternate-day fasting, time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders. Redox Biol. 2020 May;32:101535. doi: 10.1016/j.redox.2020.101535. Epub 2020 Apr 10. Erratum in: Redox Biol. 2021 Aug;44:101955. doi: 10.1016/j.redox.2021.101955. PMID: 32305005; PMCID: PMC7162980. back to text: a b c d e
109. Mohr AE, Jasbi P, Bowes DA, Dirks B, Whisner CM, Arciero KM, Poe M, Gu H, Gumpricht E, Sweazea KL, Arciero PJ. Exploratory analysis of one versus two-day intermittent fasting protocols on the gut microbiome and plasma metabolome in adults with overweight/obesity. Front Nutr. 2022 Oct 26;9:1036080. doi: 10.3389/fnut.2022.1036080. PMID: 36386914; PMCID: PMC9644216. back to text
110. Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001435. PMID: 34623232. back to text: a b c d e f g h
111. López-Yerena A, de Santisteban Villaplana V, Badimon L, Vilahur G, Padro T. Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease. Nutrients. 2024 Dec 27;17(1):52. doi: 10.3390/nu17010052. PMID: 39796486; PMCID: PMC11722674. back to text
112. Rerksuppaphol S, Rerksuppaphol L. A Randomized Double-blind Controlled Trial of Lactobacillus acidophilus Plus Bifidobacterium bifidum versus Placebo in Patients with Hypercholesterolemia. J Clin Diagn Res. 2015;9(3):KC01-KC04. PMID: 25954637. back to text
113. DiRienzo DB. Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets. Nutr Rev. 2014;72(1):18-29. PMID: 24330093. back to text
114. Abdi M, Esmaeili Gouvarchin Ghaleh H, Ranjbar R. Lactobacilli and Bifidobacterium as anti-atherosclerotic agents. Iran J Basic Med Sci. 2022 Aug;25(8):934-946. doi: 10.22038/IJBMS.2022.63860.14073. PMID: 36159325; PMCID: PMC9464336. back to text
115. Sun B, Ma T, Li Y, Yang N, Li B, Zhou X, et al. Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes. mSystems. 2022 Apr 26;7(2):e0010022. doi: 10.1128/msystems.00100-22. PMID: 35343796; PMCID: PMC9040731. back to text
116. Tang J, Wei Y, Pi C, Zheng W, Zuo Y, Shi P, et al. The therapeutic value of bifidobacteria in cardiovascular disease. NPJ Biofilms Microbiomes. 2023 Oct 30;9(1):82. doi: 10.1038/s41522-023-00448-7. PMID: 37903770; PMCID: PMC10616273. back to text
117. Zhao X, Zhong X, Liu X, Wang X, Gao X. Therapeutic and Improving Function of Lactobacilli in the Prevention and Treatment of Cardiovascular-Related Diseases: A Novel Perspective From Gut Microbiota. Front Nutr. 2021;8:693412. doi: 10.3389/fnut.2021.693412. PMID: 34164427; PMCID: PMC8215129. back to text
118. Derosa L, Routy B, Thomas AM, Iebba V, Zalcman G, Friard S, Mazieres J, Audigier-Valette C, Moro-Sibilot D, Goldwasser F, Silva CAC, Terrisse S, Bonvalet M, Scherpereel A, Pegliasco H, Richard C, Ghiringhelli F, Elkrief A, Desilets A, Blanc-Durand F, Cumbo F, Blanco A, Boidot R, Chevrier S, Daillère R, Kroemer G, Alla L, Pons N, Le Chatelier E, Galleron N, Roume H, Dubuisson A, Bouchard N, Messaoudene M, Drubay D, Deutsch E, Barlesi F, Planchard D, Segata N, Martinez S, Zitvogel L, Soria JC, Besse B. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer. Nat Med. 2022 Feb;28(2):315-324. doi: 10.1038/s41591-021-01655-5. Epub 2022 Feb 3. PMID: 35115705; PMCID: PMC9330544. back to text
119. Yu D, Fan Q, Yang J, Jin M, Shi L, Zhou B, Zhao L, Zhang J, Lin Z, Zhang T, Liu H. Gut Roseburia is a protective marker for peritoneal metastasis of gastric cancer. Cancer Med. 2024 Aug;13(15):e70037. doi: 10.1002/cam4.70037. PMID: 39109683; PMCID: PMC11304227. back to text: a b c d e
120. Luan B, Ge F, Lu X, Li Z, Zhang H, Wu J, et al. Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis. Clin Transl Oncol. 2024 Jun;26(6):1480-1496. doi: 10.1007/s12094-023-03373-5. PMID: 38217684. back to text
121. Martín R, Rios-Covian D, Huillet E, Auger S, Khazaal S, Bermúdez-Humarán LG, Sokol H, Chatel JM, Langella P. Faecalibacterium: a bacterial genus with promising human health applications. FEMS Microbiol Rev. 2023 Jul 5;47(4):fuad039. doi: 10.1093/femsre/fuad039. PMID: 37451743; PMCID: PMC10410495. back to text: a b c d
122. Koh GY, Kane A, Lee K, Xu Q, Wu X, Roper J, Mason JB, Crott JW. Parabacteroides distasonis attenuates toll-like receptor 4 signaling and Akt activation and blocks colon tumor formation in high-fat diet-fed azoxymethane-treated mice. Int J Cancer. 2018;143(7):1797-1805. doi: 10.1002/ijc.31559. PMID: 29696632. back to text: a b
123. Duan J, Li Q, Cheng Y, Zhu W, Liu H, Li F. Therapeutic potential of Parabacteroides distasonis in gastrointestinal and hepatic disease. MedComm (2020). 2024 Dec 16;5(12):e70017. doi: 10.1002/mco2.70017. PMID: 39687780; PMCID: PMC11647740. back to text: a b
124. Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23(1):107-113. PMID: 27892954. back to text: a b
125. Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. PMID: 31263284. back to text: a b
126. Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med. 2020 Jan 28;18(1):30. doi: 10.1186/s12967-020-02213-2. PMID: 32005260; PMCID: PMC6966830. back to text: a b
127. Maioli TU, Borras-Nogues E, Torres L, Barbosa SC, Martins VD, Langella P, Azevedo VA, Chatel JM. Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders. Front Pharmacol. 2021 Dec 2;12:740636. doi: 10.3389/fphar.2021.740636. PMID: 34925006; PMCID: PMC8677946. back to text: a b c d
128. Du T, Lei A, Zhang N, Zhu C. The Beneficial Role of Probiotic Lactobacillus in Respiratory Diseases. Front Immunol. 2022 May 31;13:908010. doi: 10.3389/fimmu.2022.908010. PMID: 35711436; PMCID: PMC9194447. back to text
129. Shen HT, Fang YT, Tsai WH, Chou CH, Huang MS, Yeh YT, et al. A Lactobacillus Combination Ameliorates Lung Inflammation in an Elastase/LPS-induced Mouse Model of Chronic Obstructive Pulmonary Disease. Probiotics Antimicrob Proteins. 2025 Oct;17(5):3416-3428. doi: 10.1007/s12602-024-10300-9. PMID: 38865030; PMCID: PMC12532766. back to text
130. Liu Y, Ye F, Ma L. The effect of budesonide combined with bifidobacteria and lactobacilli on lung function and gut microbiota of patients with chronic obstructive pulmonary disease. Pak J Med Sci. 2024 Mar-Apr;40(4):695-700. doi: 10.12669/pjms.40.4.8514. PMID: 38545026; PMCID: PMC10963960. back to text
131. Su Z, Ma C, Ru X, Zhang S, Wu C, Huang Y, et al. Effects of probiotic treatment on patients and animals with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized control trials. Front Cell Infect Microbiol. 2024;14:1411222. doi: 10.3389/fcimb.2024.1411222. PMID: 39324058; PMCID: PMC11422383. back to text
132. Mortaz E, Adcock IM, Ricciardolo FL, Varahram M, Jamaati H, Velayati AA, et al. Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages. PLoS One. 2015;10(8):e0136455. doi: 10.1371/journal.pone.0136455. PMID: 26317628; PMCID: PMC4552661. back to text
133. Krumina A, Bogdanova M, Gintere S, Viksna L. Gut-Lung Microbiome Interaction in COPD Patients: A Literature Review. Medicina (Kaunas). 2022 Nov 30;58(12):1760. doi: 10.3390/medicina58121760. PMID: 36556962; PMCID: PMC9785780. back to text
134. Borgeraas H, Johnson LK, Skattebu J, Hertel JK, Hjelmesaeth J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2018 Feb;19(2):219-232. doi: 10.1111/obr.12626. PMID: 29047207. back to text
135. Kim J, Yun JM, Kim MK, Kwon O, Cho B. Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. J Med Food. 2018 May;21(5):454-461. doi: 10.1089/jmf.2017.3937. Epub 2018 Apr 24. PMID: 29688793. back to text: a b
136. Shabbir U, Arshad MS, Sameen A, Oh DH. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies. Nutrients. 2021 Feb 21;13(2):690. doi: 10.3390/nu13020690. PMID: 33669988; PMCID: PMC7924846. back to text: a b c d e
137. He Y, Li B, Sun D, Chen S. Gut Microbiome: Implications in Alzheimer's Disease. J Clin Med. 2020 Jun 29;9(7):2042. doi: 10.3390/jcm9072042. PMID: 32610630; PMCID: PMC7409059. back to text: a b
138. Moon J, Lee AR, Kim H, Jhun J, Lee SY, Choi JW, Jeong Y, Park MS, Ji GE, Cho ML, Park SH. Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis. Arthritis Res Ther. 2023 Jul 26;25(1):130. doi: 10.1186/s13075-023-03118-3. PMID: 37496081; PMCID: PMC10373287. back to text: a b c
139. Liu Z, Wu Y, Luo Y, Wei S, Lu C, Zhou Y, Wang J, Miao T, Lin H, Zhao Y, Liu Q, Liu Y. Self-Balance of Intestinal Flora in Spouses of Patients With Rheumatoid Arthritis. Front Med (Lausanne). 2020 Sep 2;7:538. doi: 10.3389/fmed.2020.00538. PMID: 33681234; PMCID: PMC7931358. back to text
140. Picchianti-Diamanti A, Panebianco C, Salemi S, Sorgi ML, Di Rosa R, Tropea A, Sgrulletti M, Salerno G, Terracciano F, D'Amelio R, Laganà B, Pazienza V. Analysis of Gut Microbiome in Rheumatoid Arthritis Patients: Disease-Related Dysbiosis and Modifications Induced by Etanercept. Int J Mol Sci. 2018 Sep 27;19(10):2938. doi: 10.3390/ijms19102938. PMID: 30261687; PMCID: PMC6213034. back to text: a b
141. Wu J, Peng Y, Tian R, Yu H, Hu H, Huang Q, Xu Y, Liu L, Pan H. Investigating Correlation Between Gut Microbiome and Rheumatoid Arthritis Subtypes by Mendelian Randomization. Pathogens. 2025 Apr 15;14(4):385. doi: 10.3390/pathogens14040385. PMID: 40333164; PMCID: PMC12030498. back to text
142. Tsetseri MN, Silman AJ, Keene DJ, Dakin SG. The role of the microbiome in rheumatoid arthritis: a review. Rheumatol Adv Pract. 2023 Apr 3;7(2):rkad034. doi: 10.1093/rap/rkad034. PMID: 38606003; PMCID: PMC11007908. back to text: a b
143. Pei T, Hu R, Wang F, Yang S, Feng H, Li Q, Zhang J, Yan S, Ju L, He Z, Han Z, Yang A, Xiao W, Ma Y, Wang M. Akkermansia muciniphila ameliorates chronic kidney disease interstitial fibrosis via the gut-renal axis. Microb Pathog. 2023 Jan;174:105891. doi: 10.1016/j.micpath.2022.105891. Epub 2022 Nov 23. PMID: 36427659. back to text
144. Zhou W, Wu WH, Si ZL, Liu HL, Wang H, Jiang H, Liu YF, Alolga RN, Chen C, Liu SJ, Bian XY, Shan JJ, Li J, Tan NH, Zhang ZH. The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice. Nat Commun. 2022 Oct 14;13(1):6081. doi: 10.1038/s41467-022-33824-6. PMID: 36241632; PMCID: PMC9568537. back to text: a b
145. Bhargava S, Merckelbach E, Noels H, Vohra A, Jankowski J. Homeostasis in the Gut Microbiome in Chronic Kidney Disease. Toxins (Basel). 2022 Sep 20;14(10):648. doi: 10.3390/toxins14100648. PMID: 36287917; PMCID: PMC9610479. back to text: a b c
146. Chen HM, Kuo PH, Hsu CY, Chiu YH, Liu YW, Lu ML, Chen CH. Psychophysiological Effects of Lactobacillus plantarum PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial. Nutrients. 2021;13(11):3731. PMID: 34835987; PMCID: PMC8618644. back to text
147. Yarandi SS, Peterson DA, Treisman GJ, Moran TH, Pasricha PJ. Modulatory Effects of Gut Microbiome on the Central Nervous System: How Gut Could Play a Role in Neuropsychiatric Health and Diseases. J Neurogastroenterol Motil. 2016 Apr 30;22(2):201-12. doi: 10.5056/jnm15146. PMID: 27032544; PMCID: PMC4819858. back to text
148. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009 Mar 19;1(1):6. doi: 10.1186/1757-4749-1-6. PMID: 19338686; PMCID: PMC2664325. back to text
149. Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017;153(2):448-459.e8. doi: 10.1053/j.gastro.2017.05.003. PMID: 28483500. back to text
150. Steenbergen L, Sellaro R, van Hemert S, Bosch JA, Colzato LS. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun. 2015 Aug;48:258-64. doi: 10.1016/j.bbi.2015.04.003. Epub 2015 Apr 7. PMID: 25862297. back to text: a b
151. Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, Claes S, Van Oudenhove L, Zhernakova A, Vieira-Silva S, Raes J. The neuroactive potential of the human gut microbiome in quality of life and depression. Nat Microbiol. 2019 Apr;4(4):623-632. doi: 10.1038/s41564-018-0337-x. Epub 2019 Feb 4. PMID: 30718848. back to text: a b
152. Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME. Systematic Review of Gut Microbiome and Major Depression. Front Psychiatry. 2019 Feb 11;10:34. doi: 10.3389/fpsyt.2019.00034. PMID: 30804820; PMCID: PMC6378305. back to text: a b
153. Smith RP, Easson C, Lyle SM, Kapoor R, Donnelly CP, Davidson EJ, Parikh E, Lopez JV, Tartar JL. Gut microbiome diversity is associated with sleep physiology in humans. PLoS One. 2019 Oct 7;14(10):e0222394. doi: 10.1371/journal.pone.0222394. PMID: 31589627; PMCID: PMC6779243. back to text
154. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, Li L, Ruan B. Altered fecal microbiome composition in patients with major depressive disorder. Brain Behav Immun. 2015 Aug;48:186-94. doi: 10.1016/j.bbi.2015.03.016. Epub 2015 Apr 13. PMID: 25882912. back to text
155. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013 Dec 19;155(7):1451-1463. PMID: 24315484; PMCID: PMC3897394. back to text
156. Li H, Miao MX, Jia CL, Cao YB, Yan TH, Jiang YY, Yang F. Interactions between Candida albicans and the resident microbiome. Front Microbiol. 2022 Sep 20;13:930495. doi: 10.3389/fmicb.2022.930495. PMID: 36204612; PMCID: PMC9531752. back to text: a b c d e f g
157. Mason KL, Erb Downward JR, Mason KD, Falkowski NR, Eaton KA, Kao JY, et al. Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun. 2012 Oct;80(10):3371-3380. doi: 10.1128/IAI.00449-12. PMID: 22778094; PMCID: PMC3457555. back to text: a b c
158. Köhler GA, Assefa S, Reid G. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol. 2012;2012:636474. doi: 10.1155/2012/636474. Epub 2012 Jul 1. PMID: 22811591; PMCID: PMC3395238. back to text: a b c d
159. Matsubara VH, Wang Y, Bandara HMHN, Mayer MPA, Samaranayake LP. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl Microbiol Biotechnol. 2016 Jul;100(14):6415-6426. doi: 10.1007/s00253-016-7527-3. Epub 2016 Apr 18. PMID: 27087525. back to text: a b c
160. Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. Multi-Strain Probiotics: Synergy among Isolates Enhances Biological Activities. Biology (Basel). 2021 Apr 13;10(4):322. doi: 10.3390/biology10040322. PMID: 33924344; PMCID: PMC8070017. back to text: a b c d e f g h
161. Mao X, Ma J, Jiao C, Tang N, Zhao X, Wang D, Zhang Y, Ye Z, Xu C, Jiang J, Wu S, Cui X, Zhang H, Qiu X. Faecalibacterium prausnitzii Attenuates DSS-Induced Colitis by Inhibiting the Colonization and Pathogenicity of Candida albicans. Mol Nutr Food Res. 2021 Nov;65(21):e2100433. doi: 10.1002/mnfr.202100433. Epub 2021 Oct 7. PMID: 34558816. back to text: a b c
162. Tamanai-Shacoori Z, Smida I, Bousarghin L, Loreal O, Meuric V, Fong SB, Bonnaure-Mallet M, Jolivet-Gougeon A. Roseburia spp.: a marker of health? Future Microbiol. 2017 Feb;12:157-170. doi: 10.2217/fmb-2016-0130. PMID: 28139139. back to text: a b c
163. Koh AY, Köhler JR, Coggshall KT, Van Rooijen N, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog. 2008 Feb 8;4(2):e35. doi: 10.1371/journal.ppat.0040035. PMID: 18282097; PMCID: PMC2242836. back to text: a b c
164. Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, et al. Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med. 2015 Jul;21(7):808-814. doi: 10.1038/nm.3871. PMID: 26053625; PMCID: PMC4496259. back to text
165. Wang F, Wang Z, Tang J. The interactions of Candida albicans with gut bacteria: a new strategy to prevent and treat invasive intestinal candidiasis. Gut Pathog. 2023 Jun 27;15(1):30. doi: 10.1186/s13099-023-00559-8. PMID: 37370138; PMCID: PMC10294497. back to text
166. Xiang S, Ji JL, Li S, Cao XP, Xu W, Tan L, Tan CC. Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis. Front Aging Neurosci. 2022 Feb 3;14:730036. doi: 10.3389/fnagi.2022.730036. PMID: 35185522; PMCID: PMC8851038. back to text
167. Talapko J, Juzbaši? M, Matijevi? T, Pustijanac E, Beki? S, Kotris I, Škrlec I. Candida albicans-The Virulence Factors and Clinical Manifestations of Infection. J Fungi (Basel). 2021 Jan 22;7(2):79. doi: 10.3390/jof7020079. PMID: 33499276; PMCID: PMC7912069. back to text
168. Miles MR, Olsen L, Rogers A. Recurrent vaginal candidiasis. Importance of an intestinal reservoir. JAMA. 1977 Oct 24;238(17):1836-7. doi: 10.1001/jama.238.17.1836. PMID: 333134. back to text
169. Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, Bohórquez DV. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361(6408):eaat5236. PMID: 30237325. back to text
170. Caron J, Domenger D, Dhulster P, Ravallec R, Cudennec B. Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake. Front Endocrinol (Lausanne). 2017;8:85. doi:10.3389/fendo.2017.00085. PMID: 28484425; PMCID: PMC5401913. back to text
171. McDougle M, et al. Separate gut-brain circuits for fat and sugar reinforcement combine to promote overeating. Cell Metab. 2024. doi:10.1016/j.cmet.2023.12.014. PMID: 38242133; PMCID: PMC11898112. back to text
172. Chassaing B, Koren O, Goodrich JK, Poole AC, Srinivasan S, Ley RE, Gewirtz AT. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature. 2015 Mar 5;519(7541):92-96. PMID: 25731162. back to text: a b
173. Goswami C, Iwasaki Y, Yada T. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. J Nutr Biochem. 2018;57:130-135. PMID: 29702431. back to text
174. Hwang YK, Oh JS. Interaction of the Vagus Nerve and Serotonin in the Gut-Brain Axis. Int J Mol Sci. 2025;26(3):1160. doi:10.3390/ijms26031160. PMID: 39940928; PMCID: PMC11818468. back to text: a b
175. Okonkwo O, Zezoff D, Adeyinka A. Biochemistry, Cholecystokinin. [Updated 2023 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK534204/ back to text
176. Daly DM, Park SJ, Valinsky WC, Beyak MJ. Impaired intestinal afferent nerve satiety signalling and vagal afferent excitability in diet induced obesity in the mouse. J Physiol. 2011;589(11):2857-2870. PMID: 21486762; PMCID: PMC3112560. back to text
177. Lennerz BS, Mey JT, Henn OH, Ludwig DS. Behavioral Characteristics and Self-Reported Health Status among 2029 Adults Consuming a "Carnivore Diet". Curr Dev Nutr. 2021;5(12):nzab133. PMID: 34934897. back to text
178. Meléndez-Hevia E, De Paz-Lugo P, Cornish-Bowden A, Cárdenas ML. A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis. J Biosci. 2009 Dec;34(6):853-72. doi: 10.1007/s12038-009-0100-9. PMID: 20093739. back to text: a b
179. Yang Y, Fan X, Ji Y, Li J, Dai Z, Wu Z. Glycine represses endoplasmic reticulum stress-related apoptosis and improves intestinal barrier by activating mammalian target of rapamycin complex 1 signaling. Anim Nutr. 2022 Mar;8:1-9. PMID: 34977370; PMCID: PMC8669258. back to text: a b c
180. Howard A, Tahir I, Javed S, Waring SM, Ford D, Hirst BH. Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage. J Physiol. 2010 Mar 15;588(Pt 6):995-1009. doi: 10.1113/jphysiol.2009.186262. Epub 2010 Feb 1. PMID: 20123783; PMCID: PMC2849964. back to text: a b c
181. Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, Jahoor F. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011 Sep;94(3):847-853. PMID: 21795440; PMCID: PMC3155927. back to text: a b c
182. Li X, Bradford BU, Wheeler MD, Stimpson SA, Pink HM, Brodie TA, Schwab JH, Thurman RG. Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel. Infect Immun. 2001 Sep;69(9):5883-5891. doi: 10.1128/IAI.69.9.5883-5891.2001. PMID: 11500467; PMCID: PMC98707. back to text: a b c
183. Xu X, Wang X, Wu H, Zhu H, Liu C, Hou Y, Dai B, Liu X, Liu Y. Glycine relieves intestinal injury by maintaining mTOR signaling and suppressing AMPK, TLR4, and NOD signaling in weaned piglets after lipopolysaccharide challenge. Int J Mol Sci. 2018 Jul;19(7):1980. doi: 10.3390/ijms19071980. PMID: 29986455; PMCID: PMC6073676. back to text
184. Tsune I, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Takei Y, Sato N. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology. 2003 Sep;125(3):775-785. doi: 10.1016/s0016-5085(03)01067-9. PMID: 12949723. back to text
185. Ji Y, Fan X, Zhang Y, Li J, Dai Z, Wu Z. Glycine regulates mucosal immunity and the intestinal microbial composition in weaned piglets. Amino Acids. 2022 Mar;54(3):385-398. doi: 10.1007/s00726-021-02976-y. PMID: 33839961. back to text: a b
186. Hammes W, Schleifer KH, Kandler O. Mode of action of glycine on the biosynthesis of peptidoglycan. J Bacteriol. 1973;116:1029-1053. PMID: 4200845; PMCID: PMC285483. back to text: a b c
187. Kawai N, Sakai N, Okuro M, Karakawa S, Tsuneyoshi Y, Kawasaki N, Takeda T, Bannai M, Nishino S. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology. 2015 May;40(6):1405-1416. doi: 10.1038/npp.2014.326. PMID: 25533534; PMCID: PMC4397399. back to text
188. Mintz EM, Marvel CL, Gillespie CF, Price KM, Albers HE. Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. J Neurosci. 1999 Jun 15;19(12):5124-5130. doi: 10.1523/JNEUROSCI.19-12-05124.1999. PMID: 10366645. back to text
189. Mordel J, Karnas D, Inyushkin A, Challet E, Pévet P, Meissl H. Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus. J Physiol. 2011;589(Pt 9):2287-2300. doi: 10.1113/jphysiol.2010.204693. PMID: 21486797; PMCID: PMC3098704. back to text
190. Yasuo S, Iwamoto A, Lee SI, Ochiai S, Hitachi R, Shibata S, et al. L-Serine enhances light-induced circadian phase resetting in mice and humans. J Nutr. 2017 Dec;147(12):2347-2355. doi: 10.3945/jn.117.255380. PMID: 29070712. back to text
191. Fargue S, Knight J, Holmes RP, Rumsby G, Danpure CJ. Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay. Biochim Biophys Acta. 2016 Jun;1862(6):1055-1062. doi: 10.1016/j.bbadis.2016.02.004. PMID: 26854734; PMCID: PMC5110007. back to text: a b
192. Hoyer-Kuhn H, Kohbrok S, Volland R, Franklin J, Hero B, Beck BB, Hoppe B. Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice. Clin J Am Soc Nephrol. 2014 Mar;9(3):468-477. doi: 10.2215/CJN.06820613. PMID: 24385516; PMCID: PMC3944765. back to text: a b
193. Cleveland WL, DeLaPaz RL, Fawwaz RA, Challop RS. High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period. Neural Plast. 2009;2009:768398. doi: 10.1155/2009/768398. Epub 2010 Feb 18. PMID: 20182547; PMCID: PMC2825652. back to text: a b
194. Kim MH, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. Int J Mol Sci. 2017 May 12;18(5):1051. doi: 10.3390/ijms18051051. PMID: 28498331; PMCID: PMC5454963. back to text
195. Liu H, Birk JW, Provatas AA, Vaziri H, Fan N, Rosenberg DW, Gharaibeh RZ, Jobin C. Correlation between intestinal microbiota and urolithin metabolism in a human walnut dietary intervention. BMC Microbiol. 2024 Nov 15;24(1):476. doi: 10.1186/s12866-024-03626-5. PMID: 39548408; PMCID: PMC11566485. back to text: a b
196. Faitg J, D'Amico D, Rinsch C, Singh A. Mitophagy Activation by Urolithin A to Target Muscle Aging. Calcif Tissue Int. 2024 Jan;114(1):53-59. doi: 10.1007/s00223-023-01145-5. Epub 2023 Nov 5. PMID: 37925671; PMCID: PMC10791945. back to text: a b c d
197. Sun X, Gao C, Zhang P, Peng Y, Wang M, Liu J, Ma C, Li S, Xia Z. Urolithin A protects against calcium oxalate-induced crystal formation and kidney injury by regulating PCK1 to restore mitophagy function in kidney stone disease. Biochim Biophys Acta Mol Basis Dis. 2025 Nov 19;1872(3):168106. doi: 10.1016/j.bbadis.2025.168106. Epub ahead of print. PMID: 41265017. back to text
198. Reiter RJ, Tan DX, Manchester LC, Korkmaz A, Fuentes-Broto L, Hardman WE, Rosales-Corral SA, Qi W. A walnut-enriched diet reduces the growth of LNCaP human prostate cancer xenografts in nude mice. Cancer Invest. 2013 Jul;31(6):365-73. doi: 10.3109/07357907.2013.800095. Epub 2013 Jun 11. PMID: 23758186; PMCID: PMC3709881. back to text
199. Özkul C, Yal?nay M, Karakan T. Islamic fasting leads to an increased abundance of Akkermansia muciniphila and Bacteroides fragilis group: A preliminary study on intermittent fasting. Turk J Gastroenterol. 2019 Dec;30(12):1030-1035. doi: 10.5152/tjg.2019.19185. PMID: 31854308; PMCID: PMC6924600. back to text
200. Mruk-Mazurkiewicz H, Kulaszy?ska M, Czarnecka W, Podkówka A, Ekstedt N, Zawodny P, Wierzbicka-Wo? A, Marlicz W, Skupin B, Stachowska E, ?oniewski I, Skonieczna-?ydecka K. Insights into the Mechanisms of Action of Akkermansia muciniphila in the Treatment of Non-Communicable Diseases. Nutrients. 2024 May 29;16(11):1695. doi: 10.3390/nu16111695. PMID: 38892628; PMCID: PMC11174979. back to text
201. Pellegrino A, Coppola G, Santopaolo F, Gasbarrini A, Ponziani FR. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties. Nutrients. 2023 Apr 8;15(8):1815. doi: 10.3390/nu15081815. PMID: 37111034; PMCID: PMC10142179. back to text
202. Feng J, Hu X, Liu J, Wang W, Chen L, Pang R, Zhang A. Akkermansia muciniphila in neurological disorders: mechanisms and therapeutic potential via the gut-brain axis. Front Neurosci. 2025 Sep 11;19:1650807. doi: 10.3389/fnins.2025.1650807. PMID: 41017972; PMCID: PMC12460311. back to text: a b c d
203. Gao F, Cheng C, Li R, Chen Z, Tang K, Du G. The role of Akkermansia muciniphila in maintaining health: a bibliometric study. Front Med (Lausanne). 2025 Feb 3;12:1484656. doi: 10.3389/fmed.2025.1484656. PMID: 39967592; PMCID: PMC11833336. back to text: a b
204. Ye WY, Cai Y. Akkermansia muciniphila: a microbial guardian against oxidative stress-gut microbiota crosstalk and clinical prospects. J Transl Med. 2025 Oct 24;23(1):1169. doi: 10.1186/s12967-025-07149-z. PMID: 41137026; PMCID: PMC12551360. back to text
205. American Thyroid Association. ATA statement on the potential risks of excess iodine ingestion and exposure [Internet]. Falls Church (VA): ATA. Available from: https://www.thyroid.org/ata-statement-on-the-potential-risks-of-excess-iodine-ingestion-and-exposure back to text
206. Mubarak Z, Humaira A, Gani BA, Muchlisin ZA. Preliminary study on the inhibitory effect of seaweed Gracilaria verrucosa extract on biofilm formation of Candida albicans cultured from the saliva of a smoker. F1000Res. 2018 May 31;7:684. doi: 10.12688/f1000research.14879.3. PMID: 30210788; PMCID: PMC6107980. back to text: a b
207. Zhang CY, Wu WH, Wang J, Lan MB. Antioxidant properties of polysaccharide from the brown seaweed Sargassum graminifolium (Turn.), and its effects on calcium oxalate crystallization. Mar Drugs. 2012 Jan;10(1):119-130. doi: 10.3390/md10010119. Epub 2012 Jan 16. PMID: 22363225; PMCID: PMC3280541. back to text
208. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008 Jun;14(3):166-71. doi: 10.1016/j.anaerobe.2008.02.001. Epub 2008 Feb 29. PMID: 18396068; PMCID: PMC2494590. back to text: a b
209. Yang SC, Lin CH, Sung CT, Fang JY. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 2014 May 26;5:241. doi: 10.3389/fmicb.2014.00241. Erratum in: Front Microbiol. 2014 Dec 05;5:683. doi: 10.3389/fmicb.2014.00683. PMID: 24904554; PMCID: PMC4033612. back to text
210. Darbandi A, Asadi A, Mahdizade Ari M, Ohadi E, Talebi M, Halaj Zadeh M, Darb Emamie A, Ghanavati R, Kakanj M. Bacteriocins: Properties and potential use as antimicrobials. J Clin Lab Anal. 2022 Jan;36(1):e24093. doi: 10.1002/jcla.24093. Epub 2021 Dec 1. PMID: 34851542; PMCID: PMC8761470. back to text: a b
211. Wigner P, Bijak M, Saluk-Bijak J. Probiotics in the Prevention of the Calcium Oxalate Urolithiasis. Cells. 2022 Jan 14;11(2):284. doi: 10.3390/cells11020284. PMID: 35053400; PMCID: PMC8773937. back to text: a b
212. Turroni S, Vitali B, Bendazzoli C, Candela M, Gotti R, Federici F, Pirovano F, Brigidi P. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J Appl Microbiol. 2007 Nov;103(5):1600-1609. PMID: 17953571. back to text
213. Mukherjee SD, Batagello CA, Adler A, Agudelo J, Zampini A, Suryavanshi M, Nguyen A, Orr T, Dearing D, Monga M, Miller AW. Complex system modeling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteria. eLife. 2025 May 1;14:RP104121. doi: 10.7554/eLife.104121. PMCID: PMC12045624. back to text
214. Corrêa RO, Castro PR, Fachi JL, Nirello VD, El-Sahhar S, Imada S, Pereira GV, Pral LP, Araújo NVP, Fernandes MF, Matheus VA, de Souza Felipe J, Dos Santos Pereira Gomes AB, de Oliveira S, de Rezende Rodovalho V, de Oliveira SRM, de Assis HC, Oliveira SC, Dos Santos Martins F, Martens E, Colonna M, Varga-Weisz P, Vinolo MAR. Inulin diet uncovers complex diet-microbiota-immune cell interactions remodeling the gut epithelium. Microbiome. 2023 Apr 26;11(1):90. doi: 10.1186/s40168-023-01520-2. Erratum in: Microbiome. 2023 May 31;11(1):122. doi: 10.1186/s40168-023-01579-x. PMID: 37101209; PMCID: PMC10131329. back to text
215. Tian J, Peng J, Ge WH, Zhang J. Therapeutic effect of inulin on enteric hyperoxaluria in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Jun;36(3):313-6. doi: 10.3881/j.issn.1000-503X.2014.03.016. PMID: 24997827. back to text
216. Sheng W, Ji G, Zhang L. Immunomodulatory effects of inulin and its intestinal metabolites. Front Immunol. 2023 Aug 10;14:1224092. doi: 10.3389/fimmu.2023.1224092. PMID: 37638034; PMCID: PMC10449545. back to text: a b c d e f g h i
217. Karamad D, Khosravi-Darani K, Khaneghah AM, Miller AW. Probiotic Oxalate-Degrading Bacteria: New Insight of Environmental Variables and Expression of the oxc and frc Genes on Oxalate Degradation Activity. Foods. 2022 Sep 16;11(18):2876. doi: 10.3390/foods11182876. PMID: 36141002; PMCID: PMC9498451. back to text: a b
218. Riva A, Rasoulimehrabani H, Cruz-Rubio JM, Schnorr SL, von Baeckmann C, Inan D, Nikolov G, Herbold CW, Hausmann B, Pjevac P, Schintlmeister A, Spittler A, Palatinszky M, Kadunic A, Hieger N, Del Favero G, von Bergen M, Jehmlich N, Watzka M, Lee KS, Wiesenbauer J, Khadem S, Viernstein H, Stocker R, Wagner M, Kaiser C, Richter A, Kleitz F, Berry D. Identification of inulin-responsive bacteria in the gut microbiome via multi-modal activity-based sorting. Nat Commun. 2023 Dec 14;14(1):8210. doi: 10.1038/s41467-023-43448-z. PMID: 38097563; PMCID: PMC10721620. back to text
219. Liu RT, Rowan-Nash AD, Sheehan AE, Walsh RFL, Sanzari CM, Korry BJ, et al. Reductions in anti-inflammatory gut bacteria are associated with depression in a sample of young adults. Brain Behav Immun. 2020;88:308-324. doi: 10.1016/j.bbi.2020.03.026. PMID: 32229219. back to text
220. Paudel D, Nair DVT, Tian S, Hao F, Goand UK, Joseph G, Prodes E, Chai Z, Robert CEM, Chassaing B, Patterson AD, Singh V. Dietary fiber guar gum-induced shift in gut microbiome metabolism and intestinal immune activity enhances susceptibility to colonic inflammation. Gut Microbes. 2024 Jan-Dec;16(1):2341457. doi: 10.1080/19490976.2024.2341457. Epub 2024 Apr 17. PMID: 38630030; PMCID: PMC11028019. back to text
221. Ticinesi A, Parise A, Nouvenne A, Cerundolo N, Prati B, Meschi T. The possible role of gut microbiota dysbiosis in the pathophysiology of delirium in older persons. Microbiome Res Rep. 2023;2(3):19. doi: 10.20517/mrr.2023.15. PMID: 38046817; PMCID: PMC10688815. back to text
222. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Gomes BC, De Martinis EC, Reid G. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol. 2009 Feb;55(2):133-138. PMID: 19295645. back to text
223. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012 May 14;172(9):704-712. PMID: 22782199. back to text
224. Boahen A, Than LTL, Loke YL, Chew SY. The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections. Front Microbiol. 2022 May 26;13:787119. doi: 10.3389/fmicb.2022.787119. PMID: 35694318; PMCID: PMC9179178. back to text
225. Gill B, Wessels JM, Hayes CL, Ratcliffe J, Wokuri J, Ball E, Reid G, Kaul R, Rana J, Alkhaifi M, Tharao W, Smaill F, Kaushic C. Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial. PLoS One. 2025 Jan 21;20(1):e0315576. doi: 10.1371/journal.pone.0315576. PMID: 39836666; PMCID: PMC11750099. back to text
226. Merenstein D, Pot B, Leyer G, Ouwehand AC, Preidis GA, Elkins CA, Hill C, Lewis ZT, Shane AL, Zmora N, Petrova MI, Collado MC, Morelli L, Montoya GA, Szajewska H, Tancredi DJ, Sanders ME. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes. 2023 Jan-Dec;15(1):2185034. doi: 10.1080/19490976.2023.2185034. PMID: 36919522; PMCID: PMC10026873. back to text
227. Danhof HA, Lee J, Thapa A, Britton RA, Di Rienzi SC. Microbial stimulation of oxytocin release from the intestinal epithelium via secretin signaling. Gut Microbes. 2023 Dec;15(2):2256043. doi: 10.1080/19490976.2023.2256043. PMID: 37698879; PMCID: PMC10498800. back to text: a b
228. Gordon I, Zagoory-Sharon O, Leckman JF, Feldman R. Oxytocin and the development of parenting in humans. Biol Psychiatry. 2010 Aug 15;68(4):377-382. doi: 10.1016/j.biopsych.2010.02.005. PMID: 20359725; PMCID: PMC2908494. back to text
229. Poutahidis T, Kearney SM, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One. 2013 Oct 30;8(10):e78898. PMID: 24205344; PMCID: PMC3813596. back to text
230. Li P, Ji B, Luo H, Sundh D, Lorentzon M, Nielsen J. One-year supplementation with Lactobacillus reuteri ATCC PTA 6475 counteracts a degradation of gut microbiome in older women with low bone mineral density. NPJ Biofilms Microbiomes. 2022 Oct 19;8(1):84. doi: 10.1038/s41522-022-00348-2. PMID: 36261538; PMCID: PMC9581899. back to text
231. Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, Chatzigiagkos A, Hafler DA, Alm EJ, Erdman SE. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One. 2013 Jul 10;8(7):e68596. doi: 10.1371/journal.pone.0068596. PMID: 23874682; PMCID: PMC3707834. back to text
232. Poutahidis T, Springer A, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One. 2014 Jan 2;9(1):e84877. doi: 10.1371/journal.pone.0084877. PMID: 24392159; PMCID: PMC3879365. back to text: a b
233. Yu Z, Chen J, Liu Y, Meng Q, Liu H, Yao Q, Song W, Ren X, Chen X. The role of potential probiotic strains Lactobacillus reuteri in various intestinal diseases: New roles for an old player. Front Microbiol. 2023 Feb 2;14:1095555. doi: 10.3389/fmicb.2023.1095555. PMID: 36819028; PMCID: PMC9932687. back to text: a b c d
234. Peng Y, Ma Y, Luo Z, Jiang Y, Xu Z, Yu R. Lactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms. Front Cell Infect Microbiol. 2023 Aug 18;13:1254198. doi: 10.3389/fcimb.2023.1254198. PMID: 37662007; PMCID: PMC10471993. back to text: a b
235. Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007 Oct;20(4):593-621. doi: 10.1128/CMR.00008-07. PMID: 17934076; PMCID: PMC2176045. back to text
236. Saviano A, Brigida M, Migneco A, Gunawardena G, Zanza C, Candelli M, Franceschi F, Ojetti V. Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin? Medicina (Kaunas). 2021 Jun 23;57(7):643. doi: 10.3390/medicina57070643. PMID: 34201542; PMCID: PMC8306447. back to text
237. Ojetti V, Petruzziello C, Migneco A, Gnarra M, Gasbarrini A, Franceschi F. Effect of Lactobacillus reuteri (DSM 17938) on methane production in patients affected by functional constipation: a retrospective study. Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1702-1708. PMID: 28429333. back to text
238. Varian BJ, Poutahidis T, DiBenedictis BT, Levkovich T, Ibrahim Y, Didyk E, Shikhman L, Cheung HK, Hardas A, Ricciardi CE, Kolandaivelu K, Veenema AH, Alm EJ, Erdman SE. Microbial lysate upregulates host oxytocin. Brain Behav Immun. 2017 Mar;61:36-49. doi: 10.1016/j.bbi.2016.11.002. Epub 2016 Nov 5. PMID: 27825953; PMCID: PMC5431580. back to text
239. Wang C, Chen W, Jiang Y, Xiao X, Zou Q, Liang J, Zhao Y, Wang Q, Yuan T, Guo R, Liu X, Liu Z. A synbiotic formulation of Lactobacillus reuteri and inulin alleviates ASD-like behaviors in a mouse model: the mediating role of the gut-brain axis. Food Funct. 2024 Jan 2;15(1):387-400. doi: 10.1039/d3fo02663a. PMID: 38099485. back to text: a b c
240. Eftekhari K, Vahedi Z, Kamali Aghdam M, Noemi Diaz D. A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children. Iran J Pediatr. 2015 Dec;25(6):e2616. doi: 10.5812/ijp.2616. Epub 2015 Dec 23. PMID: 26635937; PMCID: PMC4662837. back to text
241. Sun J, Qiao Y, Qi C, Jiang W, Xiao H, Shi Y, Le GW. High-fat-diet-induced obesity is associated with decreased anti-inflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer's patches. Nutrition. 2016 Feb;32(2):265-72. doi: 10.1016/j.nut.2015.08.020. Epub 2015 Sep 25. PMID: 26620713. back to text
242. Bindels LB, Neyrinck AM, Claus SP, Le Roy CI, Grangette C, Pot B, Martinez I, Walter J, Cani PD, Delzenne NM. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J. 2016 Jun;10(6):1456-70. doi: 10.1038/ismej.2015.209. Epub 2015 Nov 27. PMID: 26613342; PMCID: PMC5029183. back to text
243. Mackos AR, Galley JD, Eubank TD, Easterling RS, Parry NM, Fox JG, Lyte M, Bailey MT. Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri. Mucosal Immunol. 2016 Mar;9(2):515-26. doi: 10.1038/mi.2015.81. Epub 2015 Sep 30. PMID: 26422754; PMCID: PMC4794400. back to text
244. Jørgensen MR, Kragelund C, Jensen PØ, Keller MK, Twetman S. Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro. J Oral Microbiol. 2017 Jan 18;9(1):1274582. doi: 10.1080/20002297.2016.1274582. PMID: 28326154; PMCID: PMC5328390. back to text
245. Chamberlain CA, Hatch M, Garrett TJ. Metabolomic profiling of oxalate-degrading probiotic Lactobacillus acidophilus and Lactobacillus gasseri. PLoS One. 2019 Sep 23;14(9):e0222393. doi: 10.1371/journal.pone.0222393. PMID: 31545840; PMCID: PMC6756784. back to text
246. Zangl I, Pap IJ, Aspöck C, Schüller C. The role of Lactobacillus species in the control of Candida via biotrophic interactions. Microb Cell. 2019 Nov 25;7(1):1-14. doi: 10.15698/mic2020.01.702. PMID: 31921929; PMCID: PMC6946018. back to text: a b c
247. Affhan S, Dachang W, Xin Y, Shang D. Lactic acid bacteria protect human intestinal epithelial cells from Staphylococcus aureus and Pseudomonas aeruginosa infections. Genet Mol Res. 2015 Dec 16;14(4):17044-58. doi: 10.4238/2015.December.16.5. PMID: 26681052. back to text
248. Deepak V, Ramachandran S, Balahmar RM, Pandian SR, Sivasubramaniam SD, Nellaiah H, Sundar K. In vitro evaluation of anticancer properties of exopolysaccharides from Lactobacillus acidophilus in colon cancer cell lines. In Vitro Cell Dev Biol Anim. 2016 Feb;52(2):163-73. doi: 10.1007/s11626-015-9970-3. Epub 2015 Dec 10. PMID: 26659393. back to text
249. Sahay B, Ge Y, Colliou N, Zadeh M, Weiner C, Mila A, Owen JL, Mohamadzadeh M. Advancing the use of Lactobacillus acidophilus surface layer protein A for the treatment of intestinal disorders in humans. Gut Microbes. 2015;6(6):392-7. doi: 10.1080/19490976.2015.1107697. Erratum in: Addendum to: Lightfoot YL, Selle K, Yang T, Goh YJ, Sahay B, Zadeh M, Owen JL, Colliou N, Li E, Johannssen T, Lepenies B, Klaenhammer TR, Mohamadzadeh M. SIGNR3-dependent immune regulation by Lactobacillus acidophilus-Surface layer protein A in Colitis. EMBO Journal 2015 Apr 1;34(7):881-95; PMID: 2566591; PMCID: PMC4388597. PMID: 26647142; PMCID: PMC4826124. back to text
250. Patterson E, Tan HTT, Groeger D, Andrews M, Buckley M, Murphy EF, Groeger JA. Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trial. Sci Rep. 2024 Feb 14;14(1):3725. doi: 10.1038/s41598-024-53810-w. PMID: 38355674; PMCID: PMC10866977. back to text: a b c
251. Yao S, Zhao Z, Wang W, Liu X. Bifidobacterium Longum: Protection against Inflammatory Bowel Disease. J Immunol Res. 2021 Jul 23;2021:8030297. doi: 10.1155/2021/8030297. PMID: 34337079; PMCID: PMC8324359. back to text
252. Allen AP, Hutch W, Borre YE, Kennedy PJ, Temko A, Boylan G, Murphy E, Cryan JF, Dinan TG, Clarke G. Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry. 2016 Nov 1;6(11):e939. doi: 10.1038/tp.2016.191. PMID: 27801892; PMCID: PMC5314114. back to text: a b
253. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, Deng Y, Blennerhassett PA, Fahnestock M, Moine D, Berger B, Huizinga JD, Kunze W, McLean PG, Bergonzelli GE, Collins SM, Verdu EF. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011 Dec;23(12):1132-1139. doi: 10.1111/j.1365-2982.2011.01796.x. PMID: 21988661; PMCID: PMC3413724. back to text
254. Sugahara H, Odamaki T, Fukuda S, Kato T, Xiao JZ, Abe F, Kikuchi J, Ohno H. Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. Sci Rep. 2015 Aug 28;5:13548. doi: 10.1038/srep13548. PMID: 26315217; PMCID: PMC4552000. back to text
255. Parvaneh K, Ebrahimi M, Sabran MR, Karimi G, Hwei AN, Abdul-Majeed S, Ahmad Z, Ibrahim Z, Jamaluddin R. Probiotics (Bifidobacterium longum) Increase Bone Mass Density and Upregulate Sparc and Bmp-2 Genes in Rats with Bone Loss Resulting from Ovariectomy. Biomed Res Int. 2015;2015:897639. doi: 10.1155/2015/897639. Epub 2015 Aug 20. PMID: 26366421; PMCID: PMC4558422. back to text
256. Kim JY, Park YJ, Lee HJ, Park MY, Kwon O. Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: a randomized, double-blind, placebo-controlled, dose-finding trial. Food Sci Biotechnol. 2017 Dec 12;27(3):853-857. doi: 10.1007/s10068-017-0296-7. PMID: 30263811; PMCID: PMC6049675. back to text
257. Lee HY, Lee J, Lim H, Kim HY, Koo YS, Lim JS, Yoon Y. Lactobacillus gasseri BNR17 Ameliorates Dexamethasone-Induced Muscle Loss in BALB/c Mice and C2C12 Myotubes. J Med Food. 2024 May;27(5):385-395. doi: 10.1089/jmf.2023.K.0278. Epub 2024 Apr 4. PMID: 38574296. back to text
258. Murru N, Blaiotta G, Peruzy MF, Santonicola S, Mercogliano R, Aponte M. Screening of Oxalate Degrading Lactic Acid Bacteria of Food Origin. Ital J Food Saf. 2017 Apr 13;6(2):6345. doi: 10.4081/ijfs.2017.6345. PMID: 28713789; PMCID: PMC5505080. back to text
259. Tyagi AM, Yu M, Darby TM, Vaccaro C, Li JY, Owens JA, Hsu E, Adams J, Weitzmann MN, Jones RM, Pacifici R. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity. 2018 Dec 18;49(6):1116-1131. PMID: 30446387; PMCID: PMC6345170. back to text
260. Tian F, Chi F, Wang G, Liu X, Zhang Q, Chen Y, Zhang H, Chen W. Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. J Microbiol. 2015 Dec;53(12):856-63. doi: 10.1007/s12275-015-5239-5. Epub 2015 Dec 2. PMID: 26626356. back to text
261. Tekbas M, Demir S, Beyazcicek E, Beyazcicek O, Gok A. Investigation of the Effects of Lacticaseibacillus rhamnosus GG Administration on Penicillin-Induced Epileptiform Activity in Rats. Neurochem Res. 2025 Nov;50(6):358. doi: 10.1007/s11064-025-04611-8. PMID: 41236682. back to text
262. Grompone G, Martorell P, Llopis S, González N, Genovés S, Mulet AP, Fernández-Calero T, Tiscornia I, Bollati-Fogolín M, Chambaud I, Foligné B, Montserrat A, Ramón D. Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans. PLoS One. 2012;7(12):e52493. doi: 10.1371/journal.pone.0052493. Epub 2012 Dec 26. PMID: 23300685; PMCID: PMC3530454. back to text
263. Paul E, Albert A, Ponnusamy S, Mishra SR, Vignesh AG, Sivakumar SM, Sivasamy G, Sadasivam SG. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats. Microbiol Res. 2018 Oct;215:65-75. doi: 10.1016/j.micres.2018.06.009. Epub 2018 Jun 22. PMID: 30172310. back to text
264. Liu YW, Liu WH, Wu CC, Juan YC, Wu YC, Tsai HP, Wang S, Tsai YC. Psychotropic effects of Lactobacillus plantarum PS128 in early life-stressed and naïve adult mice. Brain Res. 2016 Jan 15;1631:1-12. doi: 10.1016/j.brainres.2015.11.018. Epub 2015 Nov 24. PMID: 26620542. back to text
265. Xie J, Yu Q, Nie S, Fan S, Xiong T, Xie M. Effects of Lactobacillus plantarum NCU116 on Intestine Mucosal Immunity in Immunosuppressed Mice. J Agric Food Chem. 2015 Dec 30;63(51):10914-20. doi: 10.1021/acs.jafc.5b04757. Epub 2015 Dec 18. PMID: 26651209. back to text
266. Dyer KD, Drummond RA, Rice TA, Percopo CM, Brenner TA, Barisas DA, Karpe KA, Moore ML, Rosenberg HF. Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM). J Virol. 2015 Nov 4;90(2):979-91. doi: 10.1128/JVI.02279-15. PMID: 26537680; PMCID: PMC4702661. back to text
267. Yunes RA, Klimina KM, Emelyanov KV, Zakharevich NV, Poluektova EU, Danilenko VN. Draft Genome Sequences of Lactobacillus plantarum Strain 90sk and Lactobacillus brevis Strain 15f: Focusing on Neurotransmitter Genes. Genome Announc. 2015 Apr 16;3(2):e00261-15. doi: 10.1128/genomeA.00261-15. PMID: 25883284; PMCID: PMC4400427. back to text
268. Hepsomali P, Groeger JA, Nishihira J, Scholey A. Effects of Oral Gamma-Aminobutyric Acid (GABA) Administration on Stress and Sleep in Humans: A Systematic Review. Front Neurosci. 2020 Sep 17;14:923. doi: 10.3389/fnins.2020.00923. PMID: 33041752; PMCID: PMC7527439. back to text
269. Yakovlieva M, Tacheva T, Mihaylova S, Tropcheva R, Trifonova K, Tole?ova A, Danova S, Vlaykova T. Influence of Lactobacillus brevis 15 and Lactobacillus plantarum 13 on blood glucose and body weight in rats after high-fructose diet. Benef Microbes. 2015;6(4):505-12. doi: 10.3920/BM2014.0012. Epub 2015 Apr 22. PMID: 25691100. back to text
270. Tanaka Y, Takami K, Nishijima T, Aoki R, Mawatari T, Ikeda T. Short- and long-term dynamics in the intestinal microbiome following ingestion of Bifidobacterium animalis subsp. lactis GCL2505. Biosci Microbiome Food Health. 2015;34(4):77-85. doi: 10.12938/bmfh.2015-001. Epub 2015 Jul 31. PMID: 26594607; PMCID: PMC4639512. back to text
271. Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial. Br J Nutr. 2015 Nov 28;114(10):1638-46. doi: 10.1017/S0007114515003347. Epub 2015 Sep 18. PMID: 26382580; PMCID: PMC4657032. back to text
272. Brooke-Taylor S, Dwyer K, Woodford K, Kost N. Systematic Review of the Gastrointestinal Effects of A1 Compared with A2 β-Casein. Adv Nutr. 2017 Sep 15;8(5):739-748. doi: 10.3945/an.116.013953. PMID: 28916574; PMCID: PMC5593102. back to text
273. Jianqin S, Leiming X, Lu X, Yelland GW, Ni J, Clarke AJ. Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows’ milk. Nutr J. 2016 Apr 2;15:35. doi: 10.1186/s12937-016-0147-z. Erratum in: Nutr J. 2016;15(1):45. PMID: 27039383; PMCID: PMC4818854. back to text
274. Ho S, Woodford K, Kukuljan S, Pal S. Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study. Eur J Clin Nutr. 2014 Sep;68(9):994-1000. doi: 10.1038/ejcn.2014.127. PMID: 24986816. back to text
275. Ul Haq MR, Kapila R, Sharma R, Saliganti V, Kapila S. Comparative evaluation of cow β-casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut. Eur J Nutr. 2014 Jun;53(4):1039-49. doi: 10.1007/s00394-013-0606-7. PMID: 24166511. back to text
276. Barnett MP, McNabb WC, Roy NC, Woodford KB, Clarke AJ. Dietary A1 β-casein affects gastrointestinal transit time, dipeptidyl peptidase-4 activity, and inflammatory status relative to A2 β-casein in Wistar rats. Int J Food Sci Nutr. 2014 Sep;65(6):720-7. doi: 10.3109/09637486.2014.898260. PMID: 24649921. back to text
277. Duysburgh C, Verstrepen L, Van Meulebroek L, Marzorati M. Tributyrin (CoreBiome®) enhances butyrate levels and modulates the gut microbiota, barrier function, and immune response in vitro. Front Nutr. 2025;12:1712993. doi: 10.3389/fnut.2025.1712993. PMCID: PMC12746503. back to text: a b c d e f g
278. Compound Solutions. How to Formulate With CoreBiome® [Internet]. Carlsbad (CA): Compound Solutions. Available from: https://compoundsolutions.com/how-to-formulate-with-corebiome/ back to text
279. Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009 Sep;139(9):1619-1625. doi: 10.3945/jn.109.104638. PMID: 19625695; PMCID: PMC2728689. back to text: a b
280. Nguyen LN, Lopes LC, Cordero RJ, Nosanchuk JD. Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J Antimicrob Chemother. 2011 Nov;66(11):2573-2580. doi: 10.1093/jac/dkr358. PMID: 21911344; PMCID: PMC3191944. back to text: a b c d e f
281. Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, et al. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity. 2019 Feb 19;50(2):432-445.e7. doi: 10.1016/j.immuni.2018.12.018. PMID: 30683619; PMCID: PMC6382411. back to text: a b c
282. Cresci GA, Glueck B, McMullen MR, Xin W, Allende D, Nagy LE. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J Gastroenterol Hepatol. 2017 Sep;32(9):1587-1597. doi: 10.1111/jgh.13731. PMID: 28245073; PMCID: PMC5511097. back to text
283. Noverr MC, Huffnagle GB. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun. 2004 Nov;72(11):6206-6210. doi: 10.1128/IAI.72.11.6206-6210.2004. PMID: 15501745; PMCID: PMC523025. back to text: a b
284. U.S. Department of Agriculture, Agricultural Research Service. FoodData Central: Butter, salted (fatty acid 4:0, butyric acid) [Internet]. Beltsville (MD): USDA. Available from: https://fdc.nal.usda.gov/ back to text
285. van Deuren T, Blaak EE, Canfora EE. Butyrate to combat obesity and obesity-associated metabolic disorders: Current status and future implications for therapeutic use. Obes Rev. 2022 Oct;23(10):e13498. doi: 10.1111/obr.13498. PMID: 35856338; PMCID: PMC9541926. back to text
286. Force M, Sparks WS, Ronzio RA. Inhibition of enteric parasites by emulsified oil of oregano in vivo. Phytother Res. 2000 May;14(3):213-4. PMID: 10815019. back to text: a b
287. Manohar V, Ingram C, Gray J, Talpur NA, Echard BW, Bagchi D, Preuss HG. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem. 2001 Dec;228(1-2):111-7. doi: 10.1023/a:1013311632207. PMID: 11855736. back to text
288. Si W, Gong J, Tsao R, Zhou T, Yu H, Poppe C, Johnson R, Du Z. Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. J Appl Microbiol. 2006 Feb;100(2):296-305. doi: 10.1111/j.1365-2672.2005.02789.x. PMID: 16430506. back to text
289. Chedid V, Dhalla S, Clarke JO, Roland BC, Dunbar KB, Koh J, Justino E, Tomakin E, Mullin GE. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med. 2014 May;3(3):16-24. doi: 10.7453/gahmj.2014.019. PMID: 24891990; PMCID: PMC4030608. back to text
290. Hannan MA, Rahman MA, Sohag AAM, Uddin MJ, Dash R, Sikder MH, et al. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients. 2021 May 24;13(6):1784. doi: 10.3390/nu13061784. PMID: 34073784; PMCID: PMC8225153. back to text: a b
291. Almshawit H, Macreadie I. Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata. Microbiol Res. 2017 Jan;195:81-88. doi: 10.1016/j.micres.2016.11.008. PMID: 28024529. back to text
292. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Nystatin. [cited 2026 Oct 26]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548581/ back to text
293. Spaggiari L, Ardizzoni A, Ricchi F, Pedretti N, Squartini Ramos CA, Squartini Ramos GB, Kenno S, De Seta F, Pericolini E. Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro. PLoS One. 2024;19(5):e0303449. doi: 10.1371/journal.pone.0303449. back to text
294. Mihaylova MM, Cheng CW, Cao AQ, Tripathi S, Mana MD, Bauer-Rowe KE, Abu-Remaileh M, Clavain L, Erdemir A, Lewis CA, Freinkman E, Dickey AS, La Spada AR, Huang Y, Bell GW, Deshpande V, Carmeliet P, Katajisto P, Sabatini DM, Yilmaz ÖH. Fasting Activates Fatty Acid Oxidation to Enhance Intestinal Stem Cell Function during Homeostasis and Aging. Cell Stem Cell. 2018 May 3;22(5):769-778.e4. doi: 10.1016/j.stem.2018.04.001. PMID: 29727683; PMCID: PMC5940005. back to text: a b
295. Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014 Jun;14(6):810-823. doi: 10.1016/j.stem.2014.04.014. PMID: 24905167; PMCID: PMC4102383. back to text
296. McNicoll CF, Pastorino A, Farooq U, St Hill CR. Choledocholithiasis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441961/. back to text
297. Strazzabosco M, Fabris L. Functional anatomy of normal bile ducts. Anat Rec (Hoboken). 2008 Jun;291(6):653-60. doi: 10.1002/ar.20664. PMID: 18484611; PMCID: PMC3743051. back to text
298. Singh VK, Jaswal BS, Sharma J, Rai PK. Analysis of stones formed in the human gall bladder and kidney using advanced spectroscopic techniques. Biophys Rev. 2020 Jun;12(3):647-668. doi: 10.1007/s12551-020-00697-2. Epub 2020 May 14. PMID: 32410185; PMCID: PMC7311631. back to text
299. Hussain SM, Al-Jashamy KA. Determination of chemical composition of gallbladder stones and their association with induction of cholangiocarcinoma. Asian Pac J Cancer Prev. 2013;14(11):6257-6260. doi: 10.7314/apjcp.2013.14.11.6257. PMID: 24377514. back to text
300. Unalp-Arida A, Ruhl CE. Burden of gallstone disease in the United States population: Prepandemic rates and trends. World J Gastrointest Surg. 2024 Apr 27;16(4):1130-1148. doi: 10.4240/wjgs.v16.i4.1130. PMID: 38690054; PMCID: PMC11056655. back to text
301. McMillin M, DeMorrow S. Effects of bile acids on neurological function and disease. FASEB J. 2016 Nov;30(11):3658-3668. doi: 10.1096/fj.201600275R. Epub 2016 Jul 28. PMID: 27468758; PMCID: PMC5067249. back to text
302. Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica. Nat Rev Dis Primers. 2020 Oct 22;6(1):85. doi: 10.1038/s41572-020-0214-9. PMID: 33093467. back to text
303. Chen CM, Cheng ML, Liu TW, Chang CW, Ro LS, Lo YS, et al. Alteration of bile acid profile in patients with neuromyelitis optica spectrum disorders and multiple sclerosis. Mult Scler Relat Disord. 2025 Nov;103:106703. doi: 10.1016/j.msard.2025.106703. PMID: 40876370. back to text
304. Cheng X, Zhou L, Li Z, Shen S, Zhao Y, Liu C, et al. Gut Microbiome and Bile Acid Metabolism Induced the Activation of CXCR5+ CD4+ T Follicular Helper Cells to Participate in Neuromyelitis Optica Spectrum Disorder Recurrence. Front Immunol. 2022;13:827865. doi: 10.3389/fimmu.2022.827865. PMID: 35126400; PMCID: PMC8811147. back to text
305. Javadov S, Kozlov AV, Camara AKS. Mitochondria in Health and Diseases. Cells. 2020 May 9;9(5):1177. doi: 10.3390/cells9051177. PMID: 32397376; PMCID: PMC7290976. back to text: a b
306. Daniels TE, Olsen EM, Tyrka AR. Stress and Psychiatric Disorders: The Role of Mitochondria. Annu Rev Clin Psychol. 2020 May 7;16:165-186. doi: 10.1146/annurev-clinpsy-082719-104030. Epub 2020 Feb 24. PMID: 32092280; PMCID: PMC8007172. back to text
307. Jonscher KR, Chowanadisai W, Rucker RB. Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention. Biomolecules. 2021 Sep 30;11(10):1441. doi: 10.3390/biom11101441. PMID: 34680074; PMCID: PMC8533503. back to text
308. Liu D, Wang X, Kong L, Chen Z. Nicotinic acid regulates glucose and lipid metabolism through lipid independent pathways. Curr Pharm Biotechnol. 2015;16(1):3-10. doi: 10.2174/1389201015666141126123401. PMID: 25429652. back to text
309. Li Y, Yang G, Yang X, He Y, Wang W, Zhang J, Li T, Zhang W, Lin R. Nicotinic acid inhibits vascular inflammation via the SIRT1-dependent signaling pathway. J Nutr Biochem. 2015 Nov;26(11):1338-47. doi: 10.1016/j.jnutbio.2015.07.006. Epub 2015 Jul 26. PMID: 26300330. back to text: a b
310. Shade C. The Science Behind NMN-A Stable, Reliable NAD+Activator and Anti-Aging Molecule. Integr Med (Encinitas). 2020 Feb;19(1):12-14. PMID: 32549859; PMCID: PMC7238909. back to text: a b
311. Pirinen E, Auranen M, Khan NA, Brilhante V, Urho N, Pessia A, Hakkarainen A, Kuula J, Heinonen U, Schmidt MS, Haimilahti K, Piirilä P, Lundbom N, Taskinen MR, Brenner C, Velagapudi V, Pietiläinen KH, Suomalainen A. Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy. Cell Metab. 2020 Jun 2;31(6):1078-1090.e5. doi: 10.1016/j.cmet.2020.04.008. Epub 2020 May 7. Erratum in: Cell Metab. 2020 Jul 7;32(1):144. PMID: 32386566. back to text
312. Chini CCS, Peclat TR, Warner GM, Kashyap S, Espindola-Netto JM, de Oliveira GC, Gomez LS, Hogan KA, Tarragó MG, Puranik AS, Agorrody G, Thompson KL, Dang K, Clarke S, Childs BG, Kanamori KS, Witte MA, Vidal P, Kirkland AL, De Cecco M, Chellappa K, McReynolds MR, Jankowski C, Tchkonia T, Kirkland JL, Sedivy JM, van Deursen JM, Baker DJ, van Schooten W, Rabinowitz JD, Baur JA, Chini EN. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nat Metab. 2020 Nov;2(11):1284-1304. doi: 10.1038/s42255-020-00298-z. Epub 2020 Nov 16. PMID: 33199925; PMCID: PMC8752031. back to text
313. Singh A, D'Amico D, Andreux PA, Dunngalvin G, Kern T, Blanco-Bose W, Auwerx J, Aebischer P, Rinsch C. Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population. Eur J Clin Nutr. 2022 Feb;76(2):297-308. doi: 10.1038/s41430-021-00950-1. Epub 2021 Jun 11. PMID: 34117375; PMCID: PMC8821002. back to text
314. An D, Zeng Q, Zhang P, Ma Z, Zhang H, Liu Z, Li J, Ren H, Xu D. Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice. Redox Biol. 2021 Oct;46:102088. doi: 10.1016/j.redox.2021.102088. Epub 2021 Jul 30. PMID: 34364218; PMCID: PMC8353361. back to text
315. Matias MI, Yong CS, Foroushani A, Goldsmith C, Mongellaz C, Sezgin E, Levental KR, Talebi A, Perrault J, Rivière A, Dehairs J, Delos O, Bertand-Michel J, Portais JC, Wong M, Marie JC, Kelekar A, Kinet S, Zimmermann VS, Levental I, Yvan-Charvet L, Swinnen JV, Muljo SA, Hernandez-Vargas H, Tardito S, Taylor N, Dardalhon V. Regulatory T cell differentiation is controlled by αKG-induced alterations in mitochondrial metabolism and lipid homeostasis. Cell Rep. 2021 Nov 2;37(5):109911. doi: 10.1016/j.celrep.2021.109911. PMID: 34731632. back to text
316. Fogacci F, Rizzo M, Krogager C, Kennedy C, Georges CMG, Kneževi? T, et al. Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies. Antioxidants (Basel). 2020 Oct;9(10):1011. doi: 10.3390/antiox9101011. PMID: 33086555; PMCID: PMC7603186. back to text
317. Quinzii CM, Hirano M. Coenzyme Q and mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):183-8. doi: 10.1002/ddrr.108. PMID: 20818733; PMCID: PMC3097389. back to text
318. Virmani MA, Cirulli M. The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation. Int J Mol Sci. 2022 Feb 28;23(5):2717. doi: 10.3390/ijms23052717. PMID: 35269860; PMCID: PMC8910660. back to text
319. Marshall RP, Droste JN, Giessing J, Kreider RB. Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review. Nutrients. 2022 Jan 26;14(3):529. doi: 10.3390/nu14030529. PMID: 35276888; PMCID: PMC8838971. back to text
320. Eckert GP, Lipka U, Muller WE. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukot Essent Fatty Acids. 2013 Jan;88(1):105-14. doi: 10.1016/j.plefa.2012.05.006. Epub 2012 Jun 22. PMID: 22727983. back to text
321. Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chem Biol Interact. 2006 Oct 27;163(1-2):94-112. doi: 10.1016/j.cbi.2006.04.014. Epub 2006 May 1. PMID: 16765926. back to text
322. Salles J, Chanet A, Guillet C, Vaes AM, Brouwer-Brolsma EM, Rocher C, Giraudet C, Patrac V, Meugnier E, Montaurier C, Denis P, Le Bacquer O, Blot A, Jourdan M, Luiking Y, Furber M, Van Dijk M, Tardif N, Yves Boirie Y, Walrand S. Vitamin D status modulates mitochondrial oxidative capacities in skeletal muscle: role in sarcopenia. Commun Biol. 2022 Nov 24;5(1):1288. doi: 10.1038/s42003-022-04246-3. PMID: 36434267; PMCID: PMC9700804. back to text
323. KC S, Cárcamo JM, Golde DW. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J. 2005 Oct;19(12):1657-67. doi: 10.1096/fj.05-4107com. PMID: 16195374. back to text
324. Killilea DW, Killilea AN. Mineral requirements for mitochondrial function: A connection to redox balance and cellular differentiation. Free Radic Biol Med. 2022 Mar;182:182-191. doi: 10.1016/j.freeradbiomed.2022.02.022. Epub 2022 Feb 24. PMID: 35218912. back to text
325. Omar SH. Oleuropein in olive and its pharmacological effects. Sci Pharm. 2010 Apr-Jun;78(2):133-54. doi: 10.3797/scipharm.0912-18. Epub 2010 Apr 23. PMID: 21179340; PMCID: PMC3002804. back to text
326. Segura-Carretero A, Curiel JA. Current Disease-Targets for Oleocanthal as Promising Natural Therapeutic Agent. Int J Mol Sci. 2018 Sep 24;19(10):2899. doi: 10.3390/ijms19102899. PMID: 30250008; PMCID: PMC6213726. back to text
327. Peyrol J, Riva C, Amiot MJ. Hydroxytyrosol in the Prevention of the Metabolic Syndrome and Related Disorders. Nutrients. 2017 Mar 20;9(3):306. doi: 10.3390/nu9030306. PMID: 28335507; PMCID: PMC5372969. back to text
328. Nasrollahi Z, Abolhasannezhad M. Evaluation of the antifungal activity of olive leaf aqueous extracts against Candida albicans PTCC-5027. Curr Med Mycol. 2015 Dec;1(4):37-39. doi: 10.18869/acadpub.cmm.1.4.37. PMID: 28681003; PMCID: PMC5490280. back to text
329. Davison G, Marchbank T, March DS, Thatcher R, Playford RJ. Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers. Am J Clin Nutr. 2016 Aug;104(2):526-36. doi: 10.3945/ajcn.116.134403. Epub 2016 Jun 29. PMID: 27357095. back to text: a b
330. D?ugosz A, Wróblewska J, Ko?aczyk P, Wróblewska W. The Role of Lactoferrin in Combating Candida spp. Infections Through Regulation of Oxidative Stress, Immune Response, and Nutritional Support in Women and Newborns. Molecules. 2025 May 31;30(11):2416. doi: 10.3390/molecules30112416. PMID: 40509303; PMCID: PMC12156938. back to text
331. Stella MM, Soetedjo R, Tandarto K, Arieselia Z, Regina R. Bovine Lactoferrin and Current Antifungal Therapy Against Candida Albicans: A Systematic Review and Meta-Analysis. Indian J Dermatol. 2023 Nov-Dec;68(6):725. doi: 10.4103/ijd.ijd_275_22. Epub 2024 Jan 9. PMID: 38371540; PMCID: PMC10869000. back to text
332. Kamiya H, Ehara T, Matsumoto T. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa. J Infect Chemother. 2012 Feb;18(1):47-52. doi: 10.1007/s10156-011-0287-1. Epub 2011 Aug 25. PMID: 21866304. back to text
333. Ammons MC, Copié V. Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling. 2013;29(4):443-55. doi: 10.1080/08927014.2013.773317. PMID: 23574002; PMCID: PMC3648868. back to text: a b
334. Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother. 2009 Aug;53(8):3308-16. doi: 10.1128/AAC.01688-08. Epub 2009 May 18. PMID: 19451301; PMCID: PMC2715627. back to text
335. Cutone A, Rosa L, Ianiro G, Lepanto MS, Bonaccorsi di Patti MC, Valenti P, Musci G. Lactoferrin's Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules. 2020 Mar 15;10(3):456. doi: 10.3390/biom10030456. PMID: 32183434; PMCID: PMC7175311. back to text
336. Rascón-Cruz Q, Espinoza-Sánchez EA, Siqueiros-Cendón TS, Nakamura-Bencomo SI, Arévalo-Gallegos S, Iglesias-Figueroa BF. Lactoferrin: A Glycoprotein Involved in Immunomodulation, Anticancer, and Antimicrobial Processes. Molecules. 2021 Jan 3;26(1):205. doi: 10.3390/molecules26010205. PMID: 33401580; PMCID: PMC7795860. back to text
337. Boles?awska I, Boles?awska-Król N, Jakubowski K, Przys?awski J, Drzyma?a-Czy? S. Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer. Molecules. 2025 Mar 28;30(7):1507. doi: 10.3390/molecules30071507. PMID: 40286136; PMCID: PMC11990823. back to text
338. Gallo V, Antonini G. Controversial role of lactoferrin in cancer: A narrative review. Biomed Pharmacother. 2024 Dec;181:117743. doi: 10.1016/j.biopha.2024.117743. Epub 2024 Dec 10. PMID: 39662207. back to text
339. van der Strate BW, Beljaars L, Molema G, Harmsen MC, Meijer DK. Antiviral activities of lactoferrin. Antiviral Res. 2001 Dec;52(3):225-39. doi: 10.1016/s0166-3542(01)00195-4. PMID: 11675140. back to text
340. Eker F, Duman H, Ertürk M, Karav S. The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases. Front Immunol. 2024 Nov 15;15:1402135. doi: 10.3389/fimmu.2024.1402135. PMID: 39620218; PMCID: PMC11604709. back to text
341. Wakabayashi H, Oda H, Yamauchi K, Abe F. Lactoferrin for prevention of common viral infections. J Infect Chemother. 2014 Nov;20(11):666-71. doi: 10.1016/j.jiac.2014.08.003. Epub 2014 Aug 30. PMID: 25182867. back to text
342. Kim VY, Batty A, Li J, Kirk SG, Crowell SA, Jin Y, Tang J, Zhang J, Rogers LK, Deng HX, Nelin LD, Liu Y. Glutathione Reductase Promotes Fungal Clearance and Suppresses Inflammation during Systemic Candida albicans Infection in Mice. J Immunol. 2019 Oct 15;203(8):2239-2251. doi: 10.4049/jimmunol.1701686. Epub 2019 Sep 9. PMID: 31501257; PMCID: PMC6783371. back to text: a b
343. Ascione C, Sala A, Mazaheri-Tehrani E, Paulone S, Palmieri B, Blasi E, Cermelli C. Herpes simplex virus-1 entrapped in Candida albicans biofilm displays decreased sensitivity to antivirals and UVA1 laser treatment. Ann Clin Microbiol Antimicrob. 2017 Nov 14;16(1):72. doi: 10.1186/s12941-017-0246-5. PMID: 29137671; PMCID: PMC5686830. back to text
344. ClinicalTrials.gov. Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders. Identifier: NCT01720316. Results: adverse events. Available from: https://clinicaltrials.gov/study/NCT01720316. back to text
345. Xing X, Liao Z, Tan F, Zhu Z, Jiang Y, Cao Y. Effect of Nicotinamide Against Candida albicans. Front Microbiol. 2019 Mar 26;10:595. doi: 10.3389/fmicb.2019.00595. PMID: 30972047; PMCID: PMC6443637. back to text
346. Ka?mierczak-Siedlecka K, Ruszkowski J, Fic M, Folwarski M, Makarewicz W. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases. Curr Microbiol. 2020 Sep;77(9):1987-1996. doi: 10.1007/s00284-020-02053-9. Epub 2020 May 29. PMID: 32472262; PMCID: PMC7415030. back to text
347. Waitzberg D, Guarner F, Hojsak I, Ianiro G, Polk DB, Sokol H. Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis? Adv Ther. 2024 Mar;41(3):901-914. doi: 10.1007/s12325-024-02783-3. Epub 2024 Jan 30. PMID: 38286962; PMCID: PMC10879266. back to text
348. Terciolo C, Dapoigny M, Andre F. Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption. Clin Exp Gastroenterol. 2019 Feb 11;12:67-82. doi: 10.2147/CEG.S181590. PMID: 30804678; PMCID: PMC6375115. back to text
349. Moré MI, Swidsinski A. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review. Clin Exp Gastroenterol. 2015 Aug 14;8:237-55. doi: 10.2147/CEG.S85574. PMID: 26316791; PMCID: PMC4542552. back to text
350. Wu L, Lyu Y, Srinivasagan R, Wu J, Ojo B, Tang M, El-Rassi GD, Metzinger K, Smith BJ, Lucas EA, Clarke SL, Chowanadisai W, Shen X, He H, Conway T, von Lintig J, Lin D. Astaxanthin-Shifted Gut Microbiota Is Associated with Inflammation and Metabolic Homeostasis in Mice. J Nutr. 2020 Oct 12;150(10):2687-2698. doi: 10.1093/jn/nxaa222. PMID: 32810865; PMCID: PMC8023541. back to text
351. Sutanto CN, Loh WW, Kim JE. The impact of tryptophan supplementation on sleep quality: a systematic review, meta-analysis, and meta-regression. Nutr Rev. 2022 Jan 10;80(2):306-316. doi: 10.1093/nutrit/nuab027. PMID: 33942088. back to text
352. Kim S, Jo K, Hong KB, Han SH, Suh HJ. GABA and l-theanine mixture decreases sleep latency and improves NREM sleep. Pharm Biol. 2019 Dec;57(1):65-73. doi: 10.1080/13880209.2018.1557698. PMID: 30707852; PMCID: PMC6366437. back to text
353. Fatima G, Dzupina A, B Alhmadi H, Magomedova A, Siddiqui Z, Mehdi A, Hadi N. Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases. Cureus. 2024 Oct 13;16(10):e71392. doi: 10.7759/cureus.71392. PMID: 39539878; PMCID: PMC11557730. back to text
354. Schuster J, Cycelskij I, Lopresti A, Hahn A. Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nat Sci Sleep. 2025 Aug 30;17:2027-2040. doi: 10.2147/NSS.S524348. PMID: 40918053; PMCID: PMC12412596. back to text
355. Lin H, Chen D, Du Q, Pan T, Tu H, Xu Y, Teng T, Tu J, Li J, Lin Z, Wang X, Xu L, Chen YP. Dietary Copper Plays an Important Role in Maintaining Intestinal Barrier Integrity During Alcohol-Induced Liver Disease Through Regulation of the Intestinal HIF-1α Signaling Pathway and Oxidative Stress. Front Physiol. 2020 May 8;11:369. doi: 10.3389/fphys.2020.00369. PMID: 32457642; PMCID: PMC7227433. back to text
356. Takahashi A. Managing Zinc Supplementation in Hemodialysis Patients: Balancing and Preventing Deficiencies in Serum Copper and Zinc Levels with and Without HIF-PH Inhibitors. Nutrients. 2024 Nov 29;16(23):4135. doi: 10.3390/nu16234135. PMID: 39683529; PMCID: PMC11644515. back to text
357. Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR. "Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome? Photobiomodul Photomed Laser Surg. 2019 Nov;37(11):681-693. doi: 10.1089/photob.2019.4628. Epub 2019 Oct 9. PMID: 31596658; PMCID: PMC6859693. back to text
358. Mk Nair P, Silwal K, Keswani J, Tewani S, Kochar M, Sreedhar C, Inbaraj G, Pai V, Sathwik M, Ajit ND, Kumar BB, Herbert S, Vaz R, Paudel B, Sathyanath D, Devikar A, Bhartiya V. Therapeutic Sunbathing in Yoga and Naturopathy Hospitals: Establishing National Standards through the Delphi Methodology. J Lifestyle Med. 2025 Aug 31;15(2):48-56. doi: 10.15280/jlm.2025.15.2.48. PMID: 40909982; PMCID: PMC12405980. back to text
359. Wunsch A, Matuschka K. A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Photomed Laser Surg. 2014 Feb;32(2):93-100. doi: 10.1089/pho.2013.3616. Epub 2013 Nov 28. PMID: 24286286; PMCID: PMC3926176. back to text
360. Ried K, Travica N, Sali A. The Effect of Kyolic Aged Garlic Extract on Gut Microbiota, Inflammation, and Cardiovascular Markers in Hypertensives: The GarGIC Trial. Front Nutr. 2018 Dec 11;5:122. doi: 10.3389/fnut.2018.00122. PMID: 30619868; PMCID: PMC6297383. back to text
361. Liu L, Lin C, Li X, Cheng Y, Wang R, Luo C, Zhao X, Jiang Z. Protective Effect of Alkaline Mineral Water on Calcium Oxalate-Induced Kidney Injury in Mice. Evid Based Complement Alternat Med. 2023 Oct 25;2023:4559802. doi: 10.1155/2023/4559802. PMID: 37920186; PMCID: PMC10620026. back to text
362. Hasegawa T, Ito M, Hasegawa S, Teranishi M, Takeda K, Negishi S, Nishiwaki H, Takeda JI, LeBaron TW, Ohno K. Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response. Int J Mol Sci. 2022 Mar 7;23(5):2888. doi: 10.3390/ijms23052888. PMID: 35270030; PMCID: PMC8910898. back to text
363. Ogbolu DO, Oni AA, Daini OA, Oloko AP. In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, Nigeria. J Med Food. 2007 Jun;10(2):384-7. doi: 10.1089/jmf.2006.1209. PMID: 17651080. back to text
364. Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis. 2008 Nov-Dec;19(6):308-15. PMID: 19134433. back to text
365. Peedikayil FC, Sreenivasan P, Narayanan A. Effect of coconut oil in plaque related gingivitis - A preliminary report. Niger Med J. 2015 Mar-Apr;56(2):143-7. doi: 10.4103/0300-1652.153406. PMID: 25838632; PMCID: PMC4382606. back to text
366. Yadav M, Jain S, Tomar R, Prasad GB, Yadav H. Medicinal and biological potential of pumpkin: an updated review. Nutr Res Rev. 2010 Dec;23(2):184-90. doi: 10.1017/S0954422410000107. PMID: 21110905. back to text
367. Goel N, Rohilla H, Singh G, Punia P. Antifungal Activity of Cinnamon Oil and Olive Oil against Candida Spp. Isolated from Blood Stream Infections. J Clin Diagn Res. 2016 Aug;10(8):DC09-11. doi: 10.7860/JCDR/2016/19958.8339. Epub 2016 Aug 1. PMID: 27656437; PMCID: PMC5028442. back to text
368. Ahmad N, Alam MK, Shehbaz A, Khan A, Mannan A, Hakim SR, Bisht D, Owais M. Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis. J Drug Target. 2005 Dec;13(10):555-61. doi: 10.1080/10611860500422958. PMID: 16390816. back to text
369. Aghazadeh M, Zahedi Bialvaei A, Aghazadeh M, Kabiri F, Saliani N, Yousefi M, Eslami H, Samadi Kafil H. Survey of the Antibiofilm and Antimicrobial Effects of Zingiber officinale (in Vitro Study). Jundishapur J Microbiol. 2016 Feb 7;9(2):e30167. doi: 10.5812/jjm.30167. PMID: 27127591; PMCID: PMC4842230. back to text
370. Setty JV, Srinivasan I, Sathiesh RT, Kale M, Shetty VV, Venkatesh S. In vitro evaluation of antimicrobial effect of Myristica fragrans on common endodontic pathogens. J Indian Soc Pedod Prev Dent. 2020 Apr-Jun;38(2):145-151. doi: 10.4103/JISPPD.JISPPD_214_20. PMID: 32611860. back to text
371. DiNicolantonio JJ, O'Keefe JH, Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. 2018 Jan 13;5(1):e000668. doi: 10.1136/openhrt-2017-000668. Erratum in: Open Heart. 2018 Apr 5;5(1):e000668corr1. PMID: 29387426; PMCID: PMC5786912. back to text
372. Jenkins TA, Nguyen JC, Polglaze KE, Bertrand PP. Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. Nutrients. 2016 Jan 20;8(1):56. doi: 10.3390/nu8010056. PMID: 26805875; PMCID: PMC4728667. back to text
373. Yusufu I, Ding K, Smith K, Wankhade UD, Sahay B, Patterson GT, Pacholczyk R, Adusumilli S, Hamrick MW, Hill WD, Isales CM, Fulzele S. A Tryptophan-Deficient Diet Induces Gut Microbiome Dysbiosis and Increases Systemic Inflammation in Aged Mice. Int J Mol Sci. 2021 May 8;22(9):5005. doi: 10.3390/ijms22095005. PMID: 34066870; PMCID: PMC8125914. back to text: a b
374. Allerton TD, Proctor DN, Stephens JM, Dugas TR, Spielmann G, Irving BA. l-Citrulline Supplementation: Impact on Cardiometabolic Health. Nutrients. 2018 Jul 19;10(7):921. doi: 10.3390/nu10070921. PMID: 30029482; PMCID: PMC6073798. back to text: a b
375. Knight J, Madduma-Liyanage K, Mobley JA, Assimos DG, Holmes RP. Ascorbic acid intake and oxalate synthesis. Urolithiasis. 2016 Aug;44(4):289-297. PMID: 27002809; PMCID: PMC4946963. back to text
376. Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013 Mar 11;173(5):386-388. PMID: 23381591. back to text
377. Chen CT, Kitson AP, Hopperton KE, Domenichiello AF, Trépanier MO, Lin LE, Ermini L, Post M, Thies F, Bazinet RP. Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. Sci Rep. 2015 Oct 29;5:15791. doi: 10.1038/srep15791. PMID: 26511533; PMCID: PMC4625162. back to text
378. Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19. doi: 10.1186/s12868-016-0312-5. PMID: 28114887; PMCID: PMC5259863. back to text
379. Hou Y, Wu G. Nutritionally Essential Amino Acids. Adv Nutr. 2018 Nov 1;9(6):849-851. doi: 10.1093/advances/nmy054. PMID: 30239556; PMCID: PMC6247364. back to text
380. Lopez MJ, Mohiuddin SS. Biochemistry, Essential Amino Acids. [Updated 2023 Mar 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557845. back to text: a b
381. Gut P, Lizzo G, Migliavacca E, Karagounis L, Heise T, Eynatten M. Effects of glycine and n-acetylcysteine on glutathione levels and mitochondrial energy metabolism in healthy aging. Innov Aging. 2021 Dec 17;5(Suppl 1):685. doi: 10.1093/geroni/igab046.2574. PMCID: PMC8968300. back to text: a b
382. Lan Y, Zhu W, Duan X, Deng T, Li S, Liu Y, Yang Z, Wen Y, Luo L, Zhao S, Wang J, Zhao Z, Wu W, Zeng G. Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate. J Cell Physiol. 2021 Oct;236(10):6824-6835. doi: 10.1002/jcp.30370. Epub 2021 Mar 27. PMID: 33772775. back to text
383. Alves A, Bassot A, Bulteau AL, Pirola L, Morio B. Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. Nutrients. 2019 Jun 16;11(6):1356. doi: 10.3390/nu11061356. PMID: 31208147; PMCID: PMC6627940. back to text: a b c
384. Díaz-Flores M, Cruz M, Duran-Reyes G, Munguia-Miranda C, Loza-Rodríguez H, Pulido-Casas E, Torres-Ramírez N, Gaja-Rodriguez O, Kumate J, Baiza-Gutman LA, Hernández-Saavedra D. Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure. Can J Physiol Pharmacol. 2013 Oct;91(10):855-60. doi: 10.1139/cjpp-2012-0341. Epub 2013 Jun 17. PMID: 24144057. back to text
385. de Paz-Lugo P, Lupiáñez JA, Meléndez-Hevia E. High glycine concentration increases collagen synthesis by articular chondrocytes in vitro: acute glycine deficiency could be an important cause of osteoarthritis. Amino Acids. 2018 Oct;50(10):1357-1365. doi: 10.1007/s00726-018-2611-x. Epub 2018 Jul 13. PMID: 30006659; PMCID: PMC6153947. back to text: a b
386. Johnson AA, Cuellar TL. Glycine and aging: Evidence and mechanisms. Ageing Res Rev. 2023 Jun;87:101922. doi: 10.1016/j.arr.2023.101922. Epub 2023 Mar 31. PMID: 37004845. back to text: a b c
387. Cai CC, Zhu JH, Ye LX, Dai YY, Fang MC, Hu YY, Pan SL, Chen S, Li PJ, Fu XQ, Lin ZL. Glycine Protects against Hypoxic-Ischemic Brain Injury by Regulating Mitochondria-Mediated Autophagy via the AMPK Pathway. Oxid Med Cell Longev. 2019 Feb 6;2019:4248529. doi: 10.1155/2019/4248529. PMID: 30881590; PMCID: PMC6381570. back to text
388. Richard DM, Dawes MA, Mathias CW, Acheson A, Hill-Kapturczak N, Dougherty DM. L-Tryptophan: Basic Metabolic Functions, Behavioral Research and Therapeutic Indications. Int J Tryptophan Res. 2009 Mar 23;2:45-60. doi: 10.4137/ijtr.s2129. PMID: 20651948; PMCID: PMC2908021. back to text: a b c d e f g h i j k l
389. Hole?ek M. Side effects of amino acid supplements. Physiol Res. 2022 Mar 25;71(1):29-45. doi: 10.33549/physiolres.934790. Epub 2022 Jan 19. PMID: 35043647; PMCID: PMC8997670. back to text: a b c d e f g h i
390. Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW. Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA. 1990 Jul 11;264(2):213-217. PMID: 2355442. back to text
391. Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Unravelling the antimicrobial action of antidepressants on gut commensal microbes. Sci Rep. 2020 Oct 21;10(1):17878. doi: 10.1038/s41598-020-74934-9. PMID: 33087796; PMCID: PMC7578019. back to text: a b c
392. Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar;555(7698):623-628. doi: 10.1038/nature25979. PMID: 29555994; PMCID: PMC6108420. back to text
393. U.S. Food and Drug Administration. Paxil CR (paroxetine hydrochloride) extended-release tablets: prescribing information [Internet]. Silver Spring (MD): FDA; 2019 [cited 2026 Oct 12]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020936s047lbl.pdf back to text
394. Higgins A, Nash M, Lynch AM. Antidepressant-associated sexual dysfunction: impact, effects, and treatment. Drug Healthc Patient Saf. 2010;2:141-150. PMID: 21701626; PMCID: PMC3108697. back to text
395. Arterburn D, Sofer T, Boudreau DM, Bogart A, Westbrook EO, Theis MK, Simon G, Haneuse S. Long-Term Weight Change after Initiating Second-Generation Antidepressants. J Clin Med. 2016 Apr 13;5(4):48. doi: 10.3390/jcm5040048. PMID: 27089374; PMCID: PMC4850471. back to text
396. Kirsch I. Antidepressants and the Placebo Effect. Z Psychol. 2014;222(3):128-134. doi: 10.1027/2151-2604/a000176. PMID: 25279271; PMCID: PMC4172306. back to text
397. Bikle DD. Vitamin D: an ancient hormone. Exp Dermatol. 2011 Jan;20(1):7-13. doi: 10.1111/j.1600-0625.2010.01202.x. PMID: 21197695. back to text
398. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, Baggerly L, Hofflich H, Ramsdell JW, Zeng K, Heaney RP. Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Public Health. 2014 Aug;104(8):e43-50. doi: 10.2105/AJPH.2014.302034. Epub 2014 Jun 12. PMID: 24922127; PMCID: PMC4103214. back to text
399. Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B, Brenner H. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013 Apr;97(4):782-93. doi: 10.3945/ajcn.112.047712. Epub 2013 Feb 27. PMID: 23446902. back to text
400. Karadeniz Y, Özpamuk-Karadeniz F, Ahbab S, Atao?lu E, Can G. Vitamin D Deficiency Is a Potential Risk for Blood Pressure Elevation and the Development of Hypertension. Medicina (Kaunas). 2021 Nov 25;57(12):1297. doi: 10.3390/medicina57121297. PMID: 34946242; PMCID: PMC8703486. back to text
401. Xie F, Huang T, Lou D, Fu R, Ni C, Hong J, Ruan L. Effect of vitamin D supplementation on the incidence and prognosis of depression: An updated meta-analysis based on randomized controlled trials. Front Public Health. 2022 Aug 1;10:903547. doi: 10.3389/fpubh.2022.903547. PMID: 35979473; PMCID: PMC9376678. back to text
402. Gominak SC. Vitamin D deficiency changes the intestinal microbiome reducing B vitamin production in the gut. The resulting lack of pantothenic acid adversely affects the immune system, producing a "proinflammatory" state associated with atherosclerosis and autoimmunity. Med Hypotheses. 2016 Sep;94:103-7. doi: 10.1016/j.mehy.2016.07.007. Epub 2016 Jul 14. PMID: 27515213. back to text: a b c d
403. Borsche L, Glauner B, von Mendel J. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients. 2021 Oct 14;13(10):3596. doi: 10.3390/nu13103596. PMID: 34684596; PMCID: PMC8541492. back to text: a b
404. Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, Silva CBR, Franco AS, Macedo MB, Dalmolin HHH, Baggio J, Balbi GGM, Reis BZ, Antonangelo L, Caparbo VF, Gualano B, Pereira RMR. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Mar 16;325(11):1053-1060. PMID: 33595634; PMCID: PMC7890452. back to text: a b
405. Jolliffe DA, Holt H, Greenig M, et al. Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT). BMJ. 2022 Sep 7;378:e071230. PMID: 36215226; PMCID: PMC9449358. back to text: a b
406. Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. What is the Healthy Gut Microbiome Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019 Jan 10;7(1):14. doi: 10.3390/microorganisms7010014. PMID: 30634578; PMCID: PMC6351938. back to text
407. Office of Dietary Supplements, National Institutes of Health. Vitamin D: Fact Sheet for Health Professionals [Internet]. Bethesda (MD): NIH. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. back to text: a b c d
408. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024 Jul 12;109(8):1907-1947. doi: 10.1210/clinem/dgae290. PMID: 38828931. back to text
409. McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience. J Steroid Biochem Mol Biol. 2019 May;189:228-239. doi: 10.1016/j.jsbmb.2018.12.010. Epub 2019 Jan 4. PMID: 30611908. back to text: a b
410. Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018 Jun;84(6):1121-1127. PMID: 29498758; PMCID: PMC5980613. back to text
411. Ellis S, Tsiopanis G, Lad T. Risks of the 'Sunshine pill' - a case of hypervitaminosis D. Clin Med (Lond). 2018 Aug;18(4):311-313. doi: 10.7861/clinmedicine.18-4-311. PMID: 30072556; PMCID: PMC6334045. back to text
412. Jadhav N, Ajgaonkar S, Saha P, Gurav P, Pandey A, Basudkar V, Gada Y, Panda S, Jadhav S, Mehta D, Nair S. Molecular Pathways and Roles for Vitamin K2-7 as a Health-Beneficial Nutraceutical: Challenges and Opportunities. Front Pharmacol. 2022 Jun 14;13:896920. doi: 10.3389/fphar.2022.896920. PMID: 35774605; PMCID: PMC9237441. back to text: a b c d e f g h
413. Office of Dietary Supplements, National Institutes of Health. Vitamin K: Fact Sheet for Health Professionals [Internet]. Bethesda (MD): NIH. Available from: https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/. back to text
414. Uwitonze AM, Razzaque MS. Role of Magnesium in Vitamin D Activation and Function. J Am Osteopath Assoc. 2018 Mar 1;118(3):181-189. PMID: 29480918. back to text
415. Manzardo AM, Pendleton T, Poje A, Penick EC, Butler MG. Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity. Drug Alcohol Depend. 2015 Jul 1;152:257-63. doi: 10.1016/j.drugalcdep.2015.03.032. Epub 2015 Apr 8. PMID: 25908323; PMCID: PMC4550087. back to text
416. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington (DC): National Academies Press (US); 1998. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114310/ doi: 10.17226/6015. back to text: a b
417. Suwannasom N, Kao I, Pruß A, Georgieva R, Bäumler H. Riboflavin: The Health Benefits of a Forgotten Natural Vitamin. Int J Mol Sci. 2020 Jan 31;21(3):950. doi: 10.3390/ijms21030950. PMID: 32023913; PMCID: PMC7037471. back to text
418. Gasperi V, Sibilano M, Savini I, Catani MV. Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications. Int J Mol Sci. 2019 Feb 23;20(4):974. doi: 10.3390/ijms20040974. PMID: 30813414; PMCID: PMC6412771. back to text
419. Habibe MN, Kellar JZ. Niacin Toxicity. 2022 Jul 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32644563. back to text
420. Sanvictores T, Chauhan S. Vitamin B5 (Pantothenic Acid). 2022 Oct 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 33085380. back to text: a b
421. Stach K, Stach W, Augoff K. Vitamin B6 in Health and Disease. Nutrients. 2021 Sep 17;13(9):3229. doi: 10.3390/nu13093229. PMID: 34579110; PMCID: PMC8467949. back to text: a b c
422. Hemminger A, Wills BK. Vitamin B6 Toxicity. 2022 Apr 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 32119387. back to text
423. Muhamad R, Akrivaki A, Papagiannopoulou G, Zavridis P, Zis P. The Role of Vitamin B6 in Peripheral Neuropathy: A Systematic Review. Nutrients. 2023 Jun 21;15(13):2823. doi: 10.3390/nu15132823. PMID: 37447150; PMCID: PMC10343656. back to text
424. Vrolijk MF, Opperhuizen A, Jansen EHJM, Hageman GJ, Bast A, Haenen GRMM. The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function. Toxicol In Vitro. 2017 Oct;44:206-212. PMID: 28716455. back to text
425. Agrawal S, Agrawal A, Said HM. Biotin deficiency enhances the inflammatory response of human dendritic cells. Am J Physiol Cell Physiol. 2016 Sep 1;311(3):C386-91. doi: 10.1152/ajpcell.00141.2016. Epub 2016 Jul 13. PMID: 27413170; PMCID: PMC5129763. back to text
426. Bistas KG, Tadi P. Biotin. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554493/ back to text
427. Office of Dietary Supplements, National Institutes of Health. Biotin: Fact Sheet for Health Professionals [Internet]. Bethesda (MD): NIH. Available from: https://ods.od.nih.gov/factsheets/Biotin-HealthProfessional/. back to text
428. Zsigrai S, Kalmár A, Valcz G, Szigeti KA, Barták BK, Nagy ZB, Igaz P, Tulassay Z, Molnár B. A B9-vitamin élettani és kórélettani jelent?sége. Összegzés a folsav táplálékkiegészít?ként történ? alkalmazásának 30. évfordulójára [Physiological and pathophysiological significance of vitamin B9. Summary on the occasion of the 30-year introduction of folic acid as a dietary supplement]. Orv Hetil. 2019 Jul;160(28):1087-1096. Hungarian. doi: 10.1556/650.2019.31441. PMID: 31280597. back to text: a b
429. Allen LH. Vitamin B-12. Adv Nutr. 2012 Jan;3(1):54-5. doi: 10.3945/an.111.001370. Epub 2012 Jan 5. PMID: 22332101; PMCID: PMC3262614. back to text: a b
430. Ankar A, Kumar A. Vitamin B12 Deficiency. [Updated 2022 Oct 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441923/ back to text
431. Hrubisko M, Danis R, Huorka M, Wawruch M. Histamine Intolerance-The More We Know the Less We Know. A Review. Nutrients. 2021 Jun 29;13(7):2228. doi: 10.3390/nu13072228. PMID: 34209583; PMCID: PMC8308327. back to text
432. Sasahara I, Fujimura N, Nozawa Y, Furuhata Y, Sato H. The effect of histidine on mental fatigue and cognitive performance in subjects with high fatigue and sleep disruption scores. Physiol Behav. 2015 Aug 1;147:238-44. doi: 10.1016/j.physbeh.2015.04.042. Epub 2015 Apr 25. PMID: 25921948. back to text
433. Cassidy LD, Narita M. Autophagy at the intersection of aging, senescence, and cancer. Mol Oncol. 2022 Sep;16(18):3259-3275. doi: 10.1002/1878-0261.13269. Epub 2022 Jul 9. PMID: 35689420; PMCID: PMC9490138. back to text: a b
434. Ahmed F, Tripathy K. Posterior Vitreous Detachment. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563273/. PMID: 33085420. back to text
435. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007 Jun;35(4):495-516. doi: 10.1080/01926230701320337. PMID: 17562483; PMCID: PMC2117903. back to text
436. Fan YJ, Zong WX. The cellular decision between apoptosis and autophagy. Chin J Cancer. 2013 Mar;32(3):121-9. doi: 10.5732/cjc.012.10106. Epub 2012 Oct 10. PMID: 23114086; PMCID: PMC3845594. back to text
437. Spreadbury I. Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiome, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes. 2012;5:175-89. doi: 10.2147/DMSO.S33473. Epub 2012 Jul 6. PMID: 22826636; PMCID: PMC3402009. back to text: a b
438. Topiwala A, Levey DF, Zhou H, Deak JD, Adhikari K, Ebmeier KP, Bell S, Burgess S, Nichols TE, Gaziano M, Stein M, Gelernter J. Alcohol use and risk of dementia in diverse populations: evidence from cohort, case-control and Mendelian randomisation approaches. BMJ Evid Based Med. 2025 Sep 23:bmjebm-2025-113913. doi: 10.1136/bmjebm-2025-113913. Epub ahead of print. PMID: 40987604. back to text
439. Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, de Timary P, Delzenne NM. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93. doi: 10.1073/pnas.1415174111. Epub 2014 Oct 6. PMID: 25288760; PMCID: PMC4210345. back to text: a b
440. Tasnim S, Tang C, Musini VM, Wright JM. Effect of alcohol on blood pressure. Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD012787. doi: 10.1002/14651858.CD012787.pub2. PMID: 32609894; PMCID: PMC8130994. back to text
441. Manzo-Avalos S, Saavedra-Molina A. Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health. 2010 Dec;7(12):4281-304. doi: 10.3390/ijerph7124281. Epub 2010 Dec 21. PMID: 21318009; PMCID: PMC3037055. back to text: a b
442. Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015 Oct 1;3:62. doi: 10.3389/fcell.2015.00062. PMID: 26484345; PMCID: PMC4589667. back to text
443. Ghosh S, DeCoffe D, Brown K, Rajendiran E, Estaki M, Dai C, et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One. 2013;8(2):e55468. doi: 10.1371/journal.pone.0055468. PMID: 23405155; PMCID: PMC3566198. back to text
444. Ghosh S, Molcan E, DeCoffe D, Dai C, Gibson DL. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice. Br J Nutr. 2013 Aug;110(3):515-523. doi: 10.1017/S0007114512005326. PMID: 23298440. back to text
445. von Woedtke T, Schlüter B, Pflegel P, Lindequist U, Jülich WD. Aspects of the antimicrobial efficacy of grapefruit seed extract and its relation to preservative substances contained. Pharmazie. 1999 Jun;54(6):452-6. PMID: 10399191. back to text
446. Ranabir S, Reetu K. Stress and hormones. Indian J Endocrinol Metab. 2011 Jan;15(1):18-22. doi: 10.4103/2230-8210.77573. PMID: 21584161; PMCID: PMC3079864. back to text
447. Lovallo WR, Whitsett TL, al'Absi M, Sung BH, Vincent AS, Wilson MF. Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels. Psychosom Med. 2005 Sep-Oct;67(5):734-9. doi: 10.1097/01.psy.0000181270.20036.06. PMID: 16204431; PMCID: PMC2257922. back to text
448. Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol. 2011 Aug;163(7):1507-19. doi: 10.1111/j.1476-5381.2011.01379.x. PMID: 21449980; PMCID: PMC3165959. back to text
449. De Filippis D, Esposito G, Cirillo C, Cipriano M, De Winter BY, Scuderi C, Sarnelli G, Cuomo R, Steardo L, De Man JG, Iuvone T. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 2011;6(12):e28159. doi: 10.1371/journal.pone.0028159. Epub 2011 Dec 6. PMID: 22163000; PMCID: PMC3232190. back to text
450. Blumstein GW, Parsa A, Park AK, McDowell BL, Arroyo-Mendoza M, Girguis M, Adler-Moore JP, Olson J, Buckley NE. Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection. PLoS One. 2014 Jul 24;9(7):e103288. doi: 10.1371/journal.pone.0103288. PMID: 25057822; PMCID: PMC4110019. back to text
451. Kumamoto CA. Inflammation and gastrointestinal Candida colonization. Curr Opin Microbiol. 2011 Aug;14(4):386-91. doi: 10.1016/j.mib.2011.07.015. Epub 2011 Jul 28. PMID: 21802979; PMCID: PMC3163673. back to text
452. Reiss CS. Cannabinoids and Viral Infections. Pharmaceuticals (Basel). 2010 Jun 1;3(6):1873-1886. doi: 10.3390/ph3061873. PMID: 20634917; PMCID: PMC2903762. back to text
453. Ichikawa Y, Yamamoto H, Hirano SI, Sato B, Takefuji Y, Satoh F. The overlooked benefits of hydrogen-producing bacteria. Med Gas Res. 2023 Jul-Sep;13(3):108-111. doi: 10.4103/2045-9912.344977. PMID: 36571374; PMCID: PMC9979208. back to text: a b
454. Dhillon G, Buddhavarapu V, Grewal H, Sharma P, Verma RK, Munjal R, Devadoss R, Kashyap R. Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review. Int J Mol Sci. 2024 Jan 12;25(2):973. doi: 10.3390/ijms25020973. PMID: 38256045; PMCID: PMC10816294. back to text: a b c d e f g h i j k l m n o p q r s t
455. Hara F, Tatebe J, Watanabe I, Yamazaki J, Ikeda T, Morita T. Molecular Hydrogen Alleviates Cellular Senescence in Endothelial Cells. Circ J. 2016 Aug 25;80(9):2037-46. doi: 10.1253/circj.CJ-16-0227. Epub 2016 Jul 29. PMID: 27477846. back to text
456. Xie F, Jiang X, Yi Y, Liu ZJ, Ma C, He J, Xun ZM, Wang M, Liu MY, Mawulikplimi Adzavon Y, Zhao PX, Ma XM. Different effects of hydrogen-rich water intake and hydrogen gas inhalation on gut microbiome and plasma metabolites of rats in health status. Sci Rep. 2022 May 4;12(1):7231. doi: 10.1038/s41598-022-11091-1. PMID: 35508571; PMCID: PMC9068821. back to text
457. Chen KD, Wang KL, Chen C, Zhu YJ, Tang WW, Wang YJ, Chen ZP, He LH, Chen YG, Zhang W. Hydrogen-rich water alleviates constipation by attenuating oxidative stress through the sirtuin1/nuclear factor-erythroid-2-related factor 2/heme oxygenase-1 signaling pathway. World J Gastroenterol. 2024 May 28;30(20):2709-2725. doi: 10.3748/wjg.v30.i20.2709. PMID: 38855154; PMCID: PMC11154682. back to text
458. Zhang J, Hao H, Chen M, Wang H, Feng Z, Chen H. Hydrogen-rich water alleviates the toxicities of different stresses to mycelial growth in Hypsizygus marmoreus. AMB Express. 2017 Dec;7(1):107. doi: 10.1186/s13568-017-0406-1. Epub 2017 May 30. PMID: 28565883; PMCID: PMC5449350. back to text
459. Dohi K, Kraemer BC, Erickson MA, McMillan PJ, Kovac A, Flachbartova Z, Hansen KM, Shah GN, Sheibani N, Salameh T, Banks WA. Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury. PLoS One. 2014 Sep 24;9(9):e108034. doi: 10.1371/journal.pone.0108034. PMID: 25251220; PMCID: PMC4176020. back to text
460. National Institute of Diabetes and Digestive and Kidney Diseases. Kidney Disease Statistics for the United States. Accessed November 2, 2026. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. back to text
461. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes, Heart Disease, & Stroke. Accessed November 2, 2026. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/heart-disease-stroke. back to text
462. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015 Apr;72(4):334-41. doi: 10.1001/jamapsychiatry.2014.2502. PMID: 25671328; PMCID: PMC4461039. back to text
463. Sporinova B, Manns B, Tonelli M, Hemmelgarn B, MacMaster F, Mitchell N, et al. Association of mental health disorders with health care utilization and costs among adults with chronic disease. JAMA Netw Open. 2019 Aug 2;2(8):e199910. doi: 10.1001/jamanetworkopen.2019.9910. PMID: 31441939; PMCID: PMC6714022. back to text
464. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010 Mar;67(3):220-9. doi: 10.1001/archgenpsychiatry.2010.2. PMID: 20194822. back to text
465. Wang YH, Li JQ, Shi JF, Que JY, Liu JJ, Lappin JM, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020 Jul;25(7):1487-1499. doi: 10.1038/s41380-019-0595-x. PMID: 31745237. back to text
466. Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014 Dec 24;14:371. PMCID: PMC4336481. back to text
467. Holt RIG, de Groot M, Golden SH. Diabetes and depression. Curr Diab Rep. 2014 Jun;14(6):491. PMID: 24743941; PMCID: PMC4476048. back to text
468. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis. Chest. 2013 Sep;144(3):766-777. doi: 10.1378/chest.12-1911. PMID: 23429910. back to text
469. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013 May;202(5):329-35. doi: 10.1192/bjp.bp.112.118307. PMID: 23637108; PMCID: PMC3640214. back to text
470. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013 Dec;52(12):2136-48. doi: 10.1093/rheumatology/ket169. PMID: 24003249; PMCID: PMC3828510. back to text
471. Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis. 2013 Sep;62(3):493-505. doi: 10.1053/j.ajkd.2013.02.369. PMID: 23623139. back to text
472. Neis EPJG, Dejong CHC, Rensen SS. The role of microbial amino acid metabolism in host metabolism. Nutrients. 2015 Apr 16;7(4):2930-46. doi: 10.3390/nu7042930. PMID: 25894657; PMCID: PMC4425181. back to text
473. Belzer C, Chia LW, Aalvink S, Chamlagain B, Piironen V, Knol J, et al. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B12 production by intestinal symbionts. mBio. 2017 Sep 19;8(5):e00770-17. doi: 10.1128/mBio.00770-17. PMID: 28928206; PMCID: PMC5605934. back to text
474. Diether NE, Willing BP. Microbial fermentation of dietary protein: an important factor in diet-microbe-host interaction. Microorganisms. 2019 Jan 13;7(1):19. doi: 10.3390/microorganisms7010019. PMID: 30642098; PMCID: PMC6352118. back to text
475. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. doi: 10.1038/nature12820. PMID: 24336217; PMCID: PMC3957428. back to text
476. Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016 Nov 17;167(5):1339-1353.e21. doi: 10.1016/j.cell.2016.10.043. PMID: 27863247; PMCID: PMC5131798. back to text
477. Wang X, Gibson GR, Costabile A, Sailer M, Theis S, Rastall RA. Prebiotic supplementation of in vitro fecal fermentations inhibits proteolysis by gut bacteria, and host diet shapes gut bacterial metabolism and response to intervention. Appl Environ Microbiol. 2019 Apr 18;85(9):e02749-18. doi: 10.1128/AEM.02749-18. PMID: 30824442; PMCID: PMC6495761. back to text
478. Holscher HD, Guetterman HM, Swanson KS, An R, Matthan NR, Lichtenstein AH, et al. Walnut consumption alters the gastrointestinal microbiota, microbially derived secondary bile acids, and health markers in healthy adults: a randomized controlled trial. J Nutr. 2018 Jun 1;148(6):861-867. doi: 10.1093/jn/nxy004. PMID: 29726951; PMCID: PMC5991202. back to text
479. Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature. 2010 Apr 8;464(7290):908-12. doi: 10.1038/nature08937. PMID: 20376150. back to text
